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Chapter 1: Introduction 
1. Pain and the Nervous system 
1.1. Nomenclature and classifications from nociception to pain  
1.1.1. Pain 
Pain – a “necessary evil” for our survival. Pain is a subjective experience resulting from the 
transduction, transmission, and the modulation of incoming sensory inputs. The integration of 
these information is dependent on the individual’s genetic background, past learning experience, 
psychological factors, and sociocultural influences. Amongst individuals, the same noxious 
stimulus can illicit varied behavioral and emotional responses. Pain is experienced only under 
conscious state. 
Since 1979, the International Association for the Study of Pain (IASP) has defined pain as – “An 
unpleasant sensory and emotional experience associated with actual or potential tissue damage, or 
described in terms of such damage”, based on the work of Merskey (1964) (Merskey and Bogduk, 
1994). Broadly, pain can be decomposed into three components (Garland, 2012): 
1. Sensory-discriminative: This component encompasses the encoding of the modality 
(mechanical, thermal), localization, intensity and duration of the noxious stimulus. 
2. Motivational-affective: This component is linked to the aversive nature of pain and rhe 
desire to disengage from such instigators. This unpleasantness produces powerful emotions 
(e.g. anger and fear) which in turn act via psychophysiological pathways (autonomic, 
endocrine and immune systems) to influence pain perception.  
3. Cognitive-evaluative: This component represents the cognitive appraisal, based on personal 
beliefs; i.e. an individual’s subjective evaluation of incoming somatosensory inputs, whether 
it is to be considered harmful or not. Classically, the more the pain is perceived, the lower 
pain intensity is scored. 
Interestingly, the section “described in terms of such damage” highlights the existence of pain in 
the absence of tissue damage or disease, despite thorough investigation, such as the one 
experienced by people suffering from fibromyalgia.  
Recently a new definition for pain was proposed by Williams and Craig – “Pain is a distressing 
experience associated with actual or potential tissue damage with sensory, emotional, cognitive, 
  8 
and social components”. A notable addition draws attention to the sociality aspect i.e. how social 
contexts influence exposure, communication and reaction to pain (Williams and Craig, 2016). 
[Review of chronic pain in clinical context by (Gatchel et al., 2007)].   
Following acute injury, perception of pain originating from the activation of somatic nociceptors 
in the periphery occurs in two phases: (1) Fast pain – the sharp, prickling sensation (2) Slow pain 
– an unpleasant, less localized pain that happens after a longer delay. On the other hand, visceral 
pain has neither fast nor slow components but is experienced as a rather poorly localized, deep and 
dull sensation (Julius and Basbaum, 2001) [Review on comparing somatic vs. visceral pain (Cervero, 
2009)].  
Noxious stimuli (i.e. chemical, mechanical or thermal) are transmitted from the periphery along 
primary afferent fibers called nociceptors, to second-order neurons located in dorsal horn (DH) of 
the spinal cord. The DH is an important player as incoming noxious signals undergo processing 
by a complex circuit of excitatory and inhibitory DH interneurons, and are modulated at this level 
by descending controls from higher brain centers. The output of the DH is transmitted to supra-
spinal structures by projection neurons, and, depending on the subcortical or cortical structure 
reached, this will lead to the sensory-discriminative or emotional, cognitive, and social components 
of the pain experience (Almeida et al., 2004; Garland, 2012). – Fig. 1.1  
The peripherally and centrally neurons involved in the encoding of noxious stimuli have long been 
studied (Millan, 1999; Basbaum et al., 2009; Todd, 2010), yet several pieces of the puzzle are still 
missing, or more precisely their exact function is unknown. During my doctoral work, I focused 
on one of these pieces, located in the spinal cord: the spinal cholinergic system, that has been 
shown to be implicated in the modulation of sensory information processing.  Yet the cellular and 
circuit basis for this modulation are still unknown, and my thesis aimed at unraveling them.In the 
following paragraphs, I will introduce the terms and players of noxious information processing, 
with a special focus on the DH of the spinal cord. Importantly, because of this focus on the spinal 
cord, we will be talking of nociception rather than of pain (see below). 
1.1.2. Nociception 
While processing in higher brain structures is required for pain perception, nociception (the 
processing of noxious stimuli) can occur independently (Scholz and Woolf, 2002). Sherrington 
(1906) described a ‘noxious’ stimuli as events that cause harm or potential harm to tissues. Such 
stimuli have the intensity and quality sufficient to activate sensory nerves with specialized endings 
(nociceptors) ultimately leading to pain sensation. Subsequently, he coined the term nociception as 
Figure 1.1: The physiological pain pathway. The ascending tract (red) brings noxious information
arising from the periphery via second order neurons, located in the dorsal horn of the spinal cord,
to the supra-spinal areas. Axon collaterals project to the medulla and thalamus. From the thalamus,
information is relayed to cortical areas where pain is processed. Descending pathways (blue) from
cortical areas in turn activate circuits in the periaqueductal gray and reticular formation responsible
in descending controls that in turn modulate the incoming signals. [Modified from Cohen and Mao,
2014]
PAIN
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the signaling and processing of noxious stimulus, arising from external and internal environments, 
by the peripheral and central nervous system. At the spinal and supra-spinal levels, this information 
is integrated to provide the sensory-discriminative component of pain. Besides inducing the 
aversive nature of pain, noxious stimulation can result in withdrawal reflexes and autonomic 
changes (i.e. increase in heart rate). Notably, these behavioral and physiological changes can occur 
under condition preventing the experience of pain, i.e. in anesthetized and spinal cord transected 
animals. 
1.1.3. Types of Pain 
Acute pain: A transient noxious stimulus produces a limited pain sensation via the activation of 
nociceptors in the skin and other tissues in the body. When tissue injury does not occur, the 
sensation ends when the body engages into an appropriate motor response to remove the stimulus. 
This everyday life phenomenon protects individuals from physical damage arising from the 
environment or overstraining of the body. When the stimulus produces a local injury, this leads to 
change in responses at the level of the nociceptors, spinal cord and supraspinal structures. This 
allows the body to commence reparative mechanisms and prevent any further injuries. Although 
medical care is not required, it can be provided to reduce pain and speed up the healing process by 
reducing the injury period. The pain can last ranging from a few days to weeks (Loeser and Melzack, 
1999).  
Chronic pain: While acute (physiological) pain has an important protective function, persistent pain 
can become a characteristic of pathological conditions such as cancer and chemotherapy 
(Everdingen et al., 2007); diabetes (Tesfaye and Selvarajah, 2012); and neuropathy for instance. 
Chronic pain can develop long after the injury has healed and can arise even in the absence of any 
obvious instigators (Kuner, 2010).  
Epidemiological research has shown that chronic pain (broadly described as extended and long-
term pain lasting at least 3 months) and chronic recurrent pain (returning episodes of pain 
alternating with pain-free period lasting over months or years) affects 10 to 20% of adults within 
the general population (Gatchel et al., 2007). One out of five adult Europeans suffers from mild to 
severe forms of chronic pain while healthcare and socioeconomic costs associated with chronic 
pain accounts for 3 to 10% gross domestic product of Europe (Breivik et al., 2006; Breivik et al., 
2013). The quality of life experienced by patients is reduced, for instance an estimated of 4,700 
million chronic pain days per year were lost in France alone. Its persistence and recurrence leads 
to depression, reduction in physical and cognitive function, sleep problems and mood alterations 
(Phillips, 2009). This illustrates how the prevalence and costs of chronic pain are a serious physical 
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and mental clinical issue to the individual and society. [Review on epidemiology and socioeconomic 
burdens of pain (Henschke et al., 2015)]. 
1.2. Primary Sensory Neurons of the Somatosensory system 
1.2.1. General overview 
The somatosensory system has three main functions: exteroreceptive and interoreceptive, for our 
perception and reaction to stimuli originating outside and inside the body, respectively; and 
proprioceptive function, for the perception and control of body position and balance.  
The diverse sensations, arising from innocuous to noxious stimuli, are first detected and encoded 
by primary sensory neurons (PSN) or first order neurons. The cell bodies of PSN are found in 
ganglia located at the base of the skull (Trigerminal ganglia or TGs) and along the spinal cord 
(Dorsal Root Ganglia or DRGs). These neurons are ‘pseudo-unipolar’ shaped – they have no 
dendrites but rather a single axon that bifurcates to form one branch extending to the periphery 
while another project to the Central Nervous System (CNS). The peripheral nerve endings of TGs 
are distributed throughout the face and neck and they project directly to the brainstem; while the 
peripheral endings originating from DRGs are spread around the rest of the body and transmit the 
sensory information to the spinal cord. Depending on the origins of the stimulus, the information 
travels through the General Somatic Afferent (GSA) or General Visceral Afferent (GVA) fibers. 
GSA fibers have nerve endings spread throughout the skin, joints, muscles and tendons while GVA 
fibers originate from internal organs. The characteristics of the primary afferent fibers are discussed 
below with a specific focus on those encoding stimuli originating from external environments. 
1.2.2. Anatomical and physiological properties 
The primary afferent fibers can be distinguished into 3 types: Aa/Ab, Ad and C. This classification 
is based on the conduction velocity, size of the cell body and axon diameter, and myelination 
thickness [Fig. 1.2]. The Aa/Ab- fibers are fast conducting (ranging between 30 to 100 m/s), 
originating from neurons with a large soma size (>50 µm)/axon diameter (>10 µm), and are highly 
myelinated. The Ad- fibers are slower conducting than Aa/Ab (ranging between 4 to 30 m/s), 
have intermediate size of cell bodies/axon diameter (2 – 6 µm) and are thinly myelinated. The C-
fibers are slow conducting (<2.5 m/s), have small cell bodies/ axon diameter (0.4 - 1.2 µm), and 
are unmyelinated (Willis and Coggeshall, 1978). In general, the percentage of incoming cutaneous 
Figure 1.2: The mammalian cutaneous primary afferent fibers. The table summarizes information
for each fiber providing (left to right): Approximate diameter (measured in cats, ms: myelin sheath);
specific fiber type; the modality it encodes; percentage of concerned fiber with respect to total
number of cutaneous fibers; von Frey thresholds for respective fiber (mN: milli-Newtons) and
thermosensitivity shows when fiber is capable of transducing noxious heat (red)/cold (blue).
[Modified from St. John Smith and Lewin, 2009]
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fibers are distributed as: 70% of C-fibers, 10% of Ad-fibers and the remaining 20% of Ab-fibers 
(Millan, 1999).  
1.2.3. Molecular markers for identification 
Neurochemical markers and differential gene expressions during development have been used to 
further delineate primary afferents classification. The myelinated A-fibers contain exclusively a 
form of phosphorylated neurofilaments with molecular weight of 200 kDa (NF200) (Lawson and 
Waddell, 1991). Primary afferents can also be differentiated according to the modality they encode 
as will be developed below [Section 1.2.4]. It is interesting to note that there is a certain overlap 
between molecular and modality classifications. Ab-, Ad (fiber)- low threshold mechanoreceptors 
(LTMR) express eRET (early) [receptor for glial cell line-derived neurotrophic factor (GDNF)], 
TrkB (NTRK2) [receptor the brain derived growth factor (BDNF) and neurotrophin (NTF5)] and 
TrkC (NTRK3) [receptor for neurotrophin 4 (NTF4)]. A subtype of Ab LTMR are uniquely 
marked with NPY2R (Li et al., 2011). In contrast, the high threshold Ad neurons demonstrate early 
TrkA (NTRK1) [receptor for the nerve growth factor (NGF)] expression; with TrkA being found 
in all newly formed embryonic nociceptors (Woolf and Ma, 2007; Olson et al., 2016). Moreover, 
when intact somatic peripheral nerves are injected with Cholera toxin B subunit (CTb), which binds 
to the GM1 ganglioside, it is taken up and transported mainly by myelinated primary afferents 
(Hughes et al., 2003).  
The unmyelinated C-fibers can be divided into two broad categories: The peptidergic class of C-
fibers expresses neuropeptides such as substance P or calcitonin gene related peptide (CGRP) along 
with TrkA (NTRK1) receptor. The non-peptidergic class of C-fibers contains exclusively TRPC3, 
ATP gated P2X3 receptor, mass-related G protein coupled receptors (Mrgpr) D and binds to the 
histological marker isolectin (IB4). Interestingly, MrgprA3 is found to colocalize with both CGRP 
and IB4; demonstrating the fluidity of the classifications. C-LTMR have been identified with 
vesicular glutamate transporter type 3 (vGlut3) and tyrosine hydroxylase (TH) whereas MrgprB4 
has been used to define tactile C-fibers (Woolf and Ma, 2007; Lallemend and Ernfors, 2012; Le 
Pichon and Chesler, 2014). 
All primary fibers are glutamatergic, but may release other transmitters and/or co-factors such as 
ATP or substance P.  
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1.2.4. Sensory modalities  
All three types of afferent Aa/b-, Ad- and C-fibers can transmit non-noxious information. 
Although Ad- and C-fibers are usually considered as the nociceptive fibers, a proportion Ab also 
transmit noxious stimulus (Djouhri and Lawson, 2004).  
Innocuous information: 
Aa fibers are responsible for the transmission of proprioceptive signals. The muscle spindles are 
innervated by Ia and some II afferents while those projecting from Golgi tendon organs encompass 
group Ib and II afferents (Dietz, 2002).  
The Ab-LTMR can be subdivided based on their response to sustained mechanical stimulus. 
‘Rapidly adapting’ (RA) mechanoreceptors fire during the onset, sometimes at the offset and only 
occasionally or not at all during the applied stimulus. Conversely, the ‘Slowly adapting’ (SA) 
mechanoreceptors demonstrate a sustained firing both at the onset and during stimulus. The RA 
Ab-LTMRs consist of three types: (1) Meissner’s corpuscles (Type I) have small receptive field 
while responding to low frequency (30 - 40 Hz) vibrations; they are possibly responsible for velocity 
detectors of skin deformations. (2) Pacinian corpuscles (Type II) have large and less well defined 
receptive fields. They respond to high frequency vibrations (250 – 300 Hz). (3) Lanceolate endings 
surround Guard and Awl hair follicles of hairy skin; they potentially function as detectors of hair 
movement velocity (Willis and Coggeshall, 1978; Olson et al., 2016).  
The SA Ab-LTMR are as follow: (1) associated with Merkel cell, they form complexes (Type I) 
with small receptive fields on both glabrous and hairy skin. Each complex is known as ‘touch spot’ 
and ‘touch dome’ in glabrous and hairy skin respectively. Touch domes appear to innervate only 
guard hair follicles (Li et al., 2011). They are tuned for high resolution discrimination of shape and 
texture (Maricich et al., 2012). (2) Ruffini endings (Type II) have large receptive fields and respond 
to stretching of the skin (Willis and Coggeshall, 1978).  
The Ad-LTMR, also known as D hair cells, and C-LTMR form palisades of lanceolate endings 
around zigzag and awl/auchenne hair follicles in hairy skin. They are highly responsive to 
mechanical touch and respond to rapid cooling (Seal et al., 2009; Li et al., 2011).  
Tactile TH+ C-fibers have free nerve endings in hairy skin (Liu et al., 2007). It has been shown 
these neurons mediate pleasant stroking and light touch (Vrontou et al., 2013). 
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Noxious information: 
A-fibers have been classified by their response to mechanical and thermal stimuli, into: 
(i) High threshold mechanoreceptors (A-HTMR) responding to only mechanical stimuli. 
They have free nerve endings in both glabrous and hairy skin. In rat, 50% of A-HTMR 
are reported to have Ab-fiber conduction velocities. The Ad-HTMR are thought to 
contribute to first/fast mechanical pain along with contributions by Ab-HTMR 
(Djouhri, 2016) 
(ii) Mechano-heat (A-MH) units responding to noxious mechanical and short applications 
of noxious heat. The A-HM units are sub-classified in type I and II. Type I responds 
to high heat (>53 ºC) but lower mechanical thresholds (3.7 to 5 bar) whereas type II 
reacts to lower heat threshold (median 46 ºC) but relatively higher mechanical 
thresholds. Type I are found on both glabrous and hairy skin whereas type II are only 
on hairy skin. Interestingly, a third of type I are Ab-fibers while type II are purely Ad-
fibers. Type I are thought to provide the sharpness sensation to punctate stimuli. Type 
II appear to mediate mechanically evoked cutaneous pain and the first response of 
thermal pain (Djouhri and Lawson, 2004; Dubin and Patapoutian, 2010).  
The unmyelinated C-fibers terminate as free nerve endings throughout the skin. Glabrous skin is 
innervated by both CGRP and IB4 expressing fibers whereas hairy skin contains only CGRP+ 
fibers (Lallemend and Ernfors, 2012). Most C-fibers are polymodal (i.e. respond to chemical, 
mechanical and thermal noxious stimuli) while the remaining are responsive to purely noxious 
temperatures or mechanical, some by mechanical with heat and mechanical in combination with 
cold. A certain fraction (10 – 25%) of C fibers are considered as silent (i.e. do not respond to 
mechanical and thermal stimuli under physiological conditions) however, they become sensitive to 
noxious mechanical and thermal stimuli after being sensitized by inflammatory mediators (Dubin 
and Patapoutian, 2010). Generally, C-fibers are responsible for the second phase of pain (Millan, 
1999). Peptidergic C-fibers expressing CGRP are sensitive to noxious heat but neither cold nor 
mechanical stimuli. Surprisingly, the genetic ablation of these fibers induced an increase in cold 
sensitivity thus suggesting that CGRP+ fibers may play a role in tonic inhibition on fibers 
transmitting cold (McCoy et al., 2013). Many non-peptidergic C fibers, binding to IB4, also express 
MrgprD (>75%). The removal of MrgprD sensory neurons produced a phenotype where noxious 
mechanical sensitivity is reduced. (Le Pichon and Chesler, 2014) 
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1.2.5. Spinal cord terminations  
Gross anatomy of the spinal cord 
The spinal cord is part of the central nervous system (CNS), extending caudally from the medulla, 
and protected by the vertebral columns. The grey matter contains neuronal cell bodies while the 
surrounding white matter contains myelinated fibers [Fig. 1.3]. Initially, the organization of the grey 
matter, described by Rexed in cats, was divided into ten laminae based on their cytoarchitectonic 
(Nissl) stainings. This classification was later modified and applied to other mammals including 
human. The first six laminae arranged one on top of another, from dorsal to ventral plane, form 
the DH of the spinal cord. The layers VII-IX form the ventral horn while lamina X surrounds the 
ependymal canal. For functional studies, the laminae are grouped as pairs: LI-II (superficial DH), 
LIII-IV (nucleus proprius) and laminae V-VI (Deep DH) however, some studies consider LIII-IV 
as deep DH (Cordero-Erausquin et al., 2016). 
Innocuous information:  
The Ab RA LTMR main axonal branch enters the spinal cord and bifurcates to send branches in 
both the rostral and caudal axis in the spinal cord dorsal columns. Most of their ascending 
projections reach the dorsal column nuclei (Abraira and Ginty, 2013; Niu et al., 2013). The 
collaterals from axons of each subtype projects differentially onto grey matter of the DH. 
Meissner’s corpuscle afferents arborize medially in Lamina III to V (Shortland and Woolf, 1993). 
The Pacinian corpuscle neurons innervates two areas in the DH: LIII and small part of LV (Semba 
et al., 1984). The collaterals from lanceolate endings for “flame shaped” arbors in deeper laminae 
(Brown, 1982; Woodbury et al., 2001). 
As observed with Ab RA LTMR, the Ab SA LTMR have similar ascending projections to 
supraspinal structures and collateral spread into the spinal cord. The collaterals made by Merkel 
cell – neurite complexes first projects into LIV-V before making a medial C shaped turn to 
innervate LIII-V. The Ruffini ending neurons initially projects to LIII before branching off to 
innervate LIII-V (Olson et al., 2016).  
The axon of Ad LTMR runs in the spinal cord in the rostral direction for a few segments, before 
innervating LIII (dorsal to Ab LTMR termination region). The axon from either C LTMR and 
TH+ C tactile fibers also project rostrally for one or two segments. These projections form 
collaterals that terminate in LII with flame-shaped arborizations (Li et al., 2011; Vrontou et al., 
2013).  
IX
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I
Figure 1.3: Rexed divisions of the ten laminae of the spinal cord. A: A transverse section of rat
mid-lumbar spinal cord that is immunostained using an antibody (NeuN) that specifically labels
neurons. Laminar boundaries are shown by the dashed lines. The Dorsal Horn consists of LI-VI
[Modified from Todd 2010]. B: Termination patterns of primary afferent fibers in the spinal cord.
The group Ia and some group II afferents that innervate muscle spindles (spindles) project directly
to motor neurons. Group Ib afferents (which innervate golgi tendon organs, GTO, peripherally) as
well as group II afferents, connect interneurons at the intermediate zone of the spinal cord, whereas
group Ia afferents terminate more ventrally. The C-, A-delta- and A-Beta -low-threshold
mechanoreceptors (LTMRs) project to the dorsal horn where they terminate in LIIi; LIIi – LIII; and
LIII-V respectively. The A-delta myelinated fibers innervate laminae I and V whereas the peptidergic
and non-peptidergic C neurons terminates in laminae I and II. [Modified from Lallemend and
Ernfors, 2012]
A
B
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Noxious information: 
In general, Ad-fibers project mostly into lamina I, IIo, and V while Ab-fibers terminate in 
superficial laminae of cats and monkeys (Light and Perl, 1979; Djouhri and Lawson, 2004).  
Roughly, C-fibers have major terminations in LI, II and some to X (Millan, 1999; Basbaum et al., 
2009). Peptidergic fibers (CGRP+) terminate in LI, IIo while non-peptidergic (IB4 and MrgprD+ 
fibers) terminate in LIIi (Zylka et al., 2005).   
As observed, the termination regions of primary afferents appear to be located throughout the DH. 
However, it is generally accepted that LI-II receives nociceptive inputs whereas LIII and deeper 
will incorporate both noxious and innocuous information (Cordero-Erausquin et al., 2016).  
Understanding the trajectory of primary afferent axons and termination zones in the DH of the 
spinal cord is vital for analyzing the primary afferent inputs into local interneurons as we did in this 
doctoral work. Indeed, we were using spinal cord slices in different orientations (i.e. Horizontal, 
Parasagittal or Transverse) and were electrically stimulating the roots of primary afferents, left 
intact. Yet, depending on the orientation of the slice, some types of fibers would be truncated, thus 
preventing the recording of a synaptic response.  
1.2.6. Detection and transduction of nociceptive information 
Nociceptors have specialized sensors on their peripheral terminals to allow the transduction of the 
various modalities. Several channels/receptors contribute to noxious heat-, cold-, mechanical- and 
chemical-induced generated potentials [Fig. 1.4]. An important family of such receptors is the 
family of ionotropic TRP (Transient Receptor Potential), some members of which will be discussed 
below [For review on other transducer (Basbaum et al., 2009)]. The TRPV1 (TRP cation channel 
sub-family V member 1), a non-selective cation channel, is the principle detector of noxious heat 
(>42 ºC). Interestingly, TRPV1 knock-out mice have reduced sensitivity to heat while ablation of 
TRPV1 neurons removes all aversion to noxious heat (40 – 50 ºC) (Caterina et al., 2000; Pogorzala 
et al., 2013). The TRPV1 reporter mice show TRPV1 expression for all unmyelinated, peptidergic 
DRGs but the reporter protein is mostly absent from IB4+ non-peptidergic C-fibers. This is in 
contrast with previous observations in rats of TRPV1 immunoreactivity in IB4+ fibers (Guo et al., 
1999). Notably, a proportion of TRPV1+ (>20%) are present on Ad-fibers (Cavanaugh et al., 
2011).  
TRPM8 (Transient receptor potential subfamily M member 8) is expressed on subsets of small 
diameter Ad- and C-fibers, overlapping with some TRPV1 (Dhaka et al., 2008). This non-selective 
Figure 1.4: Different types of TRP thermoreceptors found on sensory neurons. Each channel is
presented at their reported thermal threshold along with range of temperatures and agonists to
which they respond to. [Modified from Jordt et al., 2003]
Mustard oil
TRPA1 TRPM8 TRPV4 TRPV3 TRPV1 TRPV2
  16 
cation channel is responsible for the detection of innocuous cooling and noxious cold.  TRPM8 
knock-out showed deficits in cold sensitivity while complete TRMP8+ cell ablation caused a loss 
of noxious temperature detection while retaining responses to heat (Pogorzala et al., 2013).  
The TRPA1 (Transient receptor potential subfamily A member 1) is found on TRPV1 expressing 
fibers (30% of all TRPV1+ fibers express TRPA1) (Story et al., 2003). These cationic channels are 
established sensors for noxious irritating electrophilic compounds while their role as a detector for 
extreme cold remains controversial (Dubin and Patapoutian, 2010). Interestingly, mice without 
TRPV1, TRPM8 and TRPA1 demonstrate deficits in the detection of a range of temperatures (5 
to 55 ºC), chemical irritants and pruritogens (Mishra et al., 2011). 
These receptors can be activated pharmacologically with their respective agonists thus providing 
an essential tool to elucidate their roles on spinal cord slices.  
1.3. Dorsal Horn of the Spinal cord 
1.3.1. Cytoarchitecture and functional properties of DH neurons  
The Rexed lamination is defined based on the density of cell bodies, their morphology, dendritic 
arborization and axonal connections (Willis and Coggeshall, 1978). The functional classification 
of DH neurons is determined through electrophysiological properties and primary afferent inputs 
based classifications.  
Lamina I:  
The most dorsal lamina covering the tip of the DH, also known as marginal zone of Walderyer, 
contains low neuronal density. Three types of neurons have been identified: fusiform, multipolar 
(‘flattened’ types were annexed) and pyramidal (Lima and Coimbra, 1986; Zhang and Craig, 1997). 
Most of these neurons have their cell bodies and dendritic arborizations orientated in the 
rostrocaudal axis, while some have their processes extending along the mediolateral axis (Lima and 
Coimbra, 1986; Yu et al., 2005). Many neurons have processes restricted locally in LI while a small 
proportion of neurons have dendritic spread into LII and deeper layers (Almarestani et al., 2007; 
Cordero-Erausquin et al., 2009). Projection neurons from LI innervate multiple supraspinal 
structures including thalamus, parabrachial nucleus and periaqueductal gray (PAG) (Todd, 2010). 
Local LI interneurons demonstrate axon branches protruding into the deep dorsal horn (LIII-IV) 
but also across several spinal segments (Szucs et al., 2013). Notably, projection neurons appear to 
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have larger soma (>200µm) compared to local interneuron populations (<200 µm) (Al Ghamdi et 
al., 2009). 
Neurons are often classified according to their electrical properties and particularly their pattern of 
action potential firing upon depolarization. In Lamina I there is some correlation between electrical 
properties and morphology. Fusiform neurons have tonic firing; pyramidal types are phasic and 
multipolar types display single spikes along with delayed onset discharge profile (Prescott and De 
Koninck, 2002). When recorded in vivo, neurons can also be defined by their function; i.e. the type 
of sensory information they respond to. There is a certain correlation between the morphologies 
and function of LI neurons recorded in cats (Han et al., 1998). These functional groups are: (i) 
Nociceptive-specific neurons responding to noxious heat and mechanical (pinch) stimulus, are 
morphologically either fusiform or multipolar. (ii) Neurons responding to only innocuous cooling 
are all pyramidal cells. (iii) The polymodal nociceptive neurons responding to noxious heat and 
mechanical (pinch) along with non-noxious cold (HPC), are denoted as multipolar shaped (Ribeiro-
da-Silva and De Koninck, 2008).  
Lamina II:  
Initially, Rolando described the substantia gelatinosa (or LII) as distinctly more gelatinous and less 
fibrous in texture compared to other grey matter regions. This is due to the presence of small and 
closely packed cells. This lamina is further divided into two sections: II outer (LIIo) and II inner 
(LIIi) for the more dorsal and ventral parts respectively. LII neurons have been divided into four 
morphological subtypes: central, islet, radial and vertical cells. Most have dendritic arbors around 
LII however, preferential orientations have been observed. Islet and central cells have their 
dendrites elongated in the rostrocaudal axis; with 1000 µm extension reported for islet cells. The 
radial and vertical have dendrites located from LI to deeper laminae (Grudt and Perl, 2002) (Yasaka 
et al., 2007). Most islet cells are observed to be inhibitory (GABA and glycine) while radial and 
vertical cells are predominately excitatory (Glutamate). In contrast, central cells contain both 
excitatory and inhibitory subpopulations (Maxwell et al., 2007; Yasaka et al., 2010). Interestingly, 
unclassified cell types were found in the studies mentioned above. The axons of LII appear to 
innervate laminae exterior to LII ranging from LI with some to deeper laminae (Eckert et al., 2003; 
Braz et al., 2005).  
These cell types exhibit various firing patterns (Tonic, Phasic, Single, Delayed) however islet and 
inhibitory central cells display preferentially tonic firing patterns (Lu and Perl, 2005). Besides the 
patterns mentioned earlier, LII neurons’ morphologies electrical properties, neurochemical 
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markers are heterogeneous therefore cannot be correlated with their possible functional roles 
(Yasaka et al., 2010). Furthermore, LII is innervated by both myelinated and unmyelinated primary 
afferent fibers (Yasaka et al., 2007). 
Lamina III-IV:  
The nucleus proprius is identified based on the increased myelinated, lower neuronal density and 
presence of larger cells compared to LII. The morphology of LIII-IV neurons are heterogeneous 
but two main dendritic arborizations patterns have been described: (i) dorsally orientated dendrites 
spreading throughout LI-III (Littlewood et al., 1995; Naim et al., 1997; Polgar et al., 1999) (ii) 
rostrocaudally elongated dendrites (Maxwell et al., 1983). A proportion of neurons showing 
dorsally orientated dendrites are NKr1+ projections neurons, with collaterals in the thalamus and 
lateral Parabrachial (LPb) (Al-Khater and Todd, 2009). In hamsters, interneurons reported with 
rostrocaudal morphology were further divided into two types: (i) local axons (LA) and deep axons 
(DA). DA neurons have a larger dendritic spread in dorso-ventral and medio-lateral orientations 
compared to LA. The axon territories for LA cells extends rostral caudally within a spinal segment 
in LIII/IV whereas DA cells axon projects ventrally before bifurcating over several spinal segments 
in rostral and caudal directions. These axon form branches innervating LIV- VI (Schneider, 1992, 
2003). Both classes contain excitatory (vGLUT2) and inhibitory (GAD) markers (Schneider and 
Lopez, 2002; Schneider and Walker, 2007).  
LIII/IV neurons exhibit a heterogeneous firing patterns whereby cell possessing tonic, phasic and 
delayed-firing patterns accounts for 47%, 38% and 15% of the total population respectively. A 
correlation between firing pattern and morphology was seen for local axon types who exhibit 
phasic firing patterns while projection neurons appeared to display tonic firing (Schneider, 2003).  
Lamina V-VI:   
The layers V and VI are called the “neck” and the “base” of the dorsal horn respectively LV forms 
a sharp medial boundary with the dorsal funiculus, and its lateral boundary has an indistinct 
reticulated appearance due to the presence of several myelinated fibers (Willis and Coggeshall, 
1978). Furthermore, LVI only exits in cervical and lumbosacral enlargements of the spinal cord. In 
these laminae are found “multi-receptive”, or now known as Wide Dynamic Range (WDR) neurons 
(i.e. receiving both noxious and innocuous information). Some display large dorsoventral spread 
ranging from LIII-LVII while presenting an extensive mediolateral and rostralcaudal coverage. In 
addition, their axons appear to ascend in the contralateral ventral white matter without making any 
collaterals in the Dorsal Horn (Ritz and Greenspan, 1985). Moreover, some LV neurons have 
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dendrites reaching LII and project to the thalamus (Braz et al., 2005). LVI neurons have dendrites 
that radiate in dorsoventral and mediolateral planes but with limited extension in longitudinal axis. 
Thus, they appear as flattened disks with long and relatively unbranched dendrites (Willis and 
Coggeshall, 1978).  
Most deep DH neurons produced a tonic discharge pattern (90%) while the remaining 
demonstrated plateau potential characterized by an accelerating firing response and a sustained 
after-discharge (Derjean et al., 2003).   
1.3.2. Neurochemistry of the spinal cord 
Excitatory transmission: 
L-glutamate is the main excitatory neurotransmitter in the CNS. Glutamate is utilized by both 
primary afferent fibers and excitatory interneurons in their communication. The detection of 
glutamatergic cell bodies through conventional immuno-histochemical approaches have not been 
straightforward due to the presence of glutamate in large quantities in all cells. Therefore, vesicular 
transporters for glutamate (vGLUT1, vGLUT2 and vGLUT3) have been used for marking axons 
of glutamatergic neurons. Alternatively, it is considered that non-GABA and/or non-Glycine 
producing cells are by default glutamatergic in nature (Todd, 2010). The developmental markers of 
glutamate cell lineage, Tlx1 and Tlx3, have been utilized for excitatory neuron detection (Cheng et 
al., 2004).  
The DH has high densities of vGLUT1 immuno-stained varicosities in LIII and LIV whereas 
vGLUT2 was reported in LI-II (Todd et al., 2003; Alvarez et al., 2004). In addition to DH neurons, 
these terminals can arise from primary afferents. Indeed, most myelinated afferent fibers injected 
with cholera toxin B subunit were vGLUT1-immunoreactive. On the other hand, peptidergic 
primary afferents expressing substance P, and non-peptidergic IB4+ C fibers showed either low 
levels of vGLUT2-immunoreactivity or were not immune-reactive to vGLUT1 and 2 (Todd et al., 
2003). Furthermore, vGLUT3 was detected in unmyelinated, non-petidergic C fibers that terminate 
in superficial layer (Seal et al., 2009), and can also have a supraspinal origin (Alvarez et al., 2004).   
vGLUT1 and vGLUT2 mRNA were detected throughout the DH however, high intensities of 
vGLUT1 was reported in the superficial DH. The vGLUT3 mRNA levels were weak in deep DH 
layers (Landry et al., 2004). However, transiently-expressing vGLUT3 interneurons in LIII have 
been implicated in the development of mechanical allodynia (Peirs et al., 2015). Previously, 
presumed glutamatergic neurons (i.e. non-GABA/Glycine) were reported to account for 74.2% 
and 62.4% of cells in LI-II and LIII respectively. Several neurochemical markers have enabled to 
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distinguish sub- populations of excitatory neurons; for instance, neuropeptides – somatostatin 
(SST), neurotensin, neurokinin B (NKB), gastrin-releasing peptide (GRP) and calcium binding 
proteins – calbindin, calretinin and PKCg (Gutierrez-Mecinas et al., 2016).   
Glutamate produces its effects via two classes of receptors: ionotropic and metabotropic receptors. 
Three ionotropic glutamate receptors have been identified: N-methyl-D-aspartate (NMDA), (R, 
S)-a-amino-3-hydroxy-5-methylisozazole-4-propionate (AMPA) and kainate (KA) receptors. By 
in-situ hybridization, subunits of NMDA, AMPA and KA receptors were detected throughout the 
DH (Tolle et al., 1993). For metabotropic glutamate receptors, mRNA of mGluR1-5 were observed 
in the DH of adult mice (Berthele et al., 1999). Generally, the binding of glutamate results in 
excitation of its target. However, it can occasionally result in inhibition. For instance, the activation 
of presynaptic AMPA and KA receptors on primary afferent terminals reduces the evoked 
glutamate release (Lee et al., 2004). [For further review (Bardoni, 2013)]. 
Inhibitory transmission: 
GABA and Glycine are the two-main fast inhibitory neurotransmitters within the spinal cord. 
GABA was detected in cells throughout the DH, with uniform levels observed in LI-III both for 
rats (Todd and Sullivan, 1990) and mice (Polgar et al., 2013a). Alternatively, GABAergic neurons 
are detected through immunolabeling of glutamate decarboxylase (GAD), the enzyme for GABA 
synthesis. Two isoforms of this protein have been identified, GAD65 and GAD67, which are 
encoded by the genes gad2 and gad1 respectively (Mackie et al., 2003). Through transgenic 
GAD67::eGFP mouse (Tamamaki et al., 2003), where enhanced green fluorescent protein eGFP 
is expressed under the GAD67 promoter, GABAergic cell bodies were observed in the DH, while 
in-situ hybridization against GAD mRNA confirmed the presence of GABAergic cells in 
superficial and deep DH layers (Castrolopes et al., 1994).  In addition, transcription factors 
determining GABAergic cell fate (Lbx1, Pax2 and Lxh1/5) can also be used to distinguish 
inhibitory from excitatory interneurons (Pillai et al., 2007; Huang et al., 2008; Larsson, 2017). 
Besides the SC, glycine acts as an inhibitory transmitter in other CNS regions such as brainstem, 
cerebellum and retina. Glycine containing cells were observed in LI-VI, although higher levels were 
seen in LIII compared to superficial layers (Todd and Sullivan, 1990; Polgar et al., 2013a). The 
expression of the neuronal glycine transporter (GlyT2) is required for the loading of glycine in 
presynaptic vesicles, and GlyT2 is considered as a reliable marker for glycinergic axons and their 
termination areas. The transgenic mice GLYT2::eGFP demonstrated the presence of eGFP+ 
glycinergic somas in LIII-IV but sparsely in superficial laminae (Zeilhofer et al., 2005).  
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Interestingly, much of LI-III glycinergic interneurons exhibit also GABA. Notably, pure glycinergic 
neurons (i.e. non-GABA) are almost non-existent (Todd and Sullivan, 1990; Polgar et al., 2003). 
Utilizing combined probes for GAD67/GlyT2 mRNA, few labelled neurons were seen is 
superficial layers whereas marked neurons in the deep dorsal were mostly medium to large in 
numbers (Hossaini et al., 2010).  
Within LI-III, inhibitory interneurons account for an estimated 30.1% and 33.9% of cells in mice 
and rats respectively (Todd and Sullivan, 1990; Polgar et al., 2003; Polgar et al., 2013a). Four   largely 
non-overlapping populations of inhibitory interneurons were identified by their expression of 
neuronal markers: NPY, galanin, nNOS and parvalbumin (Polgar et al., 2013b).  
GABAergic and glycinergic terminals are found throughout the DH (Spike et al., 1997; Mackie et 
al., 2003). A fraction of these terminals are GABAergic and glycinergic descending inputs arising 
from rostral ventromedial medulla (Antal et al., 1996). 
The transmission of GABA occurs via two types of receptors: GABA-A and GABA-B. GABA-A 
are fast-responding, ionotropic channels whereas GABA-B are slow-responding, G- protein 
coupled receptors (GPCR). In the spinal cord, GABA-A immunoreactivity was observed in high 
intensities in LII-IV while other laminae had lower detected levels (Coggeshall and Carlton, 1997). 
A uniform distribution of GABA-A subunits (a3, b2/3 and g2) mRNA was found throughout the 
various laminae of rat DH (Bohlhalter et al., 1996). Interestingly, GABA-B appeared to be more 
prevalent in the DH compared to GABA-A, especially in LI-IV (Coggeshall and Carlton, 1997). 
Furthermore, removal of primary afferent terminals, either mechanically or chemically, produced 
a reduction of GABA-A and GABA-B expression in the DH, thus suggesting their presence on 
primary afferent fibers (Singer and Placheta, 1980; Price et al., 1987). Furthermore, GABA-A 
subunit expression has been observed in DRGs and primary afferent fibers (Zeilhofer et al., 2012).  
For the DH, strychnine-sensitive glycine receptors are expressed throughout LII-VI but low level 
detections were noted for LI and the white matter (Coggeshall and Carlton, 1997). In addition, 
glycine receptors are presumed to be absent from primary afferents, due to unchanged glycine 
receptor levels in DH following neonatal capsaicin application (Singer and Placheta, 1980). 
Futhermore, the scaffolding protein Gephyrin, postsynaptic maker for inhibitory synapse, has been 
demonstrated to co-localize both GABAergic and glycinergic postsynaptic structures (Todd et al., 
1995).  
Co-transmission of GABA and glycine has been reported in the DH. Lots of evidence support the 
co-release of GABA and glycine from the same presynaptic vesicles (Bohlhalter et al., 1994; Todd 
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et al., 1996). The co-detection of these synaptic events was reported in LI (Chery and De Koninck, 
1999). Interestingly, the detection of these synaptic events depends on the developmental stage 
(Keller et al., 2001; Inquimbert et al., 2007). The GABA-A receptors found on the soma and 
dendrites of intrinsic dorsal horn neurons mediate classical postsynaptic inhibition; but also, 
presynaptic inhibition of sensory afferents terminals via primary afferent depolarization (PAD).  
Primary afferent fibers possess a high intracellular chloride concentration due to high expression 
of sodium-potassium-chloride cotransporters 1 (NKCC1) and low levels of potassium-chloride 
cotransporter 2 (KCC2) (Coull et al., 2003). GABA-A are activated by GABAergic interneurons 
leading to efflux of chloride ions leading to depolarization of primary afferents. Ultimately, synaptic 
vesicles are not released however, sodium and calcium channels are inactivated via shunting (i.e. 
prevention of action potential initiation) (Doyon et al., 2016). Different inhibitory interneuron 
populations were reported to contact unmyelinated and myelinated fibers (Betley et al., 2009). PAD 
of primary afferent fibers play a role in sensory information processing (Bardoni, 2013). [Review 
on fast inhibitory transmission in the spinal cord - (Zeilhofer et al., 2012)] 
1.3.3. Functional connectivity within the dorsal horn circuitry  
The basic neuronal components of the DH consist of local interneurons, propriospinal neurons, 
and projections neurons which form a complex circuit. In 1965, Melzack and Wall proposed the 
“gate control theory” as a framework for nociceptive processing (Perl, 2011). In the original model, 
incoming signals via high threshold nociceptors and low threshold mechano-sensitive fibers 
connect to spinal projection neurons in DH. Moreover, local interneurons connected to these 
fibers are responsible for either opening or closing the “pain gate”. Although some assumptions 
have been proven incorrect, this mode helped in delineating the roles of various DH interneuron 
populations in nociceptive information transmission [Review on the gate control theory (Mendell, 
2014)]. 
Identified DH circuit: 
Connective units between DH elements were uncovered through paired recordings of local 
neurons and electrical stimulation of primary afferent fibers [Fig. 1.5] (Cordero-Erausquin et al., 
2016). A few canonical connections have been identified: (1) inhibitory connection between the 
islet interneurons and central interneurons (2) an excitatory connection between central 
interneurons and vertical interneurons (3) Vertical interneurons and potentially LI projections 
neurons (Lu and Perl, 2003, 2005).  
Figure 1.5: Simplified circuitry in the superficial dorsal horn circuitry. Lamina I projection
neurons (PN) are contacted by C and Aδ primary afferents and vertical cells. Islet cells (Isl) are
GABAergic inhibitory interneurons that contact both tonic central cells (ToC) and Vertical (V)
cells. Inhibitory central cells display a tonic mode of action potential discharge. Excitatory central
cells preferentially display a transient mode of action potential discharge (TrC) and connect to
vertical cells. TrC are contacted by Somatostatin (SOM-) and/or PKC γ -expressing excitatory
interneurons localized at the border of laminae IIi and III. The LIII inhibitory interneurons
Glycine (GLY)/Parvalbumin (PV)/Dynorphin (DYN) form a connection onto SOM and/or
PKC γ interneurons and provide feedforward inhibition preventing transmission of non-noxious
information (Aβ fibers) into noxious pathway. Neurons in red are excitatory and utilizes
glutamate. Neurons in blue are inhibitory and use GABA and/or glycine. [Modified from
Cordero-Erausquin et al., 2016]
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Similarly, a circuitry connecting Ab fibers to the superficial layers has been demonstrated. 
Importantly, this circuit is silenced in control conditions, warranting that superficial layers are 
mostly (if not exclusively) responding to high threshold inputs. But in vivo recordings made with 
glycine receptor antagonists demonstrated that nociceptive-specific (NS) LI neurons could respond 
to Ab fiber inputs. Their results suggest that Protein Kinase C gamma (PKCg) interneurons are 
involved in this circuit (Miraucourt et al., 2007; Miraucourt et al., 2009). Indeed, Lu and colleagues 
later demonstrated a pathway between PKCg interneurons, transient central cells and vertical cells 
of LII, the latter projecting to LI neurons. PKCg receive monosynaptic Ab synapses, but Ab 
stimulation does not result in activation of this population in control situation: this is due to a 
strong feed forward inhibition they receive, mostly by glycinergic neurons that also receive Ab 
monosynaptic inputs (Lu et al., 2013).  
Moreover, the recording of NK1+ putative projection neurons in LI showed that they receive 
monosynaptic high threshold inputs (Ad and C) but none from low threshold Ab fibers. However, 
co-application of GABA-A and glycine receptor antagonists reveals Ab mediated polysynaptic 
inputs in these NK1+ LI neurons (Torsney and MacDermott, 2006).  
Another pathway involving a subpopulation of excitatory interneurons, expressing somatostatin, 
was highlighted. Therein, Ab inputs were observed on both somatostatin/PKCg populations 
located at LII/III border and somatostatin positive vertical cells, suggesting two pathways for Ab 
fiber mediated information reaching LI neurons. Furthermore, it was proposed that some 
inhibitory interneurons (including dynorphin expressing neurons), also receiving Ab inputs, were 
responsible for gating Ab input transmission to superficial layers via the somatostatin population. 
From a behavioral point of view, somatostatin ablated mice presented mechanical allodynia only 
whereas dynorphin conditional knock-out mice presented mechanical hypersensitivity (Duan et al., 
2014). Furthermore, the population transiently-expressing VGLUT3 (that receives  Ab inputs) has 
been shown to connect to downstream PKCg and excitatory calretinin populations (Peirs et al., 
2015). Moreover, LI projection neurons was shown to receive direct input from low threshold, 
primary afferent – evoked inhibitory inputs, thus hinting a postsynaptic gate control pathway (Luz 
et al., 2014).  
Intra-laminae connections 
Within LII, approximately 11% of neurons demonstrate monosynaptic connectivity (Lu and Perl, 
2003). Within LI, transsynaptic tracing demonstrated that spino-PB neurons have presynaptic 
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neurons within LI (Cordero-Erausquin et al., 2009) while paired recording showed that neurons 
projecting via the anterior lateral tract (ALT) receive excitatory inputs from local LI interneurons 
(Luz et al., 2010).  
For deeper laminae, the probability of finding a pair is 30%, with twice more inhibitory connections 
compared to excitatory. However, the failure rate of synaptic connections is approximately 44% 
thus suggesting a low reliability in synaptic transmission between LIII-IV synapses (Schneider, 
2008).  
Inter-laminae connections 
Between LI-III, both excitatory and inhibitory neurons in LII made connections with adjacent 
laminae. The inhibitory LII neurons preferentially contacted LI (53% of recorded inhibitory pairs 
with a presynaptic LII neuron) rather than LIII (13%) compared to the internal projections within 
LII (34%) (Santos et al., 2007). On the contrary, the excitatory LII neurons predominantly 
contacted neurons within their lamina (76%) compared to contacting LI (14%) or LIII (10%). 
Interestingly, the authors reported a higher probability of finding connections in their more recent 
study (25% as opposed to 10%) due to improved visibility of cells (Santos et al., 2009).  
Functional connections between superficial and deeper laminae were observed with in vivo 
recordings in rats (Biella et al., 1997; Luccarini et al., 2001). In monkey and cats, intracellularly filled 
LI-LII neurons axons formed collaterals throughout LIII-V (Light and Kavookjian, 1988). 
Furthermore, glutamate uncaging within spinal cord slices demonstrated synaptic connections 
between laminae. A subpopulation of neurons between LI-LIIo (with ventrally orientated 
dendrites) receive excitatory and inhibitory inputs from deeper laminae. These recorded neurons 
in LIIo potentially correspond to LII neurons with long ventral dendrites which are presynaptic to 
putative LI projection neurons. Their dendrites are contacted by Ab fibers in LIII as well as Ad 
and C fibers in LII (Yasaka et al., 2010; Yasaka et al., 2014).  
Glutamate encaging suggests that superficial laminae receive inputs arising below their cell bodies. 
Half of LIII/IV neurons receive their excitatory inputs from LIII/IV, while the other half 
(including neurons with long dorsally oriented dendrites) has excitatory inputs coming from 
superficial layers (LI-II). Their inhibitory inputs, in contrast, appeared to be more local (Kato et al., 
2009; Kato et al., 2013).  
Furthermore, a series of recordings performed in our lab suggests the existence of an inhibitory 
drive to LIII-IV are originating from even deeper laminae (LV-VI). Indeed, the application of 
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exogenous capsaicin and noradrenaline increased the spontaneous frequency of inhibitory inputs 
in LIII-IV of rats; however, transection between LIV and LV resulted in a loss of the response. 
This hints to an inhibitory drive arising from deeper laminae within their respective pathways 
(Petitjean et al., 2012; Seibt and Schlichter, 2015). Along these lines, loss of LI-II resulted in absence 
of capsaicin-induced increase of spontaneous excitatory and inhibitory responses in LV. Thus, 
suggesting a pathway between superficial laminae and LV (Nakatsuka et al., 2002; Cordero-
Erausquin et al., 2016).  
Other types of connections 
The communication between different spinal segments is conducted by intrinsic propriospinal 
interneurons. In de-cerebrated cats, propriospinal neurons originating from other spinal segments 
could modulate the background activity and noxious heat-evoked response of multi-receptive 
dorsal horn neurons within lumbar regions (Sandkuhler et al., 1993). From anatomical reports in 
rats, two cell groups are distinguished based on their axonal spread in rostrocaudal axis: (1) Short 
axons (2.5mm) have cell bodies in medial part of LI-IV (2) Long axons spread (lumbar 
enlargement) have their soma in lateral regions of the DH. For mediolateral projections, medial 
axons terminate in lateral areas of LIIi to IV whereas lateral axons spread from LI-VI. Moreover, 
commissural propriospinal neurons project from lateral areas of LI-IV that terminate in the 
contralateral DH; mostly in LIII-IV (Petko and Antal, 2012).  
1.3.4. Neuronal classification based on sensory afferent inputs 
DH neurons play an important role in the integration of somatosensory information. Their firing 
response to noxious and innocuous stimulation enable to distinguish three neuronal classes: 
nociceptive specific (NS) neurons, responding exclusively to noxious inputs; wide dynamic range 
(WDR) neurons responding to both noxious and non-noxious information; and non-nociceptive 
(NN) neurons, responsive to non-noxious information but not to noxious (Millan, 1999). 
NS neurons receive inputs from C and Ad fibers and are found distributed in LI and LIIo, and 
more scattered in LV-VI. They have limitations in encoding stimulus intensity but encode 
stimulation location precisely. WDR neurons receive inputs from the skin, muscles and viscera but 
are classified based on their cutaneous C, Ad and Ab fiber inputs. They are abundant in LV but 
can also be found in superficial laminae (LI-IIo). These neurons can encode the distinction between 
noxious and non-noxious information, as nociceptive inputs generate higher firing frequencies 
comparted to innocuous inputs. In addition, WDR neurons respond in a graded fashion to various 
noxious stimuli, i.e. they fire more with hotter or sharper objects. Moreover, the sub-modalities 
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(chemical, mechanical and thermal) can be distinguished based on responses in WDR neurons 
(Price et al., 2003). NN neurons receive inputs from Ab fibers and are located between LII-V. This 
group is responsive to innocuous information and acts as a relay for mechanical information 
processing (Millan, 1999; Abraira and Ginty, 2013).  
1.3.5. Ascending tracts 
Following the integration of information within the DH, the axons of projection neurons become 
part of the ascending fascicle after leaving the grey matter. The tract allows the transmission of 
sensory information (noxious and innocuous) to several supraspinal structures. The rostral 
transmission of information occurs via two phylogenetically different pathways [Table 1.1]. The 
first tract, conserved from older species, passes through the medial regions of the brainstem and 
consists of paleo-spinothalamic, spinoreticular, spinomesencephalic, spinoparabrachial and 
spinohypothalamic tracts. The latter system, more recent via evolution, is found in the lateral region 
of the brainstem and consists of neo-spinothalamic, spinocervical and postsynaptic dorsal column 
bundles (Almeida et al., 2004).  
There are several ascending pathways transmitting nociceptive information. Traditionally, the 
spinothalamic tract is accepted as the main “pain” pathway, however most projection neurons have 
multiple supraspinal targets: in lamina I most output neurons project to the parabrachial nucleus 
(PB), but have also collaterals to the thalamus (Hylden et al., 1989), while in deeper laminae a 
fraction of spino-thalamic neurons neurons also project to the periaqueducal grey matter (PAG), 
the reticular formation, the cerebellum, or the mesencephalon (Lu and Willis, 1999; Hunt and 
Mantyh, 2001) .  
Projection neurons in the DH are mostly found in LI however, they have been observed in other 
laminae as well. These axons enter the anterolateral tract (also called ventrolateral) in the ipsilateral 
side of the spinal cord. They soon decussate to the contralateral side; generally, within the same 
spinal segment before the axons travelling along the ventrolateral quadrant of the white matter 
(Todd, 2010). 
LI projection neurons terminate in two main regions in supraspinal structures. (1) In the pons, 
dense projections were observed in the lateral PB nucleus and, to a fewer extent, in the ventrolateral 
PAG. PB neurons respond to a range of stimuli, including mechanical and thermal noxious stimuli 
but also cooling. The nociceptive PB regions project to two areas: (i) Amygdala which is implicated 
in fear and anxiety behaviors, and (ii) hypothalamic ventromedial nucleus – this area is involved in 
defensive/aggressive behaviors and energy metabolism. The ventrolateral PAG area is responsible 
Table 1.1: Ascending tracts. The pathways are named based on their origins and their targets. NS:
Nociceptive-specific; WDR: Wide dynamic range; Non-N: Non-nociceptive. [Modified from
Millan 1999]
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for anti-nociceptive and defensive reactions. The LI-PAG pathway provides a feedback loop 
observed in autonomic and anti-nociceptive response to strong noxious stimuli, via descending 
controls into the DH of the spinal cord (see below). (2) Ventral posterior nucleus of the thalamus 
that projects to the primary somatosensory cortex. This provides the discriminative aspect of 
nociceptive processing in rats. Furthermore, this area receives tactile input from dorsal column 
neurons. For deep laminae projection neurons, several brainstem reticular areas have dense 
innervations. The medullary reticular formation has been implicated as a relay for nociceptive 
signals since anterolateral quadrant tracts project here. Moreover, the direct spinal projections to 
the medial thalamus are conveyed to prefrontal and anterior cingulate cortices; thus, providing 
emotional aspects of pain (Gauriau and Bernard, 2002; Villanueva et al., 2006).   
1.3.6. Descending controls 
Descending projections play a crucial role on spinal nociceptive information processing for both 
acute and chronic pain [Fig. 1.6]. These descending pathways can engage in both inhibition and 
facilitation of nociceptive information transmission. Descending controls are toniccaly active, as 
blocking brainstem-spinal pathways predominantly resulted in facilitation of heat-evoked spinal 
reflexes. Response variations exist between location (i.e. tail vs hind-paw) and sub-modality of test 
stimulation (i.e. noxious heat vs mechanical) (Kauppila et al., 1998).  
While some descending inputs are tonically active, the balance between descending inhibition (DI) 
or facilitation (DF) is dynamic. This balance can be modified by various behavioral, emotional and 
pathological states (Millan, 2002). In physiological conditions, inhibitory mechanisms reduce the 
excessive sensitivity to noxious stimuli via a negative feedback loop, i.e. the noxious stimulus 
activates brainstem nuclei involved in DI and reduces the response to incoming signals. For 
example, it is involved in stress-induced analgesia (SIA), a phenomenon that involves activation of 
endogenous analgesia (or anti-nociception) by states of extreme stress or fear (Butler and Finn, 
2009). In addition, DI sharpens the signal to noise ratio for incoming noxious signals between 
stimulus site and surrounding areas (Le Bars, 2002). However DI can shift to DF and contribute 
to hyperalgesia following inflammation, nerve injuries and chronic opioid application (Heinricher 
et al., 2009). DF is required for the maintenance, but not the induction, of nerve induced injuries 
(Vera-Portocarrero et al., 2006).   
Interestingly, Diffuse Noxious Inhibitory Controls (DNIC), simply put ‘pain inhibiting pain’, 
describes the phenomena where painful stimulation inhibits other pain information produced from 
another stimulation site to allow sharpening of the sensory system to the most potentially harmful 
stimulus. Early observations described how peripheral noxious stimuli (electrical activation of C 
Figure 1.6: Simplified descending controls. Several supraspinal structures such as brainstem,
thalamus, hypothalamus, amygdala and cortex regions suppress pain through descending
projections to the spinal dorsal horn, and in most cases their descending pain suppressive effect
is relayed through the periaqueductal gray (PAG)–rostral ventromedial medulla (RVM). [Adapted
from Colloca et al. (2017)]
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fibers or heat) reduced the responses in WDR neurons. This inhibition was observed when the 
WDR-activating noxious stimulus was applied to different regions in the body, hence it being 
‘diffuse’ in nature. Interestingly, it was observed that only WDR neurons are susceptible to DNIC, 
as opposed to neurons responding only to noxious, innocuous or proprioceptive inputs (Le Bars 
et al., 1979b; Le Bars et al., 1979a). The dorsal reticular nucleus of the medulla has been implicated 
in DNIC (Bouhassira et al., 1992). Although DNIC results in DI, it has been proposed that the 
global effect is to promote pain perception by the most threatening stimulus (Pertovaara and 
Almeida, 2006).  
Descending pathways can modulate nociception via several elements in the DH: (1) the terminals 
of the primary afferents; (2) Projection neurons; (3) local excitatory and inhibitory interneurons; 
and (4) Terminals of other descending pathways. The DI pathway may involve the reduction of 
release of pro-nociceptive molecules from noxious encoding fibers, and directly or indirectly (via 
interneurons) reduce the excitability of projection neurons. In contrast, DF operates via (i) 
descending inputs utilizing different neurotransmitter (ii) analogous neurotransmitters targeting a 
receptor coupled to another secondary messenger pathway (iii) target cell with alternate 
neurochemistry (Millan, 2002).  
Furthermore, descending controls have differential effects on C- and A-fibers modulating spinal 
nociception in physiological conditions: for example, C-fiber evoked activity is greatly reduced 
whereas A fiber responses remains untouched following PAG activation. This suggests an 
important survival adaptation in which potentially distracting C fiber information are suppressed 
while maintaining sensory-discriminative information from A fibers (Heinricher et al., 2009).  
The DI and DF pathways have overlapping supraspinal structures of origin: Brainstem – Rostral 
Ventrolateral Medulla (RVM), Nucleus Raphe Magnus (NRM), Locus Coeruleus (LC); and 
Hypothalamus. Aforementioned areas have direct projections to the spinal cord via dorsolateral 
and ventrolateral funiculi; these tracts are involved in both DI and DF processes (Millan, 2002).  
The RVM receives information from the PAG and is generally considered as the final relay area 
before the spinal cord. This structure is implicated in both DF and DI: local applications of opioid 
in the RVM produces analgesia whereas the neuropeptide cholecystokinin induces hyperalgesia 
(Fang et al., 1989; Kovelowski et al., 2000). The RVM circuitry was elucidated through correlating 
neuronal activity with noxious elicited behavior (i.e. tail flick response to noxious heat). Three 
neuronal populations have been reported: (i) “on-cells” are those that increase fire before tail-flick 
response (ii) “off-cells” have reduced firing prior to the noxious reflex and (iii) “neutral” cells have 
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no correlation with noxious behavior (Fields et al., 1983; Heinricher et al., 1989; Potrebic et al., 
1995). Both “on-cells” and “off-cells” have been shown to project to the DH. Two-thirds of each 
three types of neurons express GAD (Winkler et al., 2006). Moreover, local opioid peptide 
application resulted in elevated firing of “off-cell” following disinhibition (Fang et al., 1989). 
Recently, GABAergic RVM neurons projecting spinally have been shown to modulate noxious 
mechanical inputs via spinal enkephalin positive interneurons and GABA mediated presynaptic 
inhibition (Francois et al., 2017).  
The NRM is the principle source of serotonin (5-HT) in the DH of the spinal cord, yet some 
spinally projecting serotoninergic neurons are also found in the  nucleus paragigantocellularis and 
the ventral part of nucleus gigantocellularis (Kwiat and Basbaum, 1992). 5-HT has a bifunctional 
role in nociceptive information processing, depending on the receptor subtype. Analgesia from 
microinjection of opioids in the RVM was blocked by antagonist of 5-HT7 while 5-HT7 agonist 
reduced capsaicin-induced mechanical hypersensitivity. In contrast, 5HT3 antagonist blocked the 
hyperalgesia response produced by local cholecystokinin (CCK) supply in the RVM. [Review on 
role of 5-HT in DF (Suzuki et al., 2004a)]. 
The source of noradrenaline (NA) to the spinal cord includes the A5 (Locus coeruleus), A6 and 
A7 (Köl-linker-Füser) nuclei (Bruinstroop et al., 2012). NA projections produce DI effects via 
inhibiting the presynaptic and postsynaptic transmission of nociceptive information; commonly by 
adrenergic 2 receptors (a2R) (Howe et al., 1983; Wolff et al., 2007). [Review on noradrenergic 
system (Llorca-Torralba et al., 2016)]. 
Other neurotransmitters and neuropeptides are implicated in descending controls into the DH: 
Oxytocin (Paraventricular nucleus of the hypothalamus) (Eliava et al., 2016); Dopamine (A11 
nuclei in hypothalamus); and controversially acetylcholine (RVM) (Stornetta et al., 2013).  
1.4. Conclusion: Overview of the spinal cord 
The DH of the spinal cord plays an important role in nociceptive information processing. Through 
intricate interactions between local network of excitatory and inhibitory interneurons along with 
descending controls, the incoming information from the periphery is modulated. The ascending 
tract transmits this information to supraspinal structures for the perception of pain. Here, the 
circuit has been described in its naïve state; thus, the next section shall detail the changes of these 
players following damage to the nervous system.   
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2. Neuropathic pain   
Chronic pain can be induced by various causes  [cf. Section 1.1.3.], amongst those include 
neuropathy. The special interest group “Neuropathic Pain” of IASP has proposed a new definition 
for neuropathic pain (NeP); it states: “the pain initiated or caused by lesion or disease of the 
somatosensory system” (Jensen et al., 2011). This may result from traumatic lesions, inflammation, 
infections, cancer and consequences of pharmacological interventions (i.e. chemotherapy or anti-
viral treatments) (Dworkin et al., 2003).  
Along with NeP, inflammatory pain can arise following injury. However, inflammatory pain 
resolves in parallel with the resolution of injury (i.e. healing). Moreover, non-steroidal anti-
inflammatory drugs (NSAIDS) are effective as a treatment (Dickenson, 2010). [Review comparing 
NeP vs inflammatory pain (Xu and Yaksh, 2011)]. 
NeP is characterized by the following symptoms: hyperalgesia (an amplified response to a given 
painful stimuli), allodynia (an exaggerated response to usually non-noxious stimuli), paresthesia 
(tickling, ‘pins and needles’, numb sensations), dysesthesia (abnormal tactile sensations) and 
spontaneous pain in the absence of external stimuli, which manifests as ongoing burning or 
paroxysmal electric shock-like sensations (Kuner, 2010; Truini et al., 2013) [Primer on NeP 
(Colloca et al., 2017)].  
2.1.1. Animal models  
Animal models have been used to uncover the neurobiological changes underlying neuropathic 
pain and identify new therapeutic compounds for ‘mechanism based’ treatments. Notwithstanding, 
certain drawbacks exist that need to be considered while using these models. Firstly, a common 
factor to all animal models is the difficulty to appreciate the animal’s perception, especially due to 
the subjectivity of pain. Secondly, the procedures to induce neuropathy are standardized thus 
producing robust phenotypes such as allodynia and hyperalgesia. In contrast, nerve injuries do not 
always result in NeP while in cases that they do, ‘normal’ observed symptoms are highly variable 
(Attal et al., 2008). Finally, for ethical reasons, animals cannot be kept for extensive periods, 
however, in patients, chronic or recurrent pain lasts over years (Bridges et al., 2001; Henschke et 
al., 2015).  
Another issue concerns the appropriateness of nociceptive assessments made on these models. 
Classically, the latency or stimulus threshold of evoked avoidance behavior (i.e. withdrawal of 
hindpaw or tail) was measured. However, most patients suffer from ongoing, spontaneous pain 
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and sensory loss. Nevertheless, new assessment paradigms have been developed to try to assess 
pain, rather than nociceptive reflexes; i.e. conditional place aversion to noxious stimulus or the 
“grimace scale” for painful expressions (Barrot, 2012). 
Different types of animals models have been introduced to accommodate the diverse etiology and 
consequences of the neuropathy that include peripheral nerve injury, spinal cord injury (SCI), 
cancer and HIV induced pain, or diabetes-induced models [Review on other models (Colleoni and 
Sacerdote, 2010; Jaggi et al., 2011)]. The common models for peripheral nerve injury are discussed 
below. 
CCI model: 
The most commonly used model of peripheral neuropathy is the one developed by Bennett and 
Xie (Bennett and Xie, 1988), that corresponds to a lesion of the rat sciatic nerve. It was later adapted 
to mice: a proportion of the common sciatic branch is exposed at mid-thigh level, proximal to the 
sciatic trifurcation; and three loose ligations are made with chromic gut sutures (Sacerdote et al., 
2008). Due to the presence of the constrictive ligatures, it combines focal ischemia with Wallerian 
degeneration and an epineural inflammatory lesion. Spontaneous pain is observed along with 
behavioral changes including thermal and mechanical hyperalgesia, cold allodynia after one week 
post-surgery (De Vry et al., 2004). These changes last up to at least 7 weeks (Dowdall et al., 2005). 
Moreover, a reduction in nerve conduction combined with histopathological studies suggests 
greater damage to myelinated than non-myelinated axons (Carlton et al., 1991). Furthermore, both 
A- and C-fibers become sensitized following partial nerve damage (Gabay and Tal, 2004).  
SNI model: 
Decosterd and Woolf (Decosterd and Woolf, 2000) initially described the procedure in rats but it 
was later adapted to mice with minor alterations (Shields et al., 2003). The sciatic nerve and its 
three terminal branches (sural, the common peroneal and tibial nerves) are exposed without 
stretching the structures. Both tibial and common peroneal are axotomized while the sural nerve 
is spared. Mechanical and thermal hyperalgesia and allodynia are reported to occur within 4 days 
post-surgery and lasts up to 6 months (Bourquin et al., 2006).  
Cuff model: 
In this model, neuropathy is induced by implanting a polyethylene cuff (2 mm in length) around 
the common branch of the sciatic nerve of rats (Pitcher et al., 1999); it was later implemented in 
mice (Benbouzid et al., 2008b). This model provided calibrated, standardized sciatic nerve 
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constriction with low inter-individual variability (Yalcin et al., 2014). The induced neuropathy leads 
to long lasting allodynia (2 months) while thermal hyperalgesia lasts up to three weeks. This model 
showed minor changes in spontaneous pain (Benbouzid et al., 2008c). In rats, alterations in 
peripheral nerves were observed, with a transient decrease in number of unmyelinated and small 
myelinated axons, and a sustained decrease in large myelinated axons. Moreover, Wallerian 
degeneration combined with inflammatory reactions were observed. Interestingly, this was very 
similar to the morphological and behavioral changes observed with CCI model (Mosconi and 
Kruger, 1996). 
Functional changes following cuff implantation has been studied in rats. Cuff surgery lead to glial 
activation and hyperexcitation of LI spinal neuron activities due to a shift in anion gradient (Coull 
et al., 2003; Coull et al., 2005). Moreover, knockdown of glutamate receptors in the spinal cord 
resulted in reduction of heat hyperalgesia and mechanical allodynia in cuff rats (Fundytus et al., 
2001). Moreover, the cuff models respond to gabapentinoids and antidepressants, as is the case of 
neuropathic pain in the clinics (Benbouzid et al., 2008a; Kremer et al., 2016). In addition, the cuff 
animals demonstrated anxiety-like behavior 6 weeks post-surgery and depressive-like behavior 
following 8 weeks (Yalcin et al., 2011). 
2.1.2. Peripheral changes following nerve injury 
Tissue damage and peripheral sensitization: 
After tissue damage or inflammation, an immune response at the peripheral terminal causes the 
release of active factors from the blood, mobility of local and migrating inflammatory cells. These 
substances include prostanoids, bradykinin, and adenosine triphosphate (ATP). Peripheral 
sensitization results in reduced activation threshold, increase in membrane excitability and an 
amplified magnitude of response to noxious stimuli (Bessou and Perl, 1969). Furthermore, ectopic 
discharge of fibers are observed (Kuner, 2010). The peripheral sensitization and ongoing activation 
leads to continuous input to the SC; leading to central sensitization.  
Ectopic activity in afferent fibers: 
Following nerve damage, ectopic discharges are generated across many sites: from around the 
terminal of injury site (neuroma) and the DRG of the injured axons (Amir et al., 2005); additionally, 
from adjacent intact fibers (Wu et al., 2002). Expression of different voltage-gated sodium channels 
(VGSC) have been implicated in ectopic discharge generation: locally-applied non-selective sodium 
channel blockers produced an inhibitory effect. Nav1.3 and Nav1.8 VGSC are upregulated in the 
DRG following nerve injury (He et al., 2010). Interestingly, knockdown of Nav1.8 through small 
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interfering RNA (although not specific to the DRGs) suggests that this channel has a role in the 
development of NeP (Dong et al., 2007; Schmalhofer et al., 2008). In contrast, knock-outs Nav1.3, 
1.7 and 1.8 had no effect on NeP (Nassar et al., 2005; Nassar et al., 2006). 
It has been suggested that other voltage-gated channels expressed in the DRGs, in particular 
calcium channels (VGCC) and potassium ones, are involved in NeP. Both Cav2.2 (N-type VGCC) 
and their auxiliary subunits a2d1 are upregulated in DRGs following peripheral nerve damage 
(Newton et al., 2001; Cizkova et al., 2002). The deletion of Cav2.2 (also called a1b) reduced NeP 
associated behavior (Saegusa et al., 2001). Interestingly, in vitro experiments demonstrate that the 
VGCC auxiliary subunits a2d1 interact with gabapentin and pregabalin, the first line treatments 
for NeP, to reduce the expression Cav1 and Cav2 in cultured DRG neurons (Hendrich et al., 2008). 
Concerning potassium channels, the HCN (for hyperpolarization activated cyclic nucleotide gated 
channels) that generates pacemaker I(h) currents, is involved in spontaneous activity in DRGs: 
indeed specific HCN blockers reduced ectopic discharges (Chaplan et al., 2003; Luo et al., 2007).  
Phenotype switch: 
Nerve transection causes propagation of calcium waves to the soma (Wall et al., 1974); which are 
important for the two retrograde signaling complexes: mitogen activated protein kinases (Zrouri et 
al., 2004) and nuclear signaling molecules such as importins (Hanz et al., 2003). These signals are 
transported to the soma by dynein motors thus leading to changes in gene transcription 
(Michaelevski et al., 2010) including altered regulation of ionic channels and their associated 
subunits (Costigan et al., 2009). Furthermore, Activating Transcription Factor 3 (ATF3) is 
upregulated, which has been shown to promotes neurite outgrowth in culture DRGs (Seijffers et 
al., 2006), and is considered as a marker for nerve damage (Tsujino et al., 2000). Changes in gene 
expression can affect excitability, in addition to transduction and transmission properties of fibers 
(Cohen and Mao, 2014).  
Sprouting of nerve fibers: 
Following injury in the peripheral nerve, loss of sensation may arise, or paradoxicaly hyperalgesia 
and increased pain (de-afferentation pain). These ongoing sensations arise from distal sprouting of 
the injured DRG axons in response to local release of nerve growth factors (Cohen and Mao, 
2014). Furthermore, sprouting of the central terminals of Ab fibers from deeper laminae into LII 
was reported (Woolf et al., 1992). However, this study is now controversial, as it used CTb 
injections to label A fibers: it was later demonstrated that, after injury, the tracing is not specific to 
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A fibers (Shehab et al., 2003). More specific approaches have failed to identify sprouting of low 
threshold Ab fibers in LII following axotomy (Woodbury et al., 2008). Sprouting has been 
observed in the DRG, arising from sympathic nerves and illustrating the interaction between the 
sympathetic nervous system and somatosensory nerves (Xie et al., 2007). 
Change in peripheral excitatory / inhibitory balance: 
Following nerve injury, it should be noted that presynaptic GABA-A activation was not sufficient 
to produce presynaptic excitation, albeit having a reduced inhibitory effect (Guo and Hu, 2014). 
Upregulation of NKCC1 was reported in both mice and rats DRGs (Chen et al., 2014a; Modol et 
al., 2014). Similarly, a shift in chloride reversal potential on primary afferents were recorded in vitro 
(Pieraut et al., 2007) and in vivo (Chen et al., 2014a). Recordings of trigeminal complexes with 
voltage-dyes demonstrated that GABA-A agonists were unable to reduce the primary afferent 
terminal currents in nerve-injured animals (i.e. loss of presynaptic inhibitory effect); however, this 
was reversed with NKCC1 antagonists such as bumetanide (Wei et al., 2013). However, blocking 
BDNF prevented change in GABA-A receptor conductance and induction of neuropathic 
behavior – thus suggesting a role of BDNF in modulation of presynaptic inhibition (Chen et al., 
2014a). 
Furthermore, the excitatory drive to inhibitory interneurons was impaired following to injury. The 
study observed a reduction in miniature EPSC, and a change in paired pulse ratio suggesting a 
decrease in primary afferent transmitter release probability. Furthermore, no change in 
morphology, density nor number of excitatory contacts on inhibitory neurons were observed; thus, 
suggesting a presynaptic effect of primary afferent release (Leitner et al., 2013).  
2.1.3. Central changes following nerve injury  
Central sensitization: 
The ongoing input from primary afferents contributes to the activity-dependent plasticity within 
the spinal cord. In 1983, Woolf demonstrated that a repeated peripheral noxious heat stimulus, 
enough to produce mild inflammation of hind paw, resulted in an increased excitability of flexor 
muscles and reduced withdrawal reflex threshold (Woolf, 1983). Subsequently, it was shown that 
intense C fiber input produced an increase in the size of receptive field combined with new 
responses to innocuous inputs in DH neurons (Cook et al., 1987). This phenomenon of C-fiber 
activity-evoked plasticity is known as central sensitization. The induction of C sensitization requires 
intense, repeated and sustained noxious inputs. Two distinct temporal phases, each including 
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unique sets of molecular mechanisms, have been described for central sensitization. The early phase 
is phosphorylation-dependent and transcription independent, and involves glutamate receptors and 
other ion channels. The late phase involves gene transcription and the synthesis of new proteins 
responsible for maintenance of central sensitization (Woolf and Salter, 2000; Latremoliere and 
Woolf, 2009).  
Change in central excitatory / inhibitory balance:  
Plasticity of the spinal inhibitory system has long been proposed to play a role in central 
sensitization. A reduction in GABA and GAD65/67 expression is reported in the DH after injury 
(Castrolopes et al., 1993; Ibuki et al., 1997; Moore et al., 2002). Interestingly, a reduction of 
presumed inhibitory terminals with GAD65 has been shown to correlate spatially and temporally 
with disappearance of IB4+ primary afferents (Lorenzo et al., 2014). Whether this reduction is 
linked to a loss of GABAergic neurons is controversial. Some studies have suggested apoptosis of 
inhibitory neurons, (Scholz et al., 2005; Meisner et al., 2010), while other report that apoptotic 
markers are rather co-localized with microglia as opposed to neurons (Polgar et al., 2005). This 
latter group has also found no loss in GABA-A b3 subunits and GABAergic boutons following 
nerve injury (Polgar and Todd, 2008), as well as no loss in total number of neurons in LI-III (Polgar 
et al., 2004; Polgar et al., 2005) and unchanged numbers of GABAergic neurons (Polgar et al., 
2003). Measuring the indirect inhibitory post-synaptic currents (IPSC) evoked in the DH by 
stimulation of primary afferents is a mean to evaluate the weight of inhibitory signaling. This 
indirect IPSC is reduced in its incidence, magnitude and duration in injured animals (Moore et al., 
2002; Scholz et al., 2005). Moreover, long lasting polysynaptic excitatory responses to Ab, Ad and 
C fibers are revealed in LII in presence of GABA-A antagonists in naïve mice. However, such 
antagonists induced minimal changes in LII neurons in SNI animals thus suggesting a reduced 
GABAergic tone (Baba et al., 2003) (see also below). 
Analysis of miniature IPSCs suggested a reduction in GABA release. This is also supported by the 
observed reduction in GABA secretion from stimulated spinal cord slices (Lever et al., 2003). A 
tonic GABAergic current has been reported by some authors, due to persistent activation of 
specific extra-synaptic GABA-A receptors, containing the d subunit; such tonic current was 
reduced in neuropathic animals (Moore et al., 2002; Iura et al., 2016). In addition, the a5 subunit 
of GABBA-A has been shown to contribute to a tonic conductance in DH. In a5 k/o mice, the 
sensitization recovery duration was extended in Complete Freund's Adjuvant (CFA) models thus, 
suggesting continuously activated currents hasten recovery from hyperalgesia (Perez-Sanchez et al., 
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2017). A reduced inhibitory tone, as well as more generally disinhibition, can be explained by a 
depolarizing shift in chloride equilibrium in DH neurons (Coull et al., 2003). This depolarizing shift 
is due to a reduction in the expression of the potassium-chloride-co-transporter 2 (KCC2). In 
consequence, GABAergic and glycinergic inputs have less inhibitory effect and may even 
occasionally result in a net excitatory effect. This phenomenon involves activation of microglia 
after nerve damage and BDNF signaling. Initially, the release of cytokine CCL2 from damaged 
nerves activates microglia in the DH, and induces the upregulation of the purinergic receptor P2X4 
(Zhang and De Koninck, 2006; Thacker et al., 2009). ATP, also released following tissue damage, 
acts on P2X4 receptors on activated microglia thus leading to release of BDNF (Tsuda et al., 2003). 
The BDNF in turns binds to trkB receptors on DH neurons, thus leading to downregulation of 
KCC2 (Coull et al., 2005). Interestingly, there appears to be a sex difference concerning this 
mechanism (Mapplebeck et al., 2016).  
Circuit unmasking:  
In rats with neuropathy, stimulation of Ab primary afferents evoked an increase in calcium signals 
in LII and LIII-IV, while changes were observed only in LIII-IV in naïve rats (Schoffnegger et al., 
2008). This can be related to the excitatory feedforward circuit that exists between Ab fiber 
terminals in deeper laminae and superficial layers of DH, which is under inhibitory control in naïve 
states (see section 1.3.3). The feedforward inhibition impinging onto PKCg neurons appears to be 
perturbed following nerve injury: Indeed, glycinergic inputs to PKCg interneurons were weaken 
after neuropathy (Lu et al., 2013). Moreover, the number of appositions from parvalbumin-
expressing (PV) neurons (an inhibitory population) onto PKCg interneurons was reduced after 
neuropathy (Petitjean et al., 2015); PV neurons also receive Ab inputs. Interestingly, mechanical 
allodynia phenotype during injury was transiently rescued by activating either glycine-expressing 
neurons; parvalbumin or transient-VGLUT3 populations (Foster et al., 2015; Peirs et al., 2015; 
Petitjean et al., 2015). These results indicate that Ab inputs gain access to LI projection neurons 
through loss of multiple feedforward inhibitory circuits following nerve injury.  
As mentioned in section 1.3.3., somatostatin and dynorphin interneurons are also implicated in 
circuits linking Ab terminals in the deep DH with LI neurons. Interestingly, the ablation of 
somatostatin population in the DH results in loss of mechanical hypersensitivity following 
neuropathy. In contrary, the removal of local dynorphin populations did not exacerbate the 
mechanical allodynia observed after injury (Duan et al., 2014).  
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Glial activation: 
Microglia cells becomes activated within a day, followed by astrocytes, with their activation lasting 
up to 12 weeks after injury. Moreover, the depletion of spinal microglia in neuropathic rats has 
demonstrated their role in enhancing central sensitization through the release of proinflammatory 
cytokines/chemokines (early phase) whereas the microglia requires trophic factor brain-derived 
neurotrophic factor (BDNF) to prolong pain hypersensitivity (late phase) (Echeverry et al., 2017). 
In neuropathic states, the glial cells undergo morphological and functional changes. Astrocytes 
release several pro-nociceptive mediators including cytokines, excitatory amino acids and 
prostaglandins (Mika et al., 2013).  
Ascending pathway:  
As described within the previous sub-headings, LI projection neurons appear to receive low-
threshold inputs following to injury; this could underlie mechanical allodynia. Indeed, in 
neuropathic rats, spino-parabrachial LI projection neurons were observed to respond to innocuous 
stimulus, gain spontaneous firing and had amplified output to noxious inputs (Keller et al., 2007).  
Functional alterations were also reported, such as hyper-excitability to a range of stimuli (Tan et 
al., 2011), as well as increased spontaneous activity, reduced C fiber threshold, increased C fiber 
response and enlarged receptive fields in WDR neurons (Liu et al., 2011). In contrast, the threshold 
for innocuous tactile information was altered for the NS neurons but not for WDR neurons after 
peripheral nerve injury. Therefore, the mechanical allodynia is suggested to be due to switch in 
modality specificity within naïve nociceptive-specific spinal relay neurons rather than a change in 
gain within a projecting WDR (Lavertu et al., 2014).   
Descending pathways: 
Alongside spinal plastic events, the descending controls undergo changes that are implicated in 
central sensitization during neuropathy. In the RVM, the nociceptive modulatory neurons undergo 
changes following to continued noxious inputs (Morgan and Fields, 1994).  This has been proposed 
to play a role in the development of central sensitization (Urban and Gebhart, 1999). DF 
mechanisms have been implicated in exacerbating allodynia/hyperalgesia through enhanced 
excitatory 5HT pathway involving 5-HT3 receptors (Suzuki et al., 2004b). Interestingly, the efficacy 
of gabapentin requires the upregulation of 5HT3 mediated DF (Suzuki et al., 2005).  
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Similarly, the DI controls via noradrenergic pathways may undergo plasticity as observed with 
upregulation of a2R and elevated NA levels (Satoh and Omote, 1996) along with increased efficacy 
of local a2R agonists (Mansikka and Pertovaara, 1995).  
2.2. Conclusion: The changes during neuropathic states  
After nervous system damage, several peripheral and central adaptations occur. Each component 
in the nociceptive processing network undergoes their respective changes which interact to 
facilitate the amplification of nociceptive information and blurring the limitations of different 
modalities contributing to the pain experience. Within the spinal cord, an excitatory and inhibitory 
balance maintains these nociceptive thresholds which become aberrant after damage. Amongst 
several neurotransmitters involved, the cholinergic system is a key player for this maintenance. 
3. Spinal cholinergic system 
The cholinergic system has several roles in the nervous system from locomotion, memory, 
attention and pain modulation. In the following section, the cholinergic system regarding 
nociceptive information processing shall be discussed.  
3.1. Overview of cholinergic system 
3.1.1. The synthesis of acetylcholine 
In 1942, the first neurotransmitter to be described in the literature was Acetylcholine (ACh) (Loewi, 
1921) and subsequently the enzyme response for its synthesis : the Choline Acetyltransferase 
(ChAT) (Nachmansohn and Machado, 1943). This enzyme mediates the transfer of the acetyl 
group from acetyl coenzyme A to choline. ACh governs several biological processes including 
motor, memory, sleep-wake cycles, and nociception (Miwa et al., 2011).  
ChAT is produced in the soma and transported by both fast and slow axonal transport systems to 
the nerve terminals (Oda, 1999). In cholinergic nerve terminals, ChAT exists as both membrane 
bound and soluble forms (Gabrielle et al., 2003). In rats, the gene encoding ChAT consists of 15 
exons (a single 5’ non-coding exon followed by 14 coding exons) (Eiden, 1998). Following 
transcription, the transcript is spliced and translated into the ChAT protein (640 amino acids or 67 
kDa) (Hahn et al., 1992). ChAT mRNA is subjected to alternative splicing: alongside the ‘common’ 
form of cChAT, there is a splice variant produced due to exon skipping: pChAT. Due to its 
prevalence in the peripheral tissues, it has been coined ‘peripheral type of ChAT’ or pChAT (Bellier 
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and Kimura, 2011). For continuity, the ‘common’ or ‘central’ ChAT shall be referred to as ChAT, 
unless stated otherwise. 
Another mRNA splice variant encodes for the vesicular acetylcholine transporter (vAChT). 
Interestingly, the entire vAChT gene is in the first intron of the ChAT gene (Erickson et al., 1994). 
After synthesis, ACh is transported into synaptic vesicles via vAChT.  
The released ACh is broken down by the Acetylcholinesterase (AChE). Different types of AChE 
exist due to many slice variants. Two major types of AChE subunits in mammals are AChE-H and 
AChE-T, that differ in their targeting and functional anchoring at extracellular sites (Massoulie, 
2002). The enzyme is distributed in the CNS and Peripheral Nervous System (PNS) with variability 
in different vertebrates. In addition, it has been reported on non-neuronal and glial cells (Tripathi 
and Srivastava, 2010). However, AChE is not used as a marker for cholinergic cells due to existence 
of non-cholinergic “cholinoceptive” neurons. Therefore, ChAT is considered as an ideal marker 
for cholinergic cells (Anglade and Larabi-Godinot, 2010).  
Following the hydrolysis of acetylcholine, the acetate might be recycled at the cholinergic 
presynaptic terminal (Corthay et al., 1985). For choline, it is recaptured by the high affinity choline 
transporter (CHT) found on the membrane of cholinergic cells’ terminals. Notably, choline 
recapture is the rate-limiting step for the synthesis of ACh (Ferguson and Blakely, 2004) [Fig. 1.7].   
3.1.2. Distribution of the Cholinergic neurons  
Analysis of ChAT immunolabeling led to the definition of 5 groups of cholinergic neurons, from 
the dorsal to the ventral horn of the spinal cord (Barber et al., 1984; Borges and Iversen, 1986): 
(i) Somatic motor neurons located in VII-IX 
(ii) Partition cells located in V-VII having a dispersion between LX and the inter-
mediolateral column 
(iii) Autonomic neurons (sympathetic preganglionic neurons in the thoracic region, 
parasympathetic preganglionic neurons in the sacral parts 
(iv) Central canal neurons present in LX 
(v) Sparse cholinergic interneurons in LIII-IV of the DH 
However, the exact role of these DH cholinergic interneurons in nociceptive processing remains 
elusive. Thus, characterizing this population is one of the aims of this thesis. 
Some reports suggest the existence of non-spinal cholinergic populations projecting to the spinal 
cord: some DRGs neurons, for example, have been reported to express pChAT and co-localizes 
Figure 1.7: Cholinergic synapse. A: The acetylcholine is produced from Cholineacetyltransferase
(ChAT) and stored into vesicles by vesicular acetylcholine transporter (VAT). The released
acetylcholine in the synaptic cleft acts on metabotropic muscarinic acetylcholine receptors
(mAChR) and ionotropic nicotinic acetylcholine receptors (nAChR). The acetylcholinesterase
breaks down the ACh into choline and acetic acid. The high affinity choline transporter (CHT)
takes up the choline from the cleft and brings it back to the neuron and into the cycle. [Modified
from Ferguson and Blakely, 2004] B: The signaling pathway of AChR. The 7 transmembrane
mAChR are divided into two groups based on G protein coupling: (1) M1/M3/M5 mAChR are
coupled to Gq/G11- G protein. This activates phospholipase Cβ (PLCβ) thus generating inositol-
1,4,5-trisphosphate (IP3) and 1,2-diacylglycerol (DAG) ultimately increasing Ca+ levels (2) M2/M4
mAChR are coupled to Gi/Go type. The inhibition of adenylate cyclase reduces intracellular levels
of cAMP and enhances opening of K+ channels. Neuronal nAChR are pentameric ligand gated
ion channels, commonly found with α4, β2, and α7 subunits, are permeable to Ca2+ and Na+. The
heteromeric α4β2 receptor subtypes have different Ca2+ permeability: (α4)2(β2)3 receptors have
low whereas (α4)3(β2)2 receptors have high permeability. However, homomeric α7 nAChR shows
high Ca2+ permeability. Activation of α4β2 nAChRs can increase intracellular levels of Ca2+ by
secondary activation of Voltage Gated Calcium Channels (VDCC), whereas α7 nAChRs
preferentially elevate Ca2+ release from ryanodine-sensitive intercellular stores through Calcium
induced Calcium Release. [Modified from Jones et al., 2011]
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with unmyelinated C fibers and myelinated A fibers (Matsumoto et al., 2007). In supraspinal 
structures, several cholinergic cell bodies are confined to the striatum and basal forebrain. ChAT 
cells are commonly widespread in other regions including amygdala, globus pallidus and the 
entopeduncular nucleus (Woolf, 1991). Interestingly, within the medial part of the RVM lies a 
population of cholinergic cells which appear to be neither parasympathetic preganglionic neurons 
nor motor neurons. These have been reported to form projections to the DH of the spinal cord 
(Stornetta et al., 2013). 
Another aspect to this thesis is to determine the contribution of these different potential sources 
of ACh to contributing to the local ACh pool within the spinal cord.   
3.1.3. Cholinergic receptors in the Dorsal Horn of the Spinal Cord 
There are two types of ACh receptors: nicotinic (nAChRs) and muscarinic (mAChRs) receptors, 
respectively ligand-gated cation channels and GTP protein coupled receptors (GPCR) 
(McCormick, 1989). The nAChR consists either a hetero- or a homo-pentamer. The subunits 
composing the nAChRs found on neurons are among: alpha (a2-7, a9 and a10) and beta (b1-4). 
nAChRs conduct small monovalent and divalent cations such as Na+, K+ and Ca2+ (Dani, 2015). 
The mAChR consists of five subtypes (M1-M5) which are divided into two categories: those 
coupled with Gq/11 (i.e. M1, M3 and M5) or those with Gi/Go (i.e. M2 and M4) (Brown, 2010). 
[Further information on cholinergic receptors (Jones et al., 2012)] 
Nicotinic acetylcholine receptors: 
The binding of [3H]-epibatidine, a nAChR agonist, demonstrates the presence of nAChRs 
throughout the spinal cord, with greater density in the superficial layers of the rat DH (Khan et al., 
2003). The in-situ hybridization studies have demonstrated the presence of subunits a3, a4 and 
b2 (Wada et al., 1989), a5 (Wada et al., 1990) and a7 (Seguela et al., 1993) in rat DH. RT-PCR at 
the single level demonstrated expression of a4, a6 and b2 subunits in inhibitory interneurons 
whereas a3, a7 and b2 were expressed in excitatory interneurons along with NK1+ projection 
neurons in juvenile mice (Cordero-Erausquin et al., 2004). In addition to the spinal parenchyma, 
a3, a4, a5, a6, a7, b2 and b4 nAChR subunit transcripts were observed in DRGs (Haberberger 
et al., 2003; Khan et al., 2003; Shelukhina et al., 2009; Wieskopf et al., 2015). Most nAChR 
antibodies have been demonstrated non-specific, thus interpretation of immuno-localization 
studies should be made with caution (Moser et al., 2007).  
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Muscarinic acetylcholine receptors: 
The binding of [3H]-N-methylscopolamine, a mAChR antagonist, suggests the presence of M2, M3 
and/or M4 mAChRs in the superficial regions of the DH (Hoglund and Baghdoyan, 1997); RT-
PCR led to similar results, including M5 (Wei et al., 1994). Moreover, M2 immunoreactivity was 
detected in superficial layers of rat DH (Li et al., 2002). Similarly, M2, M3 and M4 were detected 
in both rat DH cells and DRGs (Cai et al., 2009).  
3.2. Cholinergic system and Pain Behavior 
3.2.1. Elevating Acetylcholine Levels 
Acetylcholine esterase inhibitors: 
Epidural administration of Neostigmine, an acetylcholinesterase (AChE) inhibitor provides pain 
relief during childbirth and post-operative pain in clinics (Eisenach, 2009). In post-operative 
patients, the epidural administration of neostigmine provided a mild reduction in pain score. 
However, it amplified the analgesia of systemically administered a2 adrenoceptor agonist and local 
anesthetics, as well as the effect of morphine provided epidurally. However, for laboring patients, 
the analgesia effect was more the resultant of conjunction between neostigmine and other drugs 
(i.e. clonidine, local anesthetic). This suggests that ACh can modulate pain perception through an 
action at the spinal cord level and be a potentially interesting source for alternative pain therapy. 
AChE inhibitors have also been applied locally in the spinal cord of rodents (intrathecal injections, 
or i.t.) to produce analgesia; other administration routes have also been employed, that will be 
discussed later. Neostigmine is analgesic when injected i.t. prior to thermal noxious stimulation in 
rats (Hartvig et al., 1989; Naguib and Yaksh, 1994; Chen and Pan, 2003). Furthermore, neostigmine 
increased the analgesic score in animals injected with acetic acid intraperitoneally (Miranda et al., 
2002). During a thermal test, neostigmine (i.t.) produced analgesia differently between male and 
female rats. Notably, neostigmine was more potent in females compared to males; and the effects 
was blocked by atropine in both sexes whereas mecamylamine proved effective only in females 
(Chiari et al., 1999). This demonstrates that increasing the levels of spinal ACh is analgesic in rodent 
models of acute thermal nociceptive information processing and that the underlying mechanism is 
sex-dependent. 
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The effect of AChE inhibitors has also been investigated in chronic pain models. In neuropathic 
rats, neostigmine resulted in an increase of paw withdrawal thresholds (Lavand'homme et al., 1998; 
Hwang et al., 1999; Hwang et al., 2000). Neostigmine produced an anti-allodynic effect with more 
efficacy in female than male rats. Moreover, atropine was completely effective in blocking its action 
for both sexes whereas mecamylamine resulted in a partial reduction in analgesia (Lavand'homme 
and Eisenach, 1999). Another example is in the formalin model, which consists in the injection of 
formalin (a noxious chemical stimulus) in the paw of rats. The intrathecal application of the AChE 
inhibitor physostigmine reduces flinching, the nociceptive response involving flexing and 
withdrawing of the paw injected with formalin (Yoon et al., 2003). Similarly, neostigmine produced 
anti-inflammatory effect in a zymosan induced inflammatory model (Yoon et al., 2005). These data 
suggest that it is possible to recruit the spinal cholinergic system to relieve chronic pain-related 
behaviors. 
In addition AChE inhibitors have been injected through other routes, potentially activating 
cholinergic receptors in supraspinal structures to induce anti-allodynia. However the local (spinal) 
application of antagonists suggest the contribution of spinal ACh to this effect: in neuropathic rats, 
donepezil administered orally produced analgesia which was blocked by atropine administered 
intrathecally but not mecamylamine (Clayton et al., 2007). Also, intraperitoneal injections of 
donepezil resulted in anti-hyperalgesia however, it was completely blocked by intrathecal 
administration of atropine while mecamylamine produced a partial block (Kimura et al., 2013). 
Interestingly, the dose used was effective to produce analgesia in injured animals but not analgesia 
in controls, suggesting changes in the function of AChE and/or the downstream receptors. 
Other substances: 
Beyond AChE inhibitors, other substances that induce an increase in spinal ACh levels also 
produce analgesia. Elevated levels of ACh was observed following intrathecal application of 
epibatidine (nAChR agonist) and oxotremorine (mAChR agonist) (Hoglund et al., 2000).  
Morphine and clonidine are two widely used analgesic drugs. Clonidine induces a release of ACh 
in the spinal cord of rats (DeKock and Meert, 1997; Abelson and Hoglund, 2004) and humans 
(Detweiler et al., 1993; DeKock et al., 1997). Morphine elevated ACh levels in both rats (Zhu et 
al., 2008) and monkeys (Gage et al., 2001) in the trigeminal nuclear complex and spinal cord 
respectively. 
In rats, the analgesic effect of these drugs has been shown to involve nAChRs and mAChRs 
activation. For morphine, the intravenous application elevates thermal PWT in naïve conditions. 
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Its analgesic effect was blocked by both mecamylamine and atropine applied intrathecally. This 
suggests that the effect of systemic morphine requires a spinal cholinergic component (Chen and 
Pan, 2001).  
The anti-nociceptive effects on mechanical PWT of clonidine were also blocked by intrathecal 
injections of atropine in rats and mice (Honda et al., 2002; Paqueron et al., 2003). In a diabetic 
mouse model, the analgesic effect of clonidine on PWT was abolished with co-treatment of 
intrathecal atropine (Koga et al., 2004). After SNI, the analgesic effect of clonidine in rats was 
completely blocked with atropine while partially maintained in mecamylamine. The contributions 
of different receptors following neuropathy in clonidine induced analgesia may therefore vary as a 
function of the pathology model and species under study. In addition, spinal ACh release has been 
reported during noxious stimulation via cerebrospinal fluid (CSF) sampling (Eisenach et al., 1996). 
Altogether, these experiments demonstrate that an increase of ACh levels in the spinal cord is 
principally associated with analgesia.  
3.2.2. Inhibiting the cholinergic tone 
Pharmacological blocking of cholinergic receptors: 
The spinal injection of cholinergic receptors antagonists has demonstrated the existence of an 
endogenous cholinergic tone. Indeed, mechanical and thermal nociceptive thresholds appear to be 
under the control of tonically activated nAChRs, while the contribution of mAChRs is 
controversial ((Honda et al., 2002; Paqueron et al., 2003) but see (Zhuo and Gebhart, 1991)).  
For nAChRs in rats, a reduction in mechanical thresholds was observed after i.t. delivery of 
antagonists with different pharmacological profile: mecamylamine or hexamethonium (non-
specific nicotinic antagonist), Dihydro-β-erythroidine (DHbE, that inhibits mostly non-a3b4 
nAChRs), a-conotoxin MII and N-n-decylnicotinium iodide (NDNI - a4b2 antagonist), a-
conotoxin MII (a3b2/a6b2 antagonist), while data are controversial for methyllycaconitine (MLA, 
selective for a7* nAChRs) (Rashid et al., 2006; Young et al., 2008b; Young et al., 2008a; Yalcin et 
al., 2011). In contrast, i.t. mecamylamine, DHbE or MLA had no effect on thermal withdrawal 
responses in rats (Khan et al., 1998; Rueter et al., 2000). However, in mice, i.t. application of 
mecamylamine, DHbE (but not MLA) induced thermal hyperalgesia (Rashid and Ueda, 2002; 
Rashid et al., 2006). This suggest the presence of cholinergic tone involving nAChR for mechanical 
nociceptive thresholds although their role for thermal threshold differs.   
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Cholinergic antagonists have also been injected i.t. in chronic pain models. Mechanical allodynia in 
neuropathic rats was not altered by i.t. mecamylamine, DHbE, MLA nor a-conotoxin MII 
(Lavand'homme and Eisenach, 1999; Young et al., 2008b; Young et al., 2008a). Atropine i.t. was 
also without effect on mechanical thresholds in rats with spared nerve ligation (Lavand'homme 
and Eisenach, 1999; Paqueron et al., 2003), or diabetic mice (Koga et al., 2004). Concerning the 
thermal hyperalgesia observed in neuropathic mice, it was unchanged after i.t. application of 
mecamylamine (Rashid and Ueda, 2002); atropine was also without effect on thermal hyperalgesia 
in rats (Paqueron et al., 2003). These data suggest the disappearance of the spinal cholinergic tone 
in neuropathic animals. 
Removing elements within the cholinergic system: 
Locally decreasing ACh levels through either inhibition of its synthesizing enzyme ChAT or 
ablation of cholinergic neurons has been performed. Intrathecal administration of the cholino-
toxin AF64A (Ethylcholine mustard aziridinium ion) reduces the number of cholinergic neurons 
in the spinal cord. In naïve rats, the thermal withdrawal threshold remains unchanged after 
treatment however, the analgesic effect produced by morphine is reduced (Chen and Pan, 2001). 
In neuropathic rats, AF64A did not exacerbate the mechanical allodynia. However, the analgesic 
effect of clonidine was completely abolished with 15nmol treatment with AF64A (Paqueron et al., 
2001). Inactivation of ChAT with an antisense strategy induces a reduction of both thermal and 
mechanical nociceptive thresholds in mice (Matsumoto et al., 2007). The induced loss of 
cholinergic tone appeared to affect both mechanical and thermal nociceptive thresholds in mice 
but rats remained unaffected.  
The alteration in the level of expression of cholinergic receptors perturbs nociceptive thresholds 
in mice. b2 subunit nAChR knock-out mice (b2 KO) have a reduced mechanical threshold, i.e. 
they are allodynic compared to wild types (WTs). The nicotinic antagonist hexamethonium 
becomes ineffective. Moreover, b2 KOs have thermal hyperalgesia on dynamic hot plate but not 
with (constant temperature) hot plate or in the Hargreaves test (Marubio et al., 1999; Yalcin et al., 
2011). The knock-down of a4 nAChR in the spinal cord (through an antisense strategy) similarly 
produced thermal and mechanical hyperalgesia (Rashid et al., 2006). This demonstrate that a4* and 
b2* nAChRs are necessary for the normal encoding of mechanical and thermal nociceptive 
responses in mice, and the anti-sense data suggest that the spinal cord is a key player in this effect. 
Following neuropathy, b2 KOs, as well as a6 KOs developed more intense allodynia compared to 
WTs, while a5 KOs exhibited a weaker allodynia (Vincler and Eisenach, 2005; Yalcin et al., 2011; 
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Wieskopf et al., 2015). The expression of a6 nAChR in murine DRGs were demonstrated to 
correlate with mechanical allodynia produced after neuropathy (Wieskopf et al., 2015). As observed 
with antagonists, lowering the expression of M2/M3 and M4 subtype (through small interfering 
RNA) did not alter the thermal threshold for injected rats (Cai et al., 2009). Following neuropathy, 
nAChR influences the development and maintenance of these conditions.  
These studies therefore suggest the presence of a spinal cholinergic tone that modulates nociceptive 
processing. An aim of this thesis is to better characterize the spinal cholinergic tone both in control 
and neuropathic animals to help identifying the origin of this plasticity. 
3.3. Cholinergic system and spinal nociceptive circuits 
In addition to the above mentioned behavioral experiments, electrophysiological recording have 
been performed in the DH of the spinal cord to try and identify the underlying mechanisms of 
cholinergic analgesia. 
Role of mAChR  
The application of mAChR agonist resulted in an increase in inhibitory transmission in LII in rats, 
implicating the M2, M3 and M4 mAChR subtypes (Baba et al., 1998; Zhang et al., 2005) In contrast, 
non-specific muscarinic agonists induced a decrease in inhibitory transmission in mice. Activation 
of the different muscarinic subtypes appear to have opposite effects: M2 and M4 subtype activation 
results in a decrease in the frequency of GABAergic IPSCs (possibly due to the disinhibition of 
other inhibitory interneurons) whereas M3 subtype activation facilitated them (Zhang et al., 2006; 
Pan et al., 2008). Activation of the M3 subtype also facilitated glycinergic transmission, both in rats 
and mice (Wang et al., 2006; Zhang et al., 2007b).  
Excitatory transmission was also influenced by muscarinic activation. In mice, two-thirds of LII 
neurons increased frequency of sEPSCs after oxotremorine application (Chen et al., 2010) whereas 
in rats it resulted in inhibition (Zhang et al., 2007a).  
The role of mAChR on primary afferent transmission in the DH was also explored. The amplitude 
of primary afferent evoked EPSC was reduced after application of muscarinic agonists in rats, and 
it was proposed that this effect is mediated by M2 mAChRs present on presynaptic terminals of 
primary afferent fibers. In mice, oxotremorine similarly induced an inhibitory effect on evoked 
EPSC. It was reported that M2, M4 and M5 subtypes were located on the primary afferents. To 
explain the global effect by oxotremorine, the authors suggested that the increased release of 
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glutamate, via M5 activation, acts on group II/III mGluR thus attenuating primary afferent input 
(Chen et al., 2014a).  
Because in vitro recordings are usually performed on unidentified neurons, it is difficult to infer 
the global effect of the applied drugs on the nociceptive circuit. In vivo recordings enable to go 
one step further, in particular when they are performed on identified supraspinally projecting 
neurons, i.e. the output of the circuit. Such recordings were performed in rats, where the authors 
analysed the firing frequency of the projection neurons following noxious and innocuous 
peripheral stimulations. Locally-applied muscarine, a non-specific mAChR agonist, reduced the 
action potential firing in response to both types of inputs. Therefore, this demonstrates that spinal 
mAChRs can modulate the incoming signals into the DH. In addition, the effect of muscarine was 
reduced in the presence of GABA-B antagonists thus, implicating their role in the pathway (Chen 
and Pan, 2004). 
Role of nAChR: 
In vitro experiments demonstrated that nicotine induced an increase in the frequency of both 
spontaneous and miniature IPSCs in the LII neurons of neonatal rats (Kiyosawa et al., 2001; Takeda 
et al., 2003; Genzen and McGehee, 2005; Takeda et al., 2007). There might be a developmental 
shift in type of nAChRs involved in this effect: a4b2* nAChRs appear to be involved in neonatal 
rats (Kiyosawa et al., 2001; Genzen and McGehee, 2005), while however, the elevated IPSCs 
frequency was reported to be a4b2 independent in adult rats (Takeda et al., 2003). Moreover, a 
contribution of non-a4b2* nAChRs on the effect of nicotine on inhibitory transmission has been 
suggested in young rats (Genzen and McGehee, 2005; Takeda et al., 2007; Gao et al., 2010). 
Although most studies focus on LII, an a7 nAChRs-mediated effect was found on inhibitory 
transmission in LV neurons (Takeda et al., 2007). In addition, nicotine, as well as a partial a4b2 
agonist, also produced an increase in frequency of spontaneous and miniature EPSC (Genzen and 
McGehee, 2003; Takeda et al., 2003).  
In vitro recording also enabled to gain information of nAChR located in the somato-dendritic 
compartment, leading to so-called post-synaptic responses (Takeda et al., 2003; Cordero-Erausquin 
et al., 2004; Takeda et al., 2007). Single cell RT-PCR performed on you mice suggest that excitatory 
neurons express a3b2a7* while the inhibitory neurons demonstrate a4a6b2* nAChRs (Cordero-
Erausquin et al., 2004). Application of selective antagonists suggest that superficial laminae contain 
non-a4b2 (Takeda et al., 2003) whereas LV express a4b2* nAChRs (Takeda et al., 2007).  
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There is functional evidence supporting the presence of nAChR on DRGs and primary afferent 
fibers. In DRGs of neonate rats, 4 types of response were observed: a7-like, a3b4-like, a4b2-like 
and unclassified receptor types (Genzen et al., 2001). Moreover, nicotine increased primary afferent 
evoked responses, via a7 receptors, which increased the probability of LTP in DH cells of young 
rats (Genzen and McGehee, 2003). In cultured DRG neurons from adult rats, they observed three 
nicotine evoked responses: the slow decaying currents were attributed to a3b4*; the fast decaying 
responses mediated by a7; and simultaneous fast and slow decaying currents by heteromeric 
nAChR (Fucile et al., 2005). The expression of nAChRs was studied more specifically on 
nociceptors. The capsaicin-sensitive, unmyelinated fibers expressed a7 and other nAChRs while 
other nociceptors expressed a3b4 and a3b4a5 subtypes (Rau et al., 2005). Moreover, a6b4* 
nAChRs was observed in the PNS (Smith et al., 2013). The expression of these nAChR subtypes 
can explain the pro-nociceptive behavioral effect of nicotine.  
Moreover, the nAChR have been implicated in PAD [cf section 1.3.2]. nAChR antagonists were 
reported to reduce dorsal root potential amplitude, through  a9 receptors nAChRs (Hochman et 
al., 2010). This can occur by activation of GABAergic interneurons by an upstream cholinergic 
component or by direct activation of the fibers. ACh released can act directly on the primary 
afferents via bicuculline-sensitive nAChR (i.e nAChR antagonized by classical GABA-A 
antagonists) such as a9 and a10 nAChR (Shreckengost et al., 2010).   
It has been reported that nAChRs modulate descending controls via the PAG-RVM pathways. 
Presynaptic nAChR may temporarily regulate the excitability of PAG neurons but not overexcite 
them, thus modulating the PAG output (Nakamura and Jang, 2010). Recently, it was described that 
two-thirds of PAG-RVM projection neurons expressed a7 receptors and that presynaptic nAChR 
increased glutamatergic inputs to PAG-RVM projection neurons (Umana et al., 2017) .  
Role of AChE: 
In vitro on spinal slices from adult rats, application of neostigmine (AChE inhibitor) resulted in an 
increase in the frequency of GABAergic IPSCs that is blocked by atropine, a non-specific mAChR 
antagonist (Baba et al., 1998). Similarly, neostigmine increased the frequency of spontaneous IPSCs 
in LII neurons; which was blocked by mecamylamine and DHbE (Rashid et al., 2006). In neonate 
rats, Methamidophos or neostigmine (AChE antagonists) along with atropine resulted in an 
increase in the frequency of miniature EPSCs and subsequently blocked by MLA (Genzen and 
McGehee, 2003). In the trigeminal nerve of young rats, physostigmine (AChE antagonist) reduced 
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the amplitude of primary afferent evoked EPSCs (Jeong et al., 2013). In general, ACh plays an 
important role in modulating excitatory and inhibitory transmission in the spinal cord.  
 
Endogeneous cholinergic tone  
The endogenous spinal cholinergic tone revealed by behavioral experiments proved more difficult 
to identify in vitro; and only a nicotinic component was observed. The primary afferent evoked 
EPSCs demonstrated no difference in the presence of M2, M4 and M2/M4 subtypes antagonists 
for both rats (Zhang et al., 2007a) and mice (Zhang et al., 2006). However, in the presence of 
mecamylamine, a general nAChR antagonist, spontaneous EPSCs were unaffected but different 
responses were noted for spontaneous IPSCs of adult mice. Approximately one-third of neurons 
had a reduction in frequency of spontaneous IPSCs while a small fraction had an increase. The 
DHbE reduced the frequencies for both GABAergic and glycinergic IPSCs; unlike MLA, an a7 
nAChR antagonist, which resulted in reduction in one-sixth of mecamylamine-sensitive cells 
(Rashid et al., 2006). This suggests a tonic activation of heteromeric nAChRs in inhibitory 
interneurons. Futhermore, tonic activation of cholinergic tone has been described with descending 
5HT pathway; whereby DHbE increased the basal release of serotonin (Cordero-Erausquin and 
Changeux, 2001). These electrophysiological data exemplify the diversity of the cholinergic system 
in the spinal cord, primary afferents and descending structures. [Review on role of cholinergic 
modulation of Pain (Naser and Kuner, 2017)] 
3.4.  Potential sources of spinal acetylcholine 
While preclinical and clinical behavior data have demonstrated the potential of spinal ACh to 
modulate nociceptive responses, the cellular source of this ACh was until recently controversial. 
Immunohistochemistry experiments with anti-ChAT antibodies demonstrate the presence of a 
dense plexus of cholinergic processes in DH laminae II-III (Barber et al., 1984; Olave et al., 2002). 
These processes, comprising both dendrites and axons, are therefore located in the same laminae 
where nociceptive and non-nociceptive primary afferents terminate. Moreover, they interact in a 
synaptic and reciprocal way with primary afferents. Indeed, cholinergic axons form pre-synaptic 
connections to unmyelinated and low threshold primary afferent fibers while these afferent fibers 
make synaptic contacts onto cholinergic dendrites (Ribeiro-da-Silva and Cuello, 1990). The 
interconnected and reciprocal interaction between primary afferents and cholinergic processes in 
laminae II/III appears to be the most probable substrate for cholinergic analgesia. 
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An ongoing debate continues regarding the source of the cholinergic processes observed in laminae 
II/III of the DH. Indeed the only local population of cholinergic interneurons, with cell bodies in 
laminae III/IV, is extremely scarce (Barber et al., 1984). However, there was a consensus on the 
absence of descending cholinergic controls into the DH (Kanazawa et al., 1979; Sherriff et al., 
1991), until the recent description of cholinergic fibers in LIII coming from cell bodies located in 
the medial aspect of the RVM (Stornetta et al., 2013).  
Moreover, the expression of pChAT has been reported on A- and unmyelinated C-fibers 
(Matsumoto et al., 2007). The combination of Electron microscope (EM) studies (Ribeiro-da-Silva 
and Cuello, 1990) and immunostaining in the Dorsal Root Ganglia (DRG) and spinal cord 
performed by our team has recently ruled out the primary afferent fibers as a major origin of 
cholinergic terminals in the DH (Mesnage et al., 2011). The EM data showed that the cholinergic 
fibers within the plexus are part of glomeruli. These glomeruli consist of primary afferent fiber, 
post-synaptic dendrite and presynaptic axon. The last two components arise from the DH and 
expresses ChAT, but no ChAT expression was observed in the incoming peripheral fiber. 
Furthermore, Mesnage and colleagues demonstrated that the cholinergic plexus was stained with 
cChAT whereas the DRGs remained unstained.   
Our working hypothesis was therefore that the rare DH cholinergic interneurons are the main 
source of endogenous ACh at this level.  Through EM, this population has been reported to receive 
contacts from both CTb and IB4+ expressing primary afferent fibers (Olave et al., 2002). This 
population has been reported in LIII/IV as a subpopulation of GABAergic neurons and co-
localizes with NADPH diaphorase (Todd, 1991; Laing et al., 1994).   
In a recent study by our team, these neurons were fully characterized though utilizing transgenic 
mice expressing the enhanced green fluorescent protein (EGFP) under the control of the ChAT 
promoter (ChAT::EGFP mice) (von Engelhardt et al., 2007; Mesnage et al., 2011). This allowed 
identifying these rare neurons in living tissue and filling them with a tracer to provide a detailed 
characterization of their morphology [Fig. 1.8]. They demonstrated dorsally orientated processes, 
highly elongated in the rostro-caudal direction. Their scarcity seems therefore balanced by an 
important dendritic and axonal territory (Mesnage et al., 2011). Interestingly, these cholinergic 
interneurons also express ACh, GABA and nitric oxide (Mesnage et al., 2011). Moreover, a large 
proportion of this population fires tonically. Although a similar population was thought to be 
absent from the spinal cord of primates, our team recently demonstrated the presence of a 
cholinergic interneuronal population in the DH of macaque monkeys, with similar densities with 
the one observed in rodents. Furthermore, an EM analysis demonstrated that, in the monkey too, 
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Figure 1.8: Anatomical and morphological aspects of Lamina III – IV cholinergic interneurons of
the spinal cord. The distribution of cholinergic interneurons in the DH of ChAT::EGFP+ mice
(Scale = 200 µm) (left). The morphology of this population is unique in that they have processes
orientating towards the dorsal axis (middle) and very elongated in the rostrocaudal axis (right).
[Modified from Mesnage et al , 2011]
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cholinergic boutons are presynaptic to DH neurons as well as to the terminals of sensory primary 
afferents; therefore suggesting that they are likely to modulate incoming somatosensory 
information (Pawlowski et al., 2013b). The similarities observed between primates and rodents 
validates the interest of a mouse model, and our research endeavor continues with the goal of 
understanding how such a sparse neuronal population achieves a major control of nociception. 
3.5. Conclusion: Spinal cholinergic tone and modulation of 
nociception  
In naïve rodents, a spinal cholinergic tone maintaining nociceptive thresholds is reported through 
manipulating elements of the cholinergic system; i.e. ChAT, AChE and receptors (nAChR and 
mAChR). However, the role of this endogenous tone remains unclear following neuropathy.  
A promising source for the spinal cholinergic tone is the DH cholinergic interneurons due to their 
unique morphology and localization within the DH network. Ultimately, the interplay of this sparse 
cholinergic population with surrounding nociceptive network can provide insights into 
understanding pain processing. 
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Thesis objectives 
My thesis aimed to improve our understanding of the spinal cholinergic system that is involved in 
nociceptive information processing, in naïve and neuropathic states. Two main objectives have 
been addressed: 
1. To characterize the spinal cholinergic tone involved in establishing mechanical threshold, 
in naïve and nerve injured mice 
2. To characterize the sparse population of dorsal horn cholinergic interneurons and their 
role in nociceptive information processing, in naïve and nerve injured mice 
 
The first objective can be divided into 2 parts: 
- Assessing the effect of the cholinergic system onto mechanical nociceptive threshold 
and responses of DH neurons to peripheral stimulation in vivo 
- To determine the potential source(s) of ACh contributing to establishing this threshold 
 
The second objective is divided into three parts:  
- Study the dorsal horn and peripheral inputs to spinal cholinergic interneurons, to 
identify the conditions of their recruitment 
- Characterize their electrophysiological and membrane properties, to identify their 
encoding properties   
- Identify the downstream targets to the population, to elucidate the neurons responding 
to the cholinergic system and ultimately leading to the observed behavior.  
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Chapter 2: Materials and methods 
1. Animals 
In general, our studies have utilized wild-type and transgenic CD1 and C57BL/6 mice between 3 
– 10 weeks. Mice were born and raised in the animal facility of the Institute de Physiologie et 
Chimie Biologique (from 2013-2014) and the Chronobitron of the Neurochemistry building (from 
2014 onwards). The animal facilities Chronobiotron UMS3415 are registered for animal 
experimentation under the Animal House Agreement A67-2018-38. In addition, supplementary 
wild type CD1 have been purchased from Charles River Labaratories for behavioral studies. Three 
different transgenic lines have been used: 
(1) ChAT::EGFP CD1 mice were used to identify the sparse cholinergic population in the DH 
(von Engelhardt et al., 2007).  
(2) Transgenic knock-in ChAT-Cre CD1 mouse line was utilized to allow specific expression 
of channels/receptors within cholinergic populations following virus injections. The 
C57BL/6J line was obtained from Jackson laboratories (Stock 006410, B6;129S6-
Chat<tm2(cre)Lowl>/J), and backcrossed for more than 10 generations onto CD1 
background.  
(3) The b2*-nAChR knock-out C57BL/6J mice were used as controls to assess the interaction 
between high doses of cholinergic drugs and the b2*-nAChR receptors (Yalcin et al., 2011).  
Male mice have been utilized in priority, except for b2*-nAChR knock-out control experiments, 
for which female mice was used for a single drug group. The animals were group-housed between 
two to six animals per cage and maintained on a 12-hour light/dark cycles with food and water 
provided ad libitum. All protocols were approved by the “Comité d’Ethique en Matière 
d’Expérimentation Animale de Strasbourg” (CREMEAS, CEEA35). 
2. Cuff surgery 
The cuff model is used to induce neuropathic pain in mice (Yalcin et al., 2011). The surgery was 
carried out under a mixed solution of drugs (10µl/g of animal). The mix (1 ml) solution contained: 
Ketamine (100 µl - Imalgene1000, Merial); Azepromazin (60 µl - Calmivet, Vetoquinol); 
Medetomidin (118 µl - Domitor, Orion pharma/Elanco) and NaCl 0.9% (722 µl). Following 
shaving around the surgical area, the right common sciatic nerve was exposed via blunt dissection 
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and then maintained by using wooden picks. A 2 mm section of split PE-20 polyethylene tubing 
(Harvard apparatus, Les Ulis, France) was placed around the right common branch of sciatic nerve 
in the cuff mice group. Sham-operated mice underwent the same surgical procedure without cuff 
implantation. The shaved skin was closed via suture. After the surgery, Atipamezol chlorhydrate 
(Antisedan, Orion pharma/Vetoquinol) mix (10 µl/g of animal), an antidote to medetomidin, was 
provided to speed up the recovery from the anesthesia. After one week recovery period after 
surgery, the neuropathic phenotype was assessed with von Frey tests (see below).  
3. Spinal cord dissection for in vitro electrophysiology 
3.1 Spinal cord extraction 
The ChAT::EGFP or ChAT-Cre CD1 mice were anesthetized with Ketamine (200mg/kg - 
Imalgene 1000, Merial)/Xylazine (20 mg/kg - Rompun 2%, Bayer) mix via intraperitoneal 
injections (75 µl/ 25g). Older or virus-injected animals tend to be more susceptible to dissection 
therefore transcardiac perfusion was made following to anesthesia. The animals were perfused for 
approximately 3 minutes (until the liver becomes pale due to blood loss) with sucrose Artificial 
Cerebral Spinal Fluid (ACSF) (detailed in Table 2.1). It is crucial to maintain the solution at ice-
cold temperatures (1-4°C) and continuously bubbled with carbogen (95% O2/ 5% CO2). The NaCl 
is replaced by sucrose to reduce neuronal firing and the massive release of glutamate which would 
result in excitotoxicity. Furthermore, the addition of kynurenic acid (2mM), a glutamate receptor 
antagonist, in sucrose ACSF aids in reducing excitotoxicity. 
The spinal cord can be extracted via two approaches: 
(1) Hydraulic extrusion of the spinal cord (Chery and De Koninck, 1999): The skin was incised 
parallel to the spinal column prior to decapitation. The vertebral column was cut at the 
thoracic (a few millimeters rostral to the last rib) and sacral levels (before the pelvic bone). 
A 200-mL pipette tip adapted onto a 10-mL syringe was filled up with ice cold sucrose 
ACSF solution. The pipette tip was inserted into the sacral opening of the column and 
extruded onto a petri dish (surrounded by ice) containing sucrose ACSF. The dorsal roots 
and the meninges (in part) were removed due to the rapid and forceful nature of the injected 
liquid. This dissection yield better results for younger animals (< 26 days) and was not 
appropriate for experiments requiring the attachment of dorsal roots to the spinal cord.  
(2) In vitro laminectomy (Flynn et al., 2011): The animals were quickly decapitated and 4 
incisions were made to extract the torso. Two cuts were made rostral and caudal to the 
Substances Sucrose aCSF
(mM)
aCSF
(mM)
Sucrose 252 -
NaCl - 126
KCl 2.5 2.5
CaCl2 2 2
MgCl2 2 2
Glucose 10 10
NaHCO3 26 26
NaH2PO4 1.25 1.25
Substances K+ based intra-solution 
(mM)
Cs2+ based intra-solution 
(mM)
CH3KO3S 136 -
KCl - 5
MgCl2 2 2
Cs2SO4 - 80
HEPES 10 10
Biocytin 10 10
Table 2.1: Extracellular solution used for in vitro electrophysiology
Table 2.2: Intracellular solution used for in vitro electrophysiology
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vertebral column (described above) followed by 2 more on sides flanking the vertebral 
columns. The internal organs were removed before placing the entire vertebral column into 
a petri-dish filled with ice-cold sucrose ACSF. From the ventral side, the connective tissue 
surrounding the spinal column was removed to allow clear visualization of the vertebral 
bodies. The micro-scissor was inserted from the rostral opening and the vertebral bodies 
were removed successively. After exposing the spinal cord in the vertebral column, it was 
extracted from the caudal end with precautions made to preserve the dorsal roots. The 
vertebral column/spinal cord always remained in solution except for brief moments during 
exposure and/or transfer of spinal cord from vertebral column. 
3.2 Slicing in various orientations 
After extraction, the spinal cord was transected around the lumbar enlargement while unnecessary 
roots were removed (i.e. ventral roots). Depending on the slice type, the spinal cord was prepared 
in several orientation (Fig. 2.1). 
• Horizontal slices (HS): The spinal cord was transferred to a square piece of paraffin where 
it was carefully dried. A small pliable rectangular paper piece was used to transfer the ventral 
side of the spinal cord into cyanoacrylate glue (Loctite, Henkel France) on a cutting 
platform. The blade ran along the spinal cord surface and brought down to the dorsal 
surface of the lumbar segment (in the center of the enlargement). A single slice was made 
between 200 – 300µm depending on the size and age of the spinal cord. The blade speed 
was at 0.03 – 0.04 mm/s. This first slice was experimented on as it contains the first four 
laminae of the DH.  
• Parasagittal (PS) slices: In this case the lateral edge of the spinal cord was glued onto 
cyanoacrylate glue. The blade was brought down to the lateral surface of the spinal cord. 
The first 100 – 150 µm thick slice was discarded (presumed to contain mostly white matter) 
and at least two 300 – 350 µm thick slices were subsequently made. These slices were cut 
at 0.03-0.04 mm/s. These slices contain the 6 laminae of the DH but with reduced medio-
lateral spread.  
• Transverse slices (TS): Prior to the dissection, a groove was performed in a 5% agarose 
block: its width and depth was approximately the one of the spinal cord, to maintain it in 
place during the blade movement. The piece of spinal cord was transferred into the groove, 
and the agarose block was transferred and secured onto the cutting platform with 
cyanoacrylate glue. 350 – 400µm thick slices were made at 0.2 mm/s moving blade.  
Horizontal
Transverse
Parasagittal
A B
Figure 2.1: Spinal cord dissection for in vitro electrophysiology. 9A: The extraction of the spinal
cord. The vertebral column was cut between T13 – S2 for hydraulic extrusion approach (Dashed
black lines) and T9 – S6 for the in vivo laminectomy (Full grey lines) 9B: Spinal cord preparation
in three slice orientations. The slices are made from the lumbar segments of the spinal cord.
Horizontal slices (HS, Top) contains the first four laminae of the dorsal horn (DH) of the spinal
cord. Parasagittal slices (PS, Middle) has the DH although has a restricted rostro-caudal spread.
Transverse slices (TS, Bottom) display all ten laminae of the spinal cord. The HS and PS have
large rostro-caudal spread (> 1 mm) whereas the TS are restricted longitudinally.
Modified from Flynn et al., 2011
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The cutting platform was transferred in the slicing chamber of a sliding vibratome (Leica VT1200S) 
containing ice-cold sucrose ACSF. The slices were transferred onto a nylon mesh within a stocking 
chamber filler with ACSF (Table 2.1) bubbled with carbogen at room temperature. The slices were 
allowed a one hour recovery period prior to recording.  
4. Electrophysiological recordings 
Prior to performing whole cell configuration on target cells, several technical considerations must 
be optimized to achieve a successful patch.  
4.1 Patch pipettes 
The patch pipettes were made from borosilicate capillaries (CC120F-10 model; external diameter 
= 1.2 mm, internal diameter = 0.69 mm; Harvard Apparatus) and pulled either with a horizontal 
laser P-2000 or filament P-1000 puller (Sutter Instrument Co., Novato, California, USA). The final 
pipette resistance (i.e. when the pipette with intracellular solution was placed in ACSF bath) ranged 
between 4 – 6.5 MW. 
4.2 Solutions 
During recordings, the extracellular medium was ACSF solution (Table 2.1) similarly used to 
maintain slices in the stocking chamber.  
Two intracellular solutions have been used to perform voltage and current clamp recordings. For 
voltage clamp, a cesium (Cs) based intracellular solution (Table 2.2) was used. The pH was fixed 
to 7.3 with Cesium hydroxide (CsOH) and the osmolarity was adjusted to 300 ± 10 mOsm with 
sucrose. The reversal potential of cations (Ecat) is at 0 mV while the chloride reversal potential (ECl) 
is set to -90 mV. During recordings of excitatory currents, the holding potential (Vh) was 
maintained at -60 mV and currents appeared as negative value with inward deflection (inward 
currents). For inhibitory currents recording, the Vh was held at 0 mV and these currents possessed 
positive values with outward deflection (outward currents). In addition, Cs ions are potassium (K) 
channel blockers (due to its larger size compared to K) when used as internal solution and prevents 
depolarization; thus, allowing recordings at 0 mV. 
For current clamp recordings, the K-based intracellular solution allows the recordings of action 
potentials. The pH was fixed to 7.3 with potassium hydroxide and the osmolarity was verified to 
be 300 ± 10 mOsm. Regarding the extracellular and K intracellular solution, the reversal potential 
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of cations (Ecat) is at 0 mV while the chloride reversal potential (ECl) is set to -60 mV. For both 
intracellular solutions, biocytin diffused throughout the cells during recording thus allowing post-
hoc morphological and neurochemical revelation.  
Furthermore, a silver electrode was coated with AgCl used during recordings. For both intracellular 
solutions, the liquid junction potential was not corrected.  
4.3 Visual patch recordings 
We performed patch recordings where the slices were visualized with an upright microscope (Axio 
Examiner A1, Zeiss). The slices were observed through either the eye-piece or a digital camera 
(WAT-902H Ultimate, Watec) relaying the image onto a screen. The slice was orientated at a lower 
magnification (x10 objective) and subsequently the magnification was increased (x40 objective) to 
target and patch cells. To improve optics viewed on a screen, an infrared filter was added to reduce 
the scattering of light.  
The electrophysiological experiments were performed on ChAT::EGFP animals. The cholinergic 
neurons were identified by the presence of green fluorescent protein produced under the ChAT 
promoter. Through an LED light source (Prixmatix) and appropriate filters, the green cells were 
identified prior to patching. A confirmation for patching a green cholinergic cell was made by either 
noticing a slight change in shape of the green cell when the pipette was placed on the membrane 
and/or observing a green piece of membrane within the pipette tip.  
In general, the naïve cells were recorded through the lumbar segments. For sham and cuff animal 
groups, recorded cells were in the area corresponding to termination of the sciatic nerve (end of 
L3 – L6 spinal segments). The L4 segment was first identified due to the largest nerve 
corresponding to L4 nerve. Other spinal segments were identified in accordance to their respective 
spinal nerves while considering the L4 nerve. The different laminae were identified based on 
anatomical aspects of the spinal cord and/or the spinal cholinergic system. LII was identified 
utilizing the translucent crescent (for TS) or longitudinal (for PS) band due to reduced myelination. 
In addition, the dense cholinergic plexus in LII inner confirmed this lamina. In HS, the LIII/IV 
was determined by the few ChAT::EGFP neurons located on the surface of the first slice; these 
correspond to the sparse cholinergic interneurons of the DH. For PS and TS, LIII/IV was 
determined as the region below LII coupled with the presence of the sparse DH cholinergic 
interneurons. A band of white matter, corresponding to lateral funiculus, on PS (long longitudinal 
band) and TS (invagination into the grey matter) was used to assess the beginning of LV.  
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4.4 In vitro electrophysiology 
The recording chamber was continuously perfused with ACSF solution via gravity. Different 
pharmacological substances were relayed into the recording chamber through a multi-tap system. 
In turn, the waste from the bath was removed by a peristaltic pump (Minipuls 2, Gilson). The 
reference (connected to the head-stage) was continuously immersed in the ACSF bath while a patch 
pipette approached an acute slice with micro-manipulators (MPC-200, Sutter Instruments).  
A positive pressure was applied into the pipette prior to entering the bath for two reasons (1) to 
prevent the clogging of the pipette tip (2) to “clean” the surrounding area of the targeted cell. 
Simultaneously, a – 5 mV (20 ms) voltage step was imposed on the pipette at 50 Hz. The injected 
current to maintain this voltage step is used to assess the pipette resistance. Once the pipette tip 
was slightly touching the cell membrane, the pipette was further moved diagonally onto the cell 
until pipette resistance increased between 0.5 – 0.9 MΩ. Subsequently, the pressure was quickly 
removed and a tight junction was formed between the cell membrane and pipette. A Giga-seal 
(pipette resistance to the order of 109 Ω) was established and the cell was in cell-attached mode.  
To proceed into whole cell mode, the piece of membrane was broken due to slight aspirations 
applied to the pipette tip. Two transient capacitive currents were formed at the beginning and end 
of the voltage step; thus, indicating whole cell mode. These large currents were compensated by 
internal rectification within the amplifier.  
4.5 Data acquisition 
The recordings were made through the Axopatch 200A (Axon instruments) and the Multiclamp 
700A (Molecular devices) in voltage and current clamp. The current traces were first filtered at 5 
kHz, digitalized via a digitizer (BNC-2110, National Instruments) at 20 kHz and subsequently 
stored in hard disk of a computer unit. The long duration recordings were made with WinEDR 
software (Strathclyde Electrophysiology Software V3.6.6, John Dempster, University of 
Strathclyde, Glasgow, UK). For short voltage and current clamp recordings (i.e. electrical 
stimulations or repetitive current pulses with stepwise amplitude increase) were made on WinWCP 
program (Strathclyde Electrophysiology Software V5.1.3, John Dempster, University of 
Strathclyde, Glasgow, UK).  
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4.6 Baseline recordings 
The spontaneous and miniature excitatory (EPSC) and inhibitory (IPSC) post-synaptic currents 
were recorded over a 5-minute period in voltage clamp mode. The miniature events were recorded 
in the presence of Tetrodotoxin (TTX) 0.5 µM (Table 2.3). In naïve animals, recordings were 
performed in HS, PS and TS. However, only HS and TS were utilized for sham- and neuropathic- 
animals because of the difficulty in obtaining parasagittal slices from the ipsi- and contra-lateral 
side (for comparison) from the same animal.  
4.7 Active and passive membrane properties 
In current clamp, the following parameters were studied: Resting membrane potential (Vrest) 
membrane input resistance (Rin), membrane capacitance (Cm), rheobase and firing patterns. These 
parameters were determined with repeated hyperpolarizing currents (-90 to -30 pA) and repetitive 
depolarizing current pulses (30 to 600 pA) with increasing amplitudes (30 pA increments with 700 
ms duration). These current steps were injected in the soma from resting potential and the 
membrane potential (Vm) change was recorded. To prevent cell damage, the protocol was 
terminated when it appeared the action potential discharge was trailing off following the injected 
current.  
4.8 Pharmacology 
The various pharmacological substances were relayed in different tubes merging into a common 
pipette into the bath chamber. The perfusion rate is 3.5 mL/min which remained unaltered for the 
whole experiment. For each recording, a baseline recording was made 3 minutes prior to drug 
application. These substances were stored at stock concentrations in aliquots at -20 ºC. The drugs 
were diluted to their final concentrations with ACSF just prior to the experiment. The different 
substances are summarized in Table 2.3.   
4.9 Electrical stimulations 
A suction electrode (stimulation electrode) was placed at the most distal region, relative to the 
spinal cord, of the dorsal root. A stimulation electrode was connected to an external stimulator 
(Isostim A320, World Precision Instruments).The recordings were made at both – 60 mV (mono- 
or poly-synaptic evoked EPSC) and 0 mV (polysynaptic IPSC) to assess the afferent induced 
responses. Various intensity ranges were tested (pulse duration 0.1 – 0.2 ms) to observe an afferent-
induced response, either by Ab, Ad and/or C fibers, within the recorded cell. The stimulus 
Common 
name
Technical 
name
Supplier Final 
concentration
Pharmacological 
target
Solvent Storage
Capsaicin Capsaicin Toctris, 5 µM TRPV1 receptor 
agonist
Ethanol 4 ºC
Mustard Oil Allyl 
isothiocyanat
e (AITC)
Sigma-
Aldrich
100 µM TRPA1 receptor 
agonist
Milli-Q  
H2O  
-20 ºC
Menthol (-) Menthol Sigma-
Aldrich
500 µM TRPM8 receptor 
agonist
Ethanol 4 ºC
TTX Tetrodotoxin Latoxan, 
Valence
0.5 µM Blockers of  Na+ 
voltage gated 
channels
Milli-Q  
H2O  
-20 ºC
Table 2.3: Pharmacological substances used for in vitro electrophysiology
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threshold of each evoked response is considered as the minimum current intensity to elicit at least 
one evoked current. A minimum of five stimulations were made for each intensity. To assess the 
fiber (Ab, Ad and C) nature of these responses, we performed a train of electric stimulation at 
frequencies of 1, 5, 10 and 20 Hz, as high-threshold C fibers are known not to follow at high 
stimulation intensity (Daniele and MacDermott, 2009) 
Another variable to distinguish the afferent-mediated responses is the conduction velocity of 
afferent fibers. This is calculated from the response on-set latency (with respect to the stimulation 
artifact) of each response (see below) and the distance between the stimulation electrode and the 
recoding pipette. This was assessed in either of two ways: (1) After the recording, the approximate 
distance was calculated thanks to the images that were taken by a camera fitted over the eye-piece 
of the microscope. (2) The micromanipulator reports the exact co-ordinates of the patch pipette 
in the x, y and z dimensions. After recordings, the patch pipette was moved close to stimulation 
electrode tip and the total displacement was calculated from these two sets of co-ordinates. The 
combination of conduction velocity, synaptic connectivity (mono- or poly-) and fidelity of the 
evoked response to increasing frequency trains provides information on the fibers origin of these 
evoked responses.  
4.10 Data analysis 
Voltage clamp 
The synaptic events were detected with the threshold search method with WinEDR software. The 
threshold was set, for miniature and spontaneous EPSCs, to amplitudes ³ 2 pA and a duration ³ 
1.25 ms. For miniature and spontaneous IPSCs, the thresholds were set to amplitudes ³ 3 pA and 
a duration ³ 1.75 ms. A baseline track-time of 5 ms was implemented prior to each event. Following 
the automatic detection by the software, all captured events were inspected individually, and only 
events that possessed a quick rise followed by an exponential decay were kept. The absolute 
frequency is calculated as the number of events over the total duration of the recording. The peak 
amplitudes were measured for accepted events via semi-automated procedures in WinWCP. 
However, individual events were excluded if they contained overlapping events or had an unstable 
baseline. The frequency and amplitude of currents were analyzed over a 5-minute duration. 
Current clamp 
A program written in Labview (National Instrument) allowed the measurement of Rm and Cm 
during cell hyperpolarization steps. As previously described (Mesnage et al., 2011), the membrane 
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potential (Vm) change was recorded following injected current steps. The Rin was calculated from 
the maximal membrane potential change (DVm) over the injected current step (I). The DVm is given 
by ΔVm= Vm− Vrest, where Vrest is the stable voltage phase before current injection. Assuming an 
isopotential cell, the cell membrane resistance (Rm) is equivalent to the Rin. Moreover, a membrane 
potential change is characterized by a single exponential with the time constant (t): this means that 
t seconds following the application of the current step, the voltage of the membrane will be at (1-
e-1) ≈ 63.2 percent of the maximum voltage drop (observed at the end of the current step). t was 
therefore determined as the time needed to reach 63.2 percent of final voltage drop. The total 
membrane capacitance (Cm) was calculated as Cm = t / Rm. The Cm and Rm provide information on 
the number of open channels and cell size respectively. The rheobase current was determined as 
the smallest step current to produce at least one action potential. In some neurons, injection of 
hyperpolarizing currents induced a sag potential, characterized by a minimum reached within the 
first 50 ms and then a partial repolarization. This was quantified by calculating the percentage of 
minimum negative voltage within the last 50 ms, compared to the voltage drop at the end of the 
hyperpolarizing steps. 
The software provided quantification of number of spikes with each injected depolarization 
currents and the time of inter-spike intervals (ISI). The spikes elicited by the injected step-current 
were detected using a derivative threshold method. The instantaneous frequency of spikes was 
calculated as the reciprocal of the ISI. The firing patterns were classified as previously reported 
(Gassner et al., 2013).  
Assessment of pharmacological responses 
For each neuron that has undergone pharmacological treatment, the cumulative number (N) of 
synaptic events was expressed as a function over time.  Two best-fit line equations were applied to 
the cumulative events: ! = #$ 	× 	' + )																																										#*+	'	 < 	 '-						(1) ! = #- 	× 	' + (#$ − #-) 	× 	'- + )												#*+	'	 ≥ 	 '-						(2) 
In these equation, tc corresponds to the intersection point between the two best-fit lines and 
denotes the possible time in which the pharmacological agent produces its effect. The slope f0 
represents the average frequency before tc (i.e. the average frequency of baseline period) whereas 
the slope fc accounts the average frequency after tc (the average frequency during application). The 
constant ‘a’ is equivalent to y intercept of equation (1). We considered a neuron was responding to 
the drug if it had time-locked alterations (i.e. tc occurs within the drug application period) and had 
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a change in frequency of synaptic events greater than 20% of the baseline frequency of the recorded 
cell. This change in frequency was calculated as follows:  
4ℎ)678	96	#+8:;86<=	(%) = [#- − 	#$]#$ 	× 	100	 
Electrical stimulation 
The recordings were analyzed using the clampfit software (version 10.7, Molecular Devices). The 
evoked afferent responses were screened utilizing the threshold search. Due to difficulties to 
determine the event latencies for superimposed events, only the first detected events were kept for 
this thesis. The jitter time was determined as the standard deviation of latency times of events 
evoked by a stimulation intensity. The conduction velocity was calculated as the total distance 
between the pipette tip and stimulation electrode over the averaged event latency.  
5. Biocytin revelation 
Following the recordings, the slices were stored in paraformaldehyde 4% (Original stock 32%, 
Electron Microscopy Science) diluted in sucrose ACSF to fix the tissues at 4 ºC. At the time of 
writing this manuscript, we didn’t have the time to perform the biocytin revelation and immuno-
histochemical markers.  
6. In vivo electrophysiology 
All in vivo recordings were performed by Maria-Carmen Medrano. The methods employed can be 
found in her previous publication (Medrano et al., 2016). Briefly, adult CD1 males were 
anesthetized with urethane (2.5 g/ kg, i.p.) and the trachea was cannulated. A laminectomy was 
performed to expose L3-L5 segments of the spinal cord, and a small chamber (approximately 0.1 
ml) was created with 2% agar around the exposed lumbar spinal cord; the drugs were directly 
applied in this chamber. Table 2.4 summarizes the drugs used for this study. Single-unit 
extracellular recordings were made with glass electrodes from dorsal horn neurons responding to 
mechanical stimulation of the ipsilateral hind-paw. The 10-s long stimulation was performed with: 
a camel’s hair brush (for light touch stimulus), or small serrated forceps (for pinch stimulus). 
Common name Technical 
name
Supplier Final 
concentration
Pharmacological 
target
Solvent Storage
Atropine Atropine Sigma 10 µM Muscarinic AChR 
antagonist
Milli-Q  
H2O  
-20 ºC
Mecamylamine
hydrochloride
Mecamylamine 
hydrochloride
Sigma 100 µM Nicotinic AChR 
antagonist
Milli-Q  
H2O  
-20 ºC
Bicuculline Bicuculline Sigma 10 µM GABA-A receptor 
antagonist
Milli-Q  
H2O  
-20 ºC
PMBA Phenylbenzene 
ω-phosphono-
α-amino acid
Sigma 10 µM Glycine receptor 
antagonist
Milli-Q  
H2O  
-20 ºC
Table 2.4: Pharmacological substances used for in vivo electrophysiology
Common name Technical name Supplier Final 
concentration
Pharmacological 
target
Solvent Drug 
application 
route
Atropine 
sulphate
Atropine 
sulphate
Sigma 1, 5, 10 and 15 
nmol/10µl
Muscarinic 
AChR antagonist
Saline 
0.9%
Intrathecal
Mecamylamine 
hydrochloride
Mecamylamine 
hydrochloride
Sigma 10, 20, 100, 
400 
nmol/10µl
Nicotinic AChR 
antagonist
Saline 
0.9%
Intrathecal
Scopolamine 
hydrobromide
Scopolamine 
hydrobromide
Sigma-
Aldrich
1, 5 and 10 
nmol/10µl
Muscarinic 
AChR antagonist
Saline 
0.9%
Intrathecal
Neostigmine 
bromide
Neostigmine 
bromide
Sigma-
Aldrich
10 nmol/10µl Acetylcholinester
ase inhibitors
Saline 
0.9%
Intrathecal
Physostimine/ 
Eserine
Physostimine/ 
Eserine
Sigma 1.5, 7.5 and 15 
nmol/10µl
Acetylcholinester
ase inhibitors
Saline 
0.9%
Intrathecal
CNO Clozapine N-
Oxide
Carbo-
synth
10 mg/kg Activator of 
hM4Di receptors 
(DREAD)
Milli-Q  
H2O  
Intraperitoneal 
Table 2.5: Pharmacological substances used for behaviour
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7. Behavior experiments 
7.1 Drug injections 
Intrathecal (i.t.) injections were performed under gaseous anaesthesia (3% Isoflurane for induction 
and 2% for maintenance). The animal was placed in a prone position (hunched-back) and the hair 
on their back was clipped. The caudal lumbar part, just above the iliac crests, was held rightly by 
the thumb and middle finger. The index finger was placed on the tip of the sixth lumber (L6) 
spinous process. A 33-gauge needle connected to a 50µl Hamilton syringe was inserted into the 
space between L5 and L6 vertebrae, and 10µl of the drug solution (Table 2.5), freshly dissolved, 
was injected. Solution was injected at approximately 1 µl/s. The needle was left in position for at 
least 30 s to prevent reflux of the solution. Each animal received a single dose of a single drug. For 
simplification, i.t. doses shall be denoted by their moles.  
Clozapine N-oxide was administrated intraperitoneally All drugs used for behavior experiments are 
summarized in Table 2.5. 
7.2 Nociceptive test: Mechanical sensitivity 
We assessed the role of spinal cholinergic modulation on mechanical transmission in naïve and 
neuropathic CD1 mice. The mechanical threshold for hind-paw withdrawal was assessed with von 
Frey filaments (Bioseb, Chaille, France) with calibrated bending force. Mice were habituated for 15 
minutes in clear Plexiglas boxes (7cm x 9 cm x 7 cm) on an elevated mesh screen. Filaments were 
slowly brought to the plantar surface of each hind paw and removed after a slight bent. The 
mechanical threshold is determined as three or more withdrawals observed among five consecutive 
trials. The filaments used in the study were labeled as: 0.01, 0.04, 0.07, 0.16, 0.4, 0.6, 1, 1.4, 2, 4, 6, 
8, 10 and 15 grams. The results were expressed in grams. For naïve animals, the left and right paw 
data were averaged for each time point. The mice were tested prior to injection or surgery to 
establish the baselines. A minimum of three tests were performed over 3 to 7 days to determine 
the mechanical withdrawal threshold.  
8. Virus injections via manual pressure 
Injection of viruses had two objectives: (1) To determine the source(s) of spinal cholinergic tone 
either from local spinal and/or descending and/or peripheral ChAT populations. (2) To study the 
downstream neurons to ChAT interneurons in the DH.  
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8.1 Pipette and virus preparation 
Borosilicate glass capillaries (1.2 mm OD, 0.69 mm ID, 100 mm L, Harvard Apparatus) were pulled 
with a horizontal puller to produce pipettes with long tapers (6-8 mm) and small tips. Under 
binoculars, these pipettes were recut by eye and could be resized until pipette is loaded with the 
virus. Aliquots (2.5 – 5 µl) of virus were stored at -80 ºC and unfrozen prior to the experiment. A 
droplet of virus was placed on a paraffin strip and aspired in the pipette via negative pressure. A 1 
ml syringe connected to the end of the pipette through small tubing provided this negative pressure. 
The virus-filled pipettes were stored away from light at 4 ºC prior to virus injections.  
Two different sets of viral constructs have been used: (1) AAV8- hSYN-Flex-hM4Di-mCherry 
(Neurophotonics centre, Quebec) or AAV9-hSYN-Flex-hM4Di-mCherry (Neurophotonics centre, 
Quebec) (2) AAV2-CBA-Flex-WGA (Neurophotonics centre, Quebec). 
8.2 Spinal cord injections 
ChAT-Cre animals (³ 3.5 weeks old) were anesthetized with gaseous anaesthesia (4% Isoflurane 
for induction and 2% for maintenance). After shaving the back, betadine 10% (Meda Pharma) was 
applied for 3 minutes to sterilize the area. The skin was incised with 24mm blade to reveal the 
vertebral column surrounded by connective tissue. We targeted L3-L5 spinal segments which are 
located between the T13- L1 vertebral space. The last rib was traced and marked on the muscles 
above the T13 vertebra. The vertebral column was exposed from surrounding muscles and was 
suspended with spinal clampers. The mouse was placed in a prone position revealing the intra-
vertebral space. The exposed spinal cord had its dura matter removed with a bent 33 gauge syringe. 
This successful removal can be confirmed by loss of shiny surface combined with the leakage of 
cerebrospinal fluid.  
For the injection, the pipette was zeroed at the surface on the midline of the spinal cord. The 
pipette was moved 400 µm laterally and 250 µm deep. A total volume of 180 to 270 nl of virus was 
injected via manual pressure into the spinal cord. The rate of injection was 90 nL/10s. The pipette 
was removed after 7 minutes (to prevent reflux of virus) and the opening was closed with metallic 
staples. Each mouse received 3 substances post-injection: (1) Metacam 2mg/ml (i.p. Boehringer 
Ingelheim) to treat post-surgery pain (2) Mannitol 12.5% (i.p) to improve virus infection (3) Saline 
0.9% to rehydrate the mouse.  
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8.3 RVM injection 
Similarly, adult ChAT-Cre animals have been used for RVM injections. The surgery was performed 
under gaseous anesthesia and mice were head-fixed with skull-flat stereotaxic configuration which 
aligns the bregma-lambda plane horizontally. After shaving and sterilizing the surface, the pipette 
was brought approximately 0.7 mm lateral to midline, and 1.2 mm caudal to lambda (Stornetta et 
al., 2013). The target position was marked with a pen on the skull. Subsequently, the pipette was 
retracted and an electric driller was used to perform a hole in the skull at the marked area. The 
pipette was brought back in the right position, at the surface of the brain and then down 6 mm. 
The virus was injected as previously described and the pipette removed only after 7 minutes. The 
skin was closed and mice received similar post-injection treatment as described above.  
8.4 Dorsal root ganglia infection 
To infect the DRGs, P5 ChAT-Cre heterozygous pups were bred from homozygous parents 
pairing. All pups were transferred into a separate new cage; leaving the parents in their home cage. 
The virus was drawn up into a 30 gauge needle connected to a Hamilton syringe (filled with mineral 
oil). The pup’s body and hindpaw were held steadily while the syringe was inserted onto the plantar 
area of the hinpaw. Subsquently, 5 µl of virus was injected subcutaneously and the syringe 
maintained for at least 10 seconds. After all pups were injected, the whole litter was returned to the 
home-cage. 
9. Tissue fixing and slicing preparations 
The animals were transcardially perfused under pentobarbital (Ceva Sante Animal, 54.7mg/ml, i.p. 
injection) with 0.1M phosphate buffer (PB, pH 7.4) followed by 4% Paraformaldehyde (PFA) in 
PB for 15 minutes. For spinal cord and DRG extraction, the sciatic nerve was traced thus 
preserving the L3, L4, L5 and L6 (if present) DRG and roots attached to the spinal cord. However, 
in vitro laminectomy was performed when only the spinal cord was kept. Moreover, the brain was 
quickly extracted. All removed tissue was postfixed overnight in 4% PFA in PB 0.1M and stored 
in Phosphate Buffer Solution (PBS) at 4ºC. 50µm-thick transverse or parasagittal sections were 
produced with a vibrating blade microtome (VT 1000S, Leica, Rueil-Malmaison, France) and were 
serially collected in wells. The tissues were stored away from light at 4 ºC.  
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10. Staining 
Two immunohistochemistry protocols were implemented. For sole ChAT revelation, the sections 
were washed three times with PBS and saturated with PBS/ 0.5% Triton X-100/ 5% donkey serum 
at room temperature for 45 minutes. The sections were incubated at room temperature overnight 
in PBS/ 0.5% Triton X-100/ 1% donkey serum with goat polyclonal ChAT antibodies (1:500 
dilution, Chemicon Millipore, AB 144P). After three PBS washes, the slides were incubated with 
CY3 anti-goat antibodies (1:400 dilution, Jackson Immunoresearch) for 2 hr. The sections were 
finally washed three times with PBS and mounted with fluorescent mounting media (Dako, Les 
Ulis, France).  
For WGA and ChAT revelation, the sections were washed three times with PBS/ 0.3% Triton X-
100 and saturated with PBS/ 0.3% Triton X-100/ 5% donkey serum at room temperature for 45  
donkey serum with goat polyclonal ChAT antibodies (1:250 dilution, Chemicon Millipore, AB 
144P) and rabbit polyclonal anti-WGA (Sigma-Aldrich). After three PBS/ 0.3% Triton X-100 
washes, the slides were incubated with CY3 anti-goat antibodies (1:400 dilution, Jackson 
Immunoresearch, 705-165-147) and Alexa anti-rabbit (1:400 dilution, Invitrogen, A21206 ) for 2 
hr. The sections were washed three times with PBS, placed in serial order and mounted with 
mounting media. All slides were examined under fluorescence using a microscope (Leica) and cell 
counting was made.  
11. Statistics 
The statistical analysis was performed with the statistical software R (version 3.4.1) in conjunction 
with Graphpad software (Prism 7 for Mac, GraphPad Software, Inc., San Diego, CA, USA). 
Similarly, the graphical illustrations were made with Graphpad software.  
For in vitro data, almost all statistical comparisons for frequency, amplitude and cell properties, 
considering the various dependent variables, were made with the ANOVA function. The original 
or transformed (log or inverse function) datasets were verified to show a normal distribution 
(Shapiro-Wilk normality test). For post-hoc comparisons, interactions with only one or two 
variables were made with TukeyHSD (honest significant difference) test. However, Dunnett test 
for multiple comparisons were made for interactions involving 3 or more variables. For non-
normalized dataset (i.e. Rheobase), we used the Kruskal-Wallis test. The Fisher’s exact test was 
used to compare proportion of contingency tables for pharmacological experiments. A more 
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complex 3x3x3 contingency table was performed online at http://vassarstats.net/abc.html for 
firing pattern and rebound spike observations.  
For in vivo data, statistical evaluation was carried out with non-parametric tests because most of 
the data did not show a normal distribution (Shapiro-Wilk normality test). In addition, the paired-
samples Wilcoxon test signed-rank was performed to compare the effects before and after drug 
application within the same cell. The two-sample Wilcoxon-Mann-Whitney rank-sum test was 
performed to compare independent groups.  
For behavioral data, the significance of the data was measured using non-parametric tests due to 
its non-continuous nature. The statistical software R-based plug-in “nparLD” (Noguchi et al., 
2012) provided an ANOVA type multiple-factor analysis taking into account a longitudinal variable 
(time) along with multiple dependent (right vs left paw) and independent (surgery; drug treatment) 
variables. nparLD was also used for posthoc comparisons against baseline (Time 0).  
The significance level was set at P <0.05 and data were expressed as mean ± SEM for graphs.  
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Chapter 3: Plasticity of the spinal cholinergic tone 
after neuropathy 
1. Context and objectives 
Endogenous acetylcholine (ACh) is an important modulator of nociceptive sensory processing in 
the spinal cord. Epidural administration of neostigmine, an acetylcholinesterase inhibitor - 
preventing ACh degradation thus increasing its levels, provides pain relief for child birth and post-
operation pain in clinics (Eisenach, 2009). In rodents, antagonizing nicotinic and muscarinic ACh 
receptors in the spinal cord leads to hyperalgesia and/or allodynia (Honda et al., 2002; Rashid et 
al., 2006). This suggests that a basal tone of spinal ACh modulates the threshold for nociceptive 
responses. This tone appears to be disrupted in neuropathic animals (Rashid and Ueda, 2002), 
however, the details of the plasticity of the spinal cholinergic system observed during neuropathy 
remains elusive. 
Besides well-documented evidence on the cholinergic tone, the source contributing to spinal ACh 
remains controversial. Three groups of cholinergic neurons, expressing Choline Acetyltransferase 
(ChAT), the synthesizing enzyme for ACh, potentially terminate within the Dorsal Horn (DH) of 
the spinal cord. They are located in the Dorsal Root Ganglia (DRG) (Matsumoto et al., 2007), 
Rostral Ventromedial Medulla (RVM) (Stornetta et al., 2013) and Spinal Cord (SC). Herein, the last 
structure contains a potential local source: diverse cholinergic interneuron populations have been 
described within the SC (Barber et al., 1984). 
To improve our understanding of spinal cholinergic analgesia, this section contains two main 
objectives: 
- To characterize the cholinergic tone modulating mechanical nociceptive responses and 
its plasticity after peripheral nerve injury in in vivo conditions 
- To elucidate the potential source(s) contributing to the spinal cholinergic analgesia 
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2. Characterization of the spinal cholinergic tone in naïve mice 
2.1. Behavioral characterization  
2.1.1. General overview 
Prior to the pharmacological assessment, male CD1 mice (ChAT::EGFP mice or their wild-type 
littermates, 5-9 weeks old) were tested over 3 to 7 days for their mechanical withdrawal threshold 
(Von Frey test) to ensure that their threshold was stable (at least three measures, the last one being 
on the experiment day). The value at time “0” corresponds to the last measurement made on the 
experiment day. 
Since ChAT::EGFP mice are BAC transgenic strains, the random and multiple integration of the 
transgene in the genome could impact the behavior. Therefore, the paw withdrawal threshold 
(PWT) of ChAT::EGFP mice (Mean = 3.919 ±0.087, N = 62) and of their wild-type (WT) 
littermates (Mean = 4.081 ±0.098, N = 74) in naïve conditions were compared; with no significance 
found (p = 0.2658; Mann-Whitney test; results not shown). Subsequently, the two groups of 
animals were pooled for all the behavioral study. 
Interpretation-discussion: No differences in the PWT were observed between ChAT::EGFP animals 
and their WT littermate. This suggests that the multiple insertion of the BAC transgene does not 
influence the behavior under study (PWT). 
2.1.2. Nicotinic antagonist: mecamylamine 
Mice were injected i.t. with the non-specific nicotinic antagonist mecamylamine (10-100 nmol) or 
with saline (0.9% NaCl), and tested at different time points after the injection (Fig. 3.1A). 
Mecamylamine induced a dose-dependent reduction in the mechanical withdrawal threshold that 
was visible as soon as 5min post-injection and lasted more than two hours for higher doses. 100 
nmol mecamylamine did not have a more pronounced effect than 20 nmol, although its effect 
lasted longer: the mice still had a withdrawal threshold of 1.42 g at 150 min after the 100 nmol 
injection, while their threshold was back to 2.94 g after the 20 nmol injection. 
Interpretation-discussion: We confirmed the observation that i.t. nicotinic antagonists produce 
mechanical allodynia, in another mouse line than ddY (Rashid et al., 2006). In addition, we have 
performed a full dose-response curve of this effect. The pharmacological effect of an antagonist 
suggests the existence of a spinal cholinergic tone, acting via nicotinic receptors, participating in 
the control of mechanical threshold. 
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Figure 3.1: Time course of the effect of intrathecal mecamylamine (nicotinic antagonist -Top;
3.1A), and atropine and scopolamine (muscarinic antagonists – Middle and Bottom; 3.1B,C),
antagonists on mechanical threshold of naïve Cd1 mice [Groups n = 5 - 6]. 3.1A: Mecamylamine
induced mechanical hyperalgesia at 10, 20 and 100 nmol (Drug-Time interaction: p < 0.001,
post-hoc: TukeyHSD). 3.1B: Atropine induced mechanical hyperalgesia at 10 and 15 nmol
(Drug-time interaction: p < 0.01, post-hoc: TukeyHSD). 3.1C: Scopolamine reduced mechanical
threshold at 5, 10 and 15 nmol (Drug-time interaction: p < 0.001, post-hoc: TukeyHSD). *** p <
0.001 vs baseline, ** p < 0.01, * p < 0.05.
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The effect we observed with 10 nmol mecamylamine was slightly shorter than the one observed 
by Rashid and authors, as they reported a mechanical allodynia lasting up to 90 min while we 
observed return to baseline after 45 – 60 min.  
2.1.3. Muscarinic antagonist: atropine and scopolamine 
We similarly tested the mice with i.t. injections of two non-specific muscarinic antagonists: atropine 
(1-15 nmol), or scopolamine (5-15 nmol); and with saline (0.9% NaCl). Both atropine and 
scopolamine produced a dose-dependent reduction in the mechanical withdrawal threshold (Fig. 
3.1B and C). Like for mecamylamine, this effect was visible as soon as 5 minutes post-injection 
although it reached its peak effect at 15min post-injection. It lasted more than an hour (and up to 
4 hours for the higher doses of scopolamine, result not shown). 
Interpretation-discussion: The spinal cholinergic tone is also acting via muscarinic receptors to 
modulate the mechanical threshold. The contribution of muscarinic receptors had only been 
demonstrated to date in rats, where  hyperalgesia was observed following to mechanical stimulation 
on their tails (Zhuo and Gebhart, 1991). The literature reported no change in mechanical PWT in 
mice following intrathecal application of Atropine (273 pmol); the M1 type antagonist Pirenzepine 
(50 nmol); the M3 type antagonist 4-DAMP (30 nmol) and the M2 type antagonist Methoctramine 
(15 nmol) (Honda et al., 2002). Similarly, atropine (30 µg) produced no alterations to the mechanical 
PWT of rats (Paqueron et al., 2003). In contrary, we observed a change in the PWT potentially due 
to higher doses studied. 
While nicotinic receptors are ionotropic and lead to depolarization thus excitation of the neurons, 
muscarinic receptors can produce either excitation or inhibition of the neurons depending on their 
subtype. In order to explain the similar behavioral effect of nicotinic and muscarinic antagonists in 
these experiments, there are two working hypotheses: i) the involved muscarinic receptors are of 
the M1-3-5 type, linked to Gq (with an excitatory output) and could be expressed by the same 
neurons expressing the nicotinic receptors, or ii) they are of the M2-4 type, linked to Gi/o, but are 
expressed by neurons having an opposite effect on the final behavior. 
2.1.4. Control experiments in b2 knock-out mice 
In order to obtain the dose-response curve, we had to use relatively high concentrations of 
cholinergic antagonists with potential non-specific effects. We even increased the dose of 
mecamylamine in experiments on neuropathic animals (see below). We had at our disposal b2 
nicotinic knock-out mice (b2 K/O) that enabled us to test whether these high doses of 
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Figure 3.2: Time course of the effect of intrathecal mecamylamine (nicotinic antagonist) on
mechanical threshold of naïve males (Fig. 3.2A) and female (Fig. 3.2B) WT and β2* nAChR
knock-out (β2 K/O) C57BL/6 mice [Groups n = 2 - 10]. 3.2A: Mecamylamine induced
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p < 0.05, post-hoc: Dunnett’s multiple comparisons). 3.2B: Mecamylamine induced mechanical
allodynia at 400 nmol in WT females but not β2 K/O groups (not individual time points)
(Animal:Drug interaction: p < 0.001, post-hoc: Dunnett’s multiple comparisons) *** p < 0.001,
** p < 0.01, * p < 0.05.
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mecamylamine was specific to nAChR receptors. Due to the low-success of breeding and limited 
amount of b2 K/O animals available, we used both males and females for this experiment. 
While 400 nmol i.t. mecamylamine induced a marked reduction of the mechanical withdrawal 
threshold in WT animals, it produced no effect on b2 K/O mice (Fig. 3.2).  
Interpretation-discussion: The b2 subunit of nicotinic receptors, in conjunction with a4 subunit - thus 
a4b2* nAChRs, are the most common subunit found in the CNS (Wu and Lukas, 2011). There is 
a massive reduction in nicotinic binding in b2 K/O mice (Marubio et al., 1999). In addition, these 
mice have been reported to have reduced mechanical and thermal thresholds (Yalcin et al., 2011); 
we surprisingly did not reproduce this observation. Admittedly, the mechanical PWT for wild type 
male animals in the Yalcin study was on average around 6 g, while we measured 3.5±0.18g (n = 
18). For the b2 K/O mice, the study reported approximately 2g whereas we observed 3.1±0.34g 
(n = 7). These differences could be explained by a bias due to the experimenter, or to some 
environmental (stress?) or genetic (drift?) factors.  
Importantly, we reproduced the effect of i.t. injection of a non-specific nicotinic antagonist in the 
wild-type littermates, while the effect of 400nmol mecamylamine was completely lost in b2 K/O 
mice. This strongly suggests that this antagonist acts specifically through b2*-nAChRs to control 
mechanical thresholds. In a similar fashion, the non-specific nAChR antagonist Hexamethonium 
lost its effects in b2 K/O mice thus reaffirming the requirement of b2* nAChR in establishing 
nociceptive thresholds at the spinal level (Yalcin et al., 2011).  
2.2. In vivo electrophysiological characterization  
The effect of cholinergic antagonists on dorsal horn neurons was recorded in vivo by Dr. Maria-
Carmen Medrano, a post-doctoral fellow in our team. I summarize her results here as they will be 
of interest for the discussion of my results (and part of the manuscript we are preparing).  
In the 2016 paper, Medrano demonstrated that there are spontaneously and non-spontaneously 
active neurons in the DH, and she studied them separately. However, she also demonstrated that 
some of these neurons change “phenotype” by becoming spontaneously active after neuropathy, 
blurring the borders between these two populations. We therefore decided to analyze them as a 
single population in the present study. 
***
LT
28%
WDR
68%
HT
4%
Figure 3.3: The characterization of recorded neurons in the DH. 3.3A: Location of the recorded
DH neurons (N = 24). Symbols are the individual cells and red lines are the mean ± S.E.M of
neurons. 3.3B: The effect produced by touch and pinch on neurons in naïve mice. Increase of firing
rate induced pinch was greater than in touch. Bars represent the mean ± S.E.M of the increase of
firing rate during touch and pinch application (10 s); ***p < 0.001 touch vs. pinch (Paired-samples
Wilcoxon test). 3.4C: The percentages of Low Threshold (LT), Wide Dynamic Range (WDR) and
High Threshold (HT) neurons. LT, WDR and HT classification is based on the ratio between the
effect of touch and pinch.
A B
C
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2.2.1. Properties of recorded neurons 
Recorded neurons were distributed along the dorsal horn, with an average depth of 370.8 µm ± 
29.23 µm (range: 78, 530 µm) (Fig. 3.3A). All the selected neurons responded to mechanical 
stimulation of the paw with an increase in firing rate; the increase was higher after pinch compared 
to touch (Fig. 3.3B) (N = 24, p < 0.001 for Dtouch vs Dpinch, Paired-samples Wilcoxon test). 
Three types of neurons could be distinguished based on their differential response to touch vs. 
pinch: i) low-threshold (LT) neurons responded equally or more to non-noxious touch than to 
noxious pinch; ii) wide dynamic range (WDR) neurons responded more to pinch than to touch; 
and iii) high-threshold (HT) neurons responded only to pinch, or at least ten times more to pinch 
than to touch. The large majority of recorded neurons were WDR (Fig. 3.3C). 
Interpretation-discussion: The recorded neurons had properties similar to the one already published 
(Medrano et al., 2016). 
2.2.2. Nicotinic antagonist: mecamylamine 
The nicotinic antagonist mecamylamine (100 µM) was applied locally at the surface of the spinal 
cord. It produced an elevation in the ongoing activity of the neurons. On top of this increased 
ongoing activity, touch and pinch also induced larger responses in the presence of mecamylamine 
(Fig. 3.4A) (N= 12, p <0.05 for ongoing activity and pinch & p < 0.01 for touch with drug vs 
control, Paired-samples Wilcoxon test). 
Interpretation-discussion: The effect of the nicotinic antagonist on DH neurons firing demonstrates 
that they are under the control of a cholinergic tone acting through nAChRs. Although we do not 
infer a causal link, such increase in ongoing activity is also observed in DH neurons after 
neuropathy (Medrano et al., 2016). 
In addition, these recordings demonstrate that the spinal cholinergic tone also tunes the intensity 
of DH neurons response to hindpaw mechanical stimulation. Although the neurochemical nature 
and the role of recorded neurons in nociceptive circuits is not known, it is tempting to relate their 
increased response to a peripheral input with the observed mechanical allodynia after i.t. 
mecamylamine in behaving animals. 
2.2.3. Muscarinic antagonist: atropine 
Maria Medrano similarly applied the muscarinic antagonist atropine (10 µM) locally at the surface 
of the spinal cord. This also produced an elevation in the ongoing activity of DH neurons, as well 
Figure 3.4: The effect of cholinergic drugs on touch and pinch response in DH recorded neurons.
3.4A: Effect of mecamylamine (non-specific nAChR antagonist) on touch and pinch responses
animals (N = 12). Mecamylamine increased the ongoing activity and responses to touch and pinch.
3.4B: The effect of atropine (non-specific mAChR antagonist) in touch and pinch on neurons in
naive mice (N= 12). Similarly, the ongoing activity, responses touch and pinch was elevated in the
presence of atropine during sham. However atropine lost all its effects in cuff animals. Bars
represent the mean ± S.E.M of the increase of firing rate during touch and pinch application (10 s);
** p < 0.01; *p < 0.05 touch or pinch with drug vs control (Paired-samples Wilcoxon test).
* *
**
*
*
*
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as an increase in their response to touch and pinch (Fig. 3.4B) (N= 12, p <0.05 for ongoing activity 
touch and pinch with drug vs control, Paired-samples Wilcoxon test). 
Interpretation-discussion: Again, these recordings demonstrate that the spinal cholinergic tone 
controlling DH neurons acts not only through nAChRs, but also through mAChRs. On average, 
the effect of atropine goes in the same direction as the effect of mecamylamine, as was observed 
after i.t. injections in behaving animals. The discussion about the direction of this effect is similar 
to one we proposed after the behavior experiments in 2.1.2. 
3. Plasticity of the spinal cholinergic tone in neuropathic 
conditions 
In order to investigate plasticity after nerve injury in mice, we chose the cuff model due to its 
reliability and the fact that it is mastered by our collaborator in charge of performing the surgeries 
(Dr. Ipek Yalcin) (Fig. 3.5A).  
3.1. Behavioral characterization  
3.1.1. Mechanical allodynia observed after peripheral nerve injury 
The PWT was measured before and one week after the surgery (Fig. 3.5B). We compared the PWT 
between ChAT::GFP and WT groups in neuropathic conditions. There was a significant difference 
between Animal (Sham vs Cuff., p = 1.58e-50), Paw (Left vs Right, p = 3.23e-112) but not Type 
(GFP+ vs WT, p = 1.75e-01). The Animal:Foot interaction was significantly (p = 9.50e-92) which 
was due to reduced PWT in cuff right paw (Mean = 1.053 ± 0.0177, N = 62) compared to cuff left 
paw (Mean = 3.97 ± 0.0975, N = 62,  p < 0.001, Kruskal-Wallis test) or sham right paw (Mean = 
3.871 ± 0.09, N = 62, p < 0.001, Kruskal-Wallis test). There was no significant Animal:Type:Paw 
interactions (p = 1.08e-01). Like the naïve, the GFP+ and WT animals were thus pooled for all the 
behavioral study. 
We used a non-parametric multiple comparison test (nparLD, see Methods) to compare the PWT 
between animals (Sham vs Cuff), paws (Left vs Right) and days (days after surgery: -2, -1, +7, +8, 
+9). There was a significant difference between the Animals (p =7.62e-05), Paws (p =9.18e-19) 
and Days (p = 5.83e-10). There was in addition a significant interaction Animal:Paw (p = 3.13e-
21). as sham animals showed no difference in their PWT after the surgery, while cuff mice showed 
a marked reduction in their PWT of their right hindpaw (Fig. 3.5). Post-hoc analysis demonstrated 
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Figure 3.5: The cuff model to induce peripheral neuropathy in mice. 3.5A: The surgery was
performed on > 3 week old animals. The sciatic nerve of the anesthetized animal was exposed
using wooden picks (Left panel). The cuff animals have a 2mm polyethene cuff placed on the
right sciatic nerve (Right panel) whereas the sham undergoes the same surgery but without a cuff
being placed (Middle panel). 3.5B: Following one week post-surgery, the mechanical paw
withdrawal threshold demonstrated was unchanged in sham whereas a reduction was observed in
right paw of cuff mice versus their left paw and right paw of sham mice (Animal: Day: Paw p =
9.47e-16, post-hoc: TukeyHSD). This reduction observed is the mechanical allodynia . *** p <
0.001 vs baseline, ** p < 0.01, * p < 0.05.
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that the ipsilateral PWT in cuff mice was significantly different than ipsilateral in sham and 
contralateral in cuff. 
Interpretation-discussion: As previously published (Yalcin et al., 2014), cuff animals develop a robust 
and reliable mechanical allodynia in the ipsilateral paw after the surgery. 
3.1.2. Nicotinic antagonist: mecamylamine 
As for naïve animals, drugs were injected only after a stable PWT was determined. Sham and cuff 
mice were injected i.t. with mecamylamine (10-400 nmol) or with saline (0.9% NaCl), and tested at 
different time points after the injection; the threshold at 15 and 150 min after injection is presented 
in Fig. 3.6 A,B. For either the ipsilateral or the contralateral paw, we used a non-parametric multiple 
comparison test (nparLD, see Methods) to compare the PWT between animals (Sham vs Cuff), 
Drug (saline, 10-400 nM mecamylamine) and Time (0, 15 and 150 min post i.t. injection). There 
was a significant effect of Animals and Time (p =6.2e-01), as well as a significant interaction 
between Drug and Time (p=1.04e-19). There was a significant interaction between Animal, Time 
and Drug (p = 4.60E-002). 
Mecamylamine induced a dose-dependent reduction in the mechanical withdrawal threshold of the 
contralateral hindpaw in sham and cuff mice. For the ipsilateral hindpaw, 10 nmol was ineffective 
in cuff as opposed to sham groups. The mechanical allodynia is exacerbated when higher doses 
were injected within cuff animals. However, there was a shift in the dose-response after neuropathy, 
with higher doses being necessary to obtain a significant effect (Fig. 3.6 C). Interestingly, unlike 
100 and 400 nmol mecamylamine that maintained its effect in both animal groups for 150 min; the 
PWT returned to baselines for 20 nmol mecamylamine in cuff animals.  
Interpretation-discussion: We are the first to demonstrate the presence of a spinal cholinergic tone in 
mice after peripheral neuropathy. In a study using a different neuropathy model (partial nerve 
ligation) and a different strain of mice (ddY), Rashid and co-authors had demonstrated that a 10 
nmol mecamylamine dose after neuropathy did not affect the thermal PWT.  
We decided to further investigate this point by performing a dose-response curve. Interestingly, we 
started to see an exacerbation of the allodynia with 20 nmol mecamylamine. The effect was even 
stronger with increasing doses. This led us to the conclusion that the spinal cholinergic tone was 
still present in cuff animals, involving nAChRs and affecting mechanical responses.  
Because baseline PWT are very different between cuff and sham mice, it was difficult to directly 
compare the “potency” of mecamylamine effect between these two groups. We thus decided to 
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Figure 3.6: Time course of the effect of intrathecal mecamylamine (nicotinic antagonist) on mechanical
paw withdrawal threshold [PWT] of neuropathic Cd1 mice [Groups n = 4 - 5]. 3.6A,B: Treatment with 10
nmol mecamylamine did not intensify mechanical allodynia (lowering of PWT) in ipsilateral paw of cuff
mice. The mechanical allodynia in the ipsilateral paw was further potentiated when treated with 20, 100 and
400 nmol mecamylamine (bottom right) (Animal -Drug-Time interaction: p < 0.001). 3.6C: Dose response
curve for mecamylamine at 15 min post-injection for the ipsilateral paw of sham and cuff mice. (Animal -
Drug-Time interaction: p < 0.001). The relative response for time point (t) = ("#$%& "#$'))** ×100. *** p <
0.001 vs baseline, *p < 0.05 vs Time 0
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express the drug effect as a relative response (see legend of Fig. 3.6 C). It then became evident that 
there was, in cuff mice, a shift to the right in the dose-response curve for mecamylamine, suggesting 
that a plasticity took place in the spinal cholinergic system. 
3.1.3. Muscarinic antagonist: atropine and scopolamine 
Atropine (15-30 nmol) or Scopolamine (10-20 nmol) was similarly injected i.t. in cuff and sham 
mice. For either drugs, and either the ipsilateral or the contralateral paw, we used a non-parametric 
multiple comparison test (nparLD, see Methods) to compare the PWT between animals (Sham vs 
Cuff), Drug (saline, 15-30 nmol atropine or 10-20 nmol scopolamine) and Time (0, 15 and 60 min 
post i.t. injection).  
It produced dose dependent reduction in PWT in sham mice as observed in the naïve animals. In 
cuff mice, 15 and 30 nmol atropine had no effect on mechanical PWT in cuff ipsilateral paw but 
remains effective for both hind-paws in sham and contralateral paw of cuff group (Fig. 3.7A). In 
contrary, we observed a further decrease in the mechanical PWT with Scopolamine (10 – 20 nmol).  
Interpretation-discussion: The presence of a muscarinic component of the spinal cholinergic tone had 
never been investigated in mice after peripheral neuropathy.  The scopolamine data suggest the 
presence of a cholinergic tone acting via mAChR even after peripheral neuropathy. Somehow 
surprisingly, we did a different observation with atropine. In general, both atropine and 
scopolamine are non-selective antagonists to mAChR. Both compounds have been reported to 
cross the blood brain barrier. They have similar structures except for scopolamine that has an 
additional epoxide group that reduces its basic strength thus allowing it to penetrate the CNS more 
readily (Crespo et al., 2010). However, we did not observe any difference in the onset of reduction 
of PWT in both sham and naïve groups which could be due to the more direct drug administration 
via it. injections. Furthermore, the affinities to different subtypes of (human) mAChRs are similar 
between atropine (Peralta et al., 1987; Buckley et al., 1989) and scopolamine (Huang et al., 2001). 
Yet, these two drugs have different CNS-depressive effects such as drowsiness, amnesia, fatigue 
and dreamless sleep (Corallo et al., 2009). Although difficult to explain from a mechanistic point 
of view, the different effect of scopolamine vs. atropine in cuff mice is therefore not completely 
unexpected. 
Atropine was tested in diabetic neuropathic models yet did not alter the mechanical withdrawal 
threshold (Koga et al., 2004). In rats, atropine was also ineffective in altering the nociceptive 
mechanical thresholds following peripheral neuropathy (Lavand'homme and Eisenach, 1999; 
Paqueron et al., 2003).  
Figure 3.7: Time course of the effect of intrathecal atropine and scopolamine (muscarinic
antagonist) on mechanical paw withdrawal threshold [PWT] of neuropathic Cd1 mice [Groups n = 3
- 10]. 3.7A: Treatment with 15 and 30 nmol atropine did not intensify mechanical allodynia (lowering
of PWT) in ipsilateral paw of cuff mice (bottom right) but did in sham (bottom left) animals. (Drug-
Time interaction: p < 0.01). 3.7B: Treatment with 10 and 20 nmol scopolamine intensified
mechanical allodynia in sham and cuff mice. (Contralateral: Drug-Time interaction: p < 0.01;
Ipsilateral: Animal: Drug: Time p < 0.01) *** p < 0.001 vs baseline, *p < 0.05 vs Time 0
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3.2. In vivo electrophysiological characterization  
3.2.1. Properties of recorded neurons 
DH neurons were recorded from both sham (N = 46) and cuff mice (N = 32). Recorded neurons 
had in sham were more superficial compared to cuff groups (Fig. 3.8A) (# p < 0.05, paired-sample 
Wilcoxon test). The neurons recoded in sham were distributed along the dorsal horn, with an 
average depth of 316.1  µm ± 21.21 µm (range: 30, 622 µm) whereas with the cuff animals – the 
average depth was at 394.5 µm ± 23.06 µm (range: 89, 602 µm). There was no change in the touch 
and pinch, but the response to mean ongoing activity was increased in cuff animals compared to 
sham ones (Fig. 3.8B) (* p < 0.05, paired-sample Wilcoxon test). The basal ongoing activity has 
increased in cuff compared to sham animals (## p < 0.01, two-sample Wilcoxon test). The 
proportion of neurons remained similar between sham and cuff groups (Fig. 3.8C). 
Interpretation-discussion: The previously published study (Medrano et al., 2016) distinguished 
spontaneously and non-spontaneously active neurons (SA and NSA); the reported ratio was 
1SA:1NSA in sham vs. 4SA:1NSA in cuff. On average, the firing property of SA neurons was 
unchanged after neuropathy. But taking into account the reduced number of “silent” NSA neurons 
in cuff mice, we observe a rise in global ongoing activity (including all SA and NSA neurons).  
As SA neurons accounts for 80% of the recorded neurons in cuff, we do not observe an increased 
response to touch in these animals as previously reported in SA neuron in cuff animals. In addition, 
the larger number of WDR neurons sampled in our cuff group could introduce a bias towards 
neurons responding less to touch.  
3.2.2. Nicotinic antagonist: mecamylamine 
Neurons recorded in sham-operated mice responded to the local application of 100 µM 
mecamylamine as the ones recorded in naïve mice, i.e. by an increased ongoing firing as well as an 
increased response to touch and pinch (Fig. 3.9A) (N = 14, p < 0.05 ongoing activity, touch and 
pinch with drug vs control, Paired-samples Wilcoxon test). In contrast, mecamylamine had no 
effect on the ongoing activity of DH neurons recorded from cuff mice, neither on their response 
to pinch. It only induced an increased response to touch (N = 11, p < 0.05 touch with drug vs 
control, Paired-samples Wilcoxon test). 
Interpretation-discussion: The nicotinic antagonist still has an effect on the response of DH neurons 
to touch in cuff animals, demonstrating that there is a spinal cholinergic tone present in these 
neuropathic animals, acting through nicotinic receptors. However, the absence of effect on the 
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Figure 3.8: The characterization of recorded DH neurons after peripheral neuropathy. 3.8A: The
localization of the recorded DH neurons in sham (N = 46) and cuff (N = 32 ) animals. Symbols are
the individual cells and red lines are the mean ± S.E.M of neurons (# p < 0.05, paired-sample
Wilcoxon test). 3.4B: The effect produced by touch and pinch on neurons in neuropathic mice.
Higher firing rate induced by pinch compared to touch was observed in sham but not cuff mice (* p
< 0.05, paired-sample Wilcoxon test). The basal ongoing activity has increased in cuff compared to
sham animals (## p < 0.01, two-sample Wilcoxon test). Bars represent the mean ± S.E.M of the
increase of firing rate during touch and pinch application (10 s). 3.4C: The percentages of Low
Threshold (LT), Wide Dynamic Range (WDR) and High Threshold (HT) neurons in sham and cuff
animals.
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ongoing activity or on the response to pinch suggests that the spinal cholinergic system (or the 
circuit up- or down-stream to it) has undergone plasticity. Interestingly, this plasticity appears to 
affect differentially non-nociceptive and nociceptive circuits. 
3.2.3. Muscarinic antagonist: atropine 
Similarly, neurons recorded in sham-operated mice responded to the local application of 10 µM 
atropine as the ones recorded in naïve mice, i.e. by an increased ongoing firing as well as an 
increased response to touch and pinch (Fig. 3.9B) (N = 13, p < 0.05 ongoing activity, touch and 
pinch with drug vs control, Paired-samples Wilcoxon test). In contrast, atropine had no effect on 
any of the investigated properties of DH neurons recorded from cuff mice (N = 9). 
Interpretation-discussion: Recordings in the presence of 10 µM atropine in cuff mice suggest that the 
spinal cholinergic tone is not acting through muscarinic receptors after neuropathy. However, we 
cannot exclude that higher doses of atropine (or more specific antagonists acting only on the M1-
M3-M5 or M2-M4 subtypes of mAChRs) could reveal the presence of a muscarinic component of 
the cholinergic tone in cuff mice. In all cases, our data strengthen the demonstration of a plasticity 
of the spinal cholinergic system after neuropathy. 
3.2.4. Interplay with the inhibitory circuits 
In order to further investigate the interplay between the spinal cholinergic system and spinal 
inhibitory circuits, Maria Medrano repeated the previous experiments in the presence (or absence) 
of antagonists for GABA-A and glycine receptors, respectively bicuculline (10 µM), and 
Phenylbenzene O-phosphono-A-amino acid (PMBA) (10 µM). The combination of these 
antagonists is hereafter called inhAnt. 
In sham mice, the application of inhAnt induced an increased response to touch and pinch 
(Mecamylamine: N = 10, p< 0.05 Pinch, p < 0.001 Touch with drug group vs control, Paired-
samples Wilcoxon test &  Atropine: N = 10, p < 0.01 Touch and Pinch with drug group vs control, 
Paired-samples Wilcoxon test). The subsequent application of 100 µM mecamylamine or of 10 µM 
atropine (on top of the inhAnta) had no further effect (Right - Fig. 3.10 A and Fig. 3.10 B).  
As previously published, the application of inhAnt in neurons recorded in cuff mice did not have 
any effect. Moreover, the subsequent application of 100 µM mecamylamine or of 10 µM atropine 
(on top of the inhAnta) had no further effect (Right - Fig. 3.10 A and Fig. 3.10 B) (Mecamylamine: 
N = 11 & Atropine N = 9). 
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Figure 3.9: The effect of cholinergic drugs on touch and pinch response in DH recorded neurons
following peripheral neuropathy. 3.9A: Effect of mecamylamine (non-specific nAChR antagonist) on
touch and pinch responses of sham (Left, N = 14) and cuff (Right, N = 11) animals. Mecamylamine
increased the ongoing activity and responses to touch and pinch. However, only an increase in firing
after touch was observed after neuropathy. 3.9B: The effect of atropine (non-specific mAChR
antagonist) in touch and pinch on neurons in sham (Left, N = 13) and cuff (Right, N = 9) mice.
Similarly, the ongoing activity, responses touch and pinch was elevated in the presence of atropine
during sham. However atropine lost all its effects in cuff animals. Bars represent the mean ± S.E.M
of the increase of firing rate during touch and pinch application (10 s); *p < 0.05 ongoing activity or
touch or pinch with drug vs control (Paired-samples Wilcoxon test).
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Interpretation-discussion: In the previous publication, Medrano and authors observed that the 
application of InhAnt induced the development of ongoing activity in previously “silent” neurons 
(NSA neurons), and increased the ongoing activity of SA recorded in sham mice. We were therefore 
expecting an increased ongoing activity in our sham sample, which we did not observe. A possible 
explanation is the smaller number of recorded neurons in the present study. We however 
confirmed the increased response to touch and pinch observed in the study. This indicates that 
DH neurons are submitted to an inhibitory tone that controls their response to peripheral 
mechanical stimulation. 
In sham mice, mecamylamine and atropine have no effect when applied on top of inhAnta, 
suggesting the involvement of inhibitory neurons in the effect of cholinergic antagonists. Potential 
circuits will be discussed below. 
Medrano previously demonstrated that the net effect of the inhibitory tone was entirely lost in cuff 
mice, and we confirmed this observation with the present sample. Like in sham mice, the effect of 
cholinergic antagonists was lost in the presence of inhAnt; however, in cuff mice, the only effect 
of cholinergic antagonists was the effect of mecamylamine on the response to touch (Fig. 3.9 A - 
Right). Therefore, the inhAnt experiment suggests that this effect is mediated by inhibitory 
neurons.  
The most straightforward hypothesis would be that cholinergic receptors (tonically activated in 
sham) are expressed by inhibitory neurons impinging onto the recorded cell: in the presence of 
inhAnt, even though the presynaptic neuron is less active because of antagonism of the cholinergic 
tone by mecamylamine, this has no effect on the recorded neuron as inhibitory transmission is 
silenced. Of course, more complex circuits are conceivable, with the intervention of excitatory 
neurons.  
4. In search for the source of the spinal cholinergic tone 
The following section entails a joint work with Dr. Yunuen Moreno-Lopez, a post-doc within our 
team where she has optimized the virus injection technique in adult mice. Several potential sources 
of the spinal cholinergic innervation have been described (see introduction section 3.4). We aimed 
to unravel the contributing of each of these cholinergic populations to the modulation of 
nociceptive processing by utilizing a DREADD approach. We induced expression of hM4Di 
receptors, that are modified muscarinic receptors. When activated by a specific ligand – Clozapine 
N-oxide (CNO), they induce inhibition of the neuron. In our experimental paradigm, we injected 
adult ChAT::Cre mice with Cre­inducible recombinant AAV vectors: AAV8­hSYN­FLEX-
AB
Figure 3.10: The pharmacological induced disinhibition of the spinal cord in sham and cuff animals.
The inhibitory antagonists (InhAnt) added were non-specific GABA-A antagonist, bicuculline
(10µM) and non-specific glycinergic receptor antagonist, PMBA (10µM). 3.10A: Effect of
mecamylamine (non-specific nAChR antagonist) with InhAnt on touch and pinch responses of sham
(Left, N = 10) and cuff (Right, N = 6) animals. InhAnt increased the responses to touch and pinch
but not in cuff. Moreover, mecamylamine with InhAnt had no effects in sham and cuff animals.
3.10B: The effect of atropine on touch and pinch responses of neurons in sham (Left, N = 9) and
cuff (Right, N = 5) mice. Similarly, the responses to touch and pinch was elevated in the presence of
InhANT during sham but not cuff mice. However, atropine with InhAnt lost all its effects in sham
and cuff animals. Bars represent the mean ± S.E.M of the increase of firing rate during touch and
pinch application (10 s); (* p< 0.05, ** p < 0.01, *** p < 0.001, drug group vs control, Paired-
samples Wilcoxon test).
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hM4Di-mCfherry (AAV8-hM4Di) and AAV9-hSYN-FLEX-hM4Di-mCherry (AAV9-hM4Di). 
The different candidate structures are the spinal cord, RVM and DRG. Following the injections, 
the animals are tested with the von Frey test to identify the populations contributing to the spinal 
cholinergic tone involved in establishing mechanical nociceptive threshold.  
4.1. ChAT-Cre animals 
As a control for the expression, we crossed ChAT-Cre animals with a reporter line, ROSA-26 
tdTomato. Surprisingly, we observed expression of the tdTomato reporter protein (red) in a large 
quantity of non-ChAT expressing cells in adult reporter mice (N = 3, Fig. 3.11).  
Interpretation-discussion: The different techniques used to produce transgenic mice are differently 
prone to non-specific expression. Indeed, the level of expression of  BAC transgenic mice is highly 
dependent on the site(s) of insertion of transgene. However the ChAT-Cre mice that we use are 
knock-in animals: we therefore expected a pattern of expression strictly identical to the endogenous 
ChAT. However by crossing these mice with a mouse expressing a floxed-version of tdTomato, 
we have no control over the moment where the recombination occurs. We suspect that the non-
ChAT tdTOM+ neurons were ChAT expressing cells at some point before adulthood.The Cre-
recombinase enzyme present during younger developmental stages may have permanently enabled 
the transcription of the tdTomato construct thus allowing these neurons to remain tdTOM+.  
Our project mostly involved injection of Cre-dependent viruses in adult mice, and was therefore 
not impacted by this developmental issue. Only DRG-targeting injections were performed in 
neonatal mice (see Methods) and deserved particular control for specificity of expression.  
4.2. Expression of the viral construct 
Following a minimum of three weeks for recovery and sufficient time for expression of viral 
constructs (or to reach adulthood for DRG targeted mice), the mechanical PWT of these animals 
were assessed, in control conditions and after injection of CNO. After their behavioral assessment, 
the histological experiments were performed to verify the reporter protein expression (mCherry), 
colocalization with ChAT and their location in the different structures. 
4.2.1. Spinal injection 
A total of 14 adult ChAT-Cre animals were injected with both AAV8- and AA9- hM4Di viral 
constructs (Median injected volume = 540 µl; range 90 to 764 µl). The co-ordinates ranged from 
150 – 250 µm in depth and 350 – 400 µm laterally from the midline of the spinal cord. In our 
Endogenous tdTOMChAT Merged
Figure 3.11: Expression of tdTomato reporter protein in ChAT-Cre x ROSA26-tdTomato adult
mice. Immunoreactivity against Choline acetylcholinetranferase (ChAT) (Green, Left panel) to verify
the expression of reporter protein (Red, Middle panel) in cholinergic neurons (N = 3). In the merged
images (Yellow, Right panel), a number of cells colocalized with both ChAT and tdTomato (arrows)
however, a large proportion of cells were expressed in potentially non-ChAT cells (arrowheads).
(Scale = 100 µm)
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preliminary experiments, we directly mounted the perfused tissue for verification (without ChAT 
immunohistochemistry). These two injected mice (injected volume = 630 µl) contained large 
infections in the DH, central canal and even some motor neuron populations in the ipsilateral side 
of the spinal cord (Fig. 3.12A). Herein, infected neurons ranged from L3 – L6 spinal segments. We 
subsequently reduced the injected volumes (< 540 µl) to prevent at least the infection of autonomic 
and motor cholinergic pools; preliminary data demonstrated that this enabled to restrict the 
infection to the dorsal horn. Baseline PWT were undistinguishable from those of CD1 mice 
(personal observation). We tested the effect of CNO on the animals injected with these lower 
volumes (see below); they now await for histological analysis that can confirm hM4Di receptor 
expression in cholinergic cells and the exact spread of this expression. 
Two spinally injected mice (and two mice injected in the spinal cord and RVM, see below) 
demonstrated a reduction in PWT with 10 mg/kg CNO (Fig. 3.13). This reduction was profound, 
robust and reproducible: it could be observed on different testing days, and the same animals did 
not respond to saline. However the other spinally-injected mice showed no response to CNO. 
Interpretation-discussion: In preliminary experiments, a successful expression of viral constructs was 
observed in the spinal cord. Unsurprisingly, the larger volume of virus resulted in wider expression 
observed in the dorsal, central and ventral regions of the spinal cord. The response to CNO was 
extremely variable amongst injected mice, as most did not respond while 4 responded robustly. We 
are analyzing all variables (quality and freshness of CNO aliquot, conditions of solubilization) that 
could explain such difference, without a clear lead. The analysis of the spread of infection might 
provide insight. 
4.2.2. RVM injection 
We have performed a total of 9 injections to target the descending cholinergic populations in the 
RVM (Median injected volume = 540 µl, ranging from 450 – 810 µl). The current targets co-
ordinates are approximately 0.7 mm lateral to midline, 5.2 mm caudal to Bregma and 5 mm ventral 
to the cerebellar surface. Similarly, to the spinal cord injections, the injection sites were verified in 
preliminary experiments. We observed expression of mCherry reporter protein that localizes with 
a proportion of ChAT neurons in the RVM of a mouse (Fig. 3.12B).  
Baseline PWT were undistinguishable from those of CD1 mice (personal observation). As 
mentioned above, two animals injected in the RVM that were also injected spinally, demonstrated 
reduction in PWT with 10 mg/kg CNO (Fig. 3.13). The other animals did not respond to CNO. 
All animals have been perfused and await histological verification.  
mCherry
L4/5
mCherry
L6
mCherryChAT Merged 
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Figure 3.12: Expression of hM4Di - mCherry reporter protein in spinal cord and RVM of ChAT
Cre animals. 3.12A: The spinal injected ChAT Cre mice expressed (N = 2) endogenous mCherry
coupled to hM4Di in potentially ChAT neurons located in the Dorsal, Intermediate and Ventral
regions of the spinal cord (Scale = 200 µm). 3.12B: The ChAT Cre mouse injected in the Rostral
Ventromedial Medulla (RVM) (N = 1). Immunoreactivity against Choline acetylcholinetranferase
(ChAT) (Green, Left panel) to verify the expression of mCherry reporter protein (Red, Middle panel)
in cholinergic neurons. In the merged images (Yellow, Right panel), a number of cells colocalized
with both ChAT and mCherry (arrows) (Scale = 100 µm).
Figure 3.13: Time course of the effect of intraperitoneal Clozapine N-oxide (CNO) in ChAT
Cre animals injected with AAV8-hSYN-hM4Di-mCherry and AAV9-hSYN-hM4Di-mCherry [N:
Spinal cord only = 2, Spinal cord +RVM = 2]. The same animals were tested over several days.
For control experiments, the mice received i.p. injection of MilliQ water. After 5 days, CNO (10
mg.kg) induced mechanical allodynia in injected animals. (Ipsilateral side: Drug:Time interaction:
p < 0.01; post-hoc: Dunnett’s multiple comparisons) ## p < 0.01, #p < 0.05 vs Time 0
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Interpretation-discussion: Because the two responder mice were also injected in the spinal cord, we 
hypothesize that their response is due to the expression of hM4Di in the spinal cord. However we 
need to wait for histological analysis. For RVM injection, two technical points needs to be 
addressed. First, as the target area is ventrally located thus implicating a long travel route for the 
pipette. This potentially allows damage to the intermediate structures. In consequence, the pipettes 
were adapted to possess a thin long taper. Secondly, other cholinergic populations (i.e. autonomic 
and motor neurons) are located within these areas (Stornetta et al., 2013). We might need to adjust 
the injected volumes and improved precision in co-ordinates to prevent infection of undesired 
populations, and thus potential side effects of CNO application. 
4.2.3. DRG injection 
We performed two batches of injection aiming at silencing potential cholinergic neurons in the 
DRG. For this, we performed a unilateral s.c. injection in the hindpaw of P5-P8 animals, and waited 
for 3 weeks. This procedure has been shown to induce expression of the viral construct in DRG 
neurons. Similarly as for silencing DH and RVM neurons, we used a floxed version of the 
DREADD receptors injected in ChAT::Cre mice. The animals are awaiting pharmacological 
assessment prior to histological control. Although with completed behavioral data for spinal cord 
and RVM groups, we are unable to form constructive interpretation until histological experiments 
are performed to confirm the location and the nature of the infected cells. Nevertheless, our 
preliminary data suggests that the DREADD approach is working by producing mechanical 
allodynia in infected animals. 
5. Discussion 
In this chapter, we have demonstrated the presence of a spinal cholinergic tone modulating 
mechanical nociceptive threshold in naïve adult mice. In addition, we have shown that this tone 
was altered after a surgery inducing peripheral nerve injury.  
5.1. Spinal cholinergic tone 
The “cholinergic tone” was defined from pharmacological experiments, either at the behavior level 
or the circuit level (in vivo recordings). For both experimental approaches, selective antagonists 
for nAChRs and mAChRs (mecamylamine and atropine) were used and demonstrated that their 
respective receptors where endogenously activated under basal conditions, and that their activation 
controlled the way the mice (or the DH neurons) responded to mechanical stimulation.  
  81 
The term “tone” might be misleading because it is of the same family than “tonic”, commonly used 
to describe an effect that occurs repetitively (i.e. “tonic firing”). The existence of a 
“pharmacological tone” does not require “tonic” release of ACh: ACh could actually be released 
phasically as a consequence of the mechanical stimulation. Only the effect of the antagonists on 
the ongoing firing activity of DH neurons suggests some kind of “ambient level” of ACh in basal 
conditions. 
We only used a general nicotinic antagonist, mecamylamine, but previous papers have shown 
similar effect using the a4b2 nAChR antagonist, DHbE (1-10 nmol) in mice (Rashid et al., 2006). 
The a7 nAChR antagonistMLA (10 nmol) had no effet, suggesting that mechanical PWT is 
dependent on a4b2 nAChR but not a7 nAChR in mice (Rashid et al., 2006). Interestingly, the 
a3b2*/a6b2* nAChR antagonist, a-CTX-MII (0.03 – 0.1 pmol) reduced the paw withdrawal 
thresholds in naïve rats (Young et al., 2008b). This suggests that an endogenous spinal cholinergic 
tone acts to inhibit the transmission of nociceptive mechanical stimuli via various subtypes of 
nAChR in rodents. 
5.2. Technical considerations 
Certain considerations shall be made for the technical approaches used within our study. For the 
behavior, we have utilized the von Frey test to determine the PWT of animals. Although the 
animals are unrestricted during tests, the changes in the behavioral state (deep sleep, light sleep, 
resting, grooming and alert) can modulate the outcome of the mechanical threshold assessment. 
Interestingly, animals undergoing grooming appear to be hypoalgesic (reduced sensitivity to pain 
stimulus) even in nerve injured animals (Callahan et al., 2008). There was certain variability in the 
baseline responses of animals, which we related to these different behavioral states. Other 
mechanical tests exist for rats such as the Randall Selitto test in which a blunt point is exerted on 
the fixed paw of the rats to determine their PWT (Randall and Selitto, 1957). Moreover, calibrated 
forceps have been described as a quick and reliable manner to determine the mechanical threshold 
comparted to classical von Frey tests in rats (Luis-Delgado et al., 2006). Although they have been 
used to assess tail withdrawal threshold of mice (Kashiwadani et al., 2017), they are not yet adapted 
to study paw withdrawal. von Frey testing remains the most well-established and robust technique 
to assess mechanical paw thresholds in mice with models of peripheral neuropathy.  
Intrathecal injections have been suggested to directly deliver drugs into the subarachnoid space and 
eventually joining the cerebral spinal fluid. However, this can potentially act on both the central 
(spinal) and peripheral (PNS) nervous systems. Cholinergic receptors are expressed on primary 
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afferents (see Introduction section 3.3), and their potential contribution to the observed effects will 
be discussed below. 
It has been reported that non-specific interaction of cholinergic drugs may occur at higher 
concentrations used. Although we are unaware of unspecific interaction for mecamylamine, given 
the high concentration used, we decided to perform a control on β2* nAChR K/O mice. This 
demonstrated that β2* nAChR are the receptors involved in the observed behavior. Atropine and 
scopolamine have reported non-specific binding. In the presence 1µM atropine, nicotinic inward 
currents were either inhibited (α3β2, α3β4), less inhibited (α2β4, α7), or potentiated (α4β2, α4β4) 
(Zwart and Vijverberg, 1997). Although these interactions do not all involve β2* nAChR, we plan 
to test the effect of atropine in β2 K/O mice to at least rule out some of these non-specific effects. 
Furthermore, the 5 HT-3 serotonin receptor responses were inhibited by both scopolamine (IC50 
= 2.09µM) and atropine (IC50 = 1.74 µM) in xenopus oocytes (Lochner and Thompson, 2016).  
Some nicotinic antagonists, such as hexamethonium, have been reported to interact with M2 and 
M3 mAChR subtypes in vitro at concentrations at 0.1 to 10mM respectively (Eglen  et al., 1989 ). 
Similarly to β2 K/O mice, we test the antagonists with their respective knock-out mice (i.e. 
nicotinic antagonist with nAChR subunit knock-out mice. Alternatively, we can test the same drug 
in the proposed knock-out version of the proposed receptor (for hexamethonium – using an M2 
or M3 mAChR K/O mice). This could provide some clarity concerning the specificity.   
We observed differences between the effect of atropine and scopolamine however, their 
pharmacokinetics appear similar:  Atropine (pKi): M1 = 8.5 – 9.6; M2 = 7.8 – 9.2; M3 = 8.9 – 9.8; 
M4 = 8.7 – 9. 5; M5 = 9.3 – 9.7. Scopolamine (pKi): M1 = 9.0, M2 = 8.7; M3 = 9.4; M4 = 9.5  
DREADD experiments (using hM3D receptors) have been successfully used to elucidate the 
functional role of two spinal populations in the nociceptive circuit (Peirs et al., 2015; Petitjean et 
al., 2015). Interestingly, the number of hM3D-mCherry expressing neurons within the population 
of interest (PV neurons) was very sparse (c.f. Supplementary S6), yet CNO-induced behavior effect 
was still observed. This drove us to expect a significant effect of CNO beside the modest size of 
targeted cholinergic populations.  
Recently, it has been reported clozapine, an antipsychotic drug, may presumably bind to the CNS 
expressed DREADD receptors. Following systemic injection, CNO is degraded into clozapine that 
readily crosses the BBB unlike CNO. This is raising caution in the experimental design and 
conclusions drawn from DREADD experiments (Gomez et al., 2017).  
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5.3. Plasticity of the spinal cholinergic tone and potential underlying 
circuits 
In naïve (and sham) mice, our experiments demonstrated the presence of a cholinergic tone pacing 
the on-going spiking activity of DH neurons, as well as their response to touch and pinch; in 
behaving animals the global output of the tone is antinociceptive (for mechanical PWT).  
Peripheral component to the tone: As mentioned above, intrathecal administrations potentially impact 
the peripheral nervous system. Cholinergic receptors are present on primary afferents (see 
Introduction). For example, a3a5b4* nAChR subtypes have been detected in unmyelinated C 
fibers. Nicotinic activation induces axonal excitability, an effect blocked by mecamylamine. This 
indicates a pro-nociceptive effect of these nAChRs (Lang et al., 2003). This conclusion is reinforced 
by the observation that the knockdown in a5 nAChR alleviates mechanical allodynia after 
peripheral injury (Vincler and Eisenach, 2005). Such components go in the opposite direction (pro-
nociceptive) to our observations, and therefore do not contribute predominantly to them. 
However, there is an anti-nociceptive peripheral non-b2* nAChR component, that was revealed 
by the administration of a nicotinic antagonist that does not cross the BBB. In b2 K/O mice, 
intrathecal hexamethanonium did not produce any effect; however i.p. injections reduced the 
mechanical thresholds in WT and b2 K/O littermates. This suggests that there is a peripheral (but 
not spinal) nicotinic anti-nociceptive component acting on non-b2* nAChR (Yalcin et al., 2011).  
Muscarinic receptors are also present on primary afferents. In rat skin nerve preparation, muscarine 
induced a marked decrease in the response to mechanical and heat stimuli which is blocked by 
scopolamine and the M2 subtype specific antagonist, gallamine (Bernardini et al., 2001). The anti-
nociceptive effect produced by muscarine was lost in M2 K/O mice but was not significantly 
altered in M4 K/O mice in isolated skin preparations. This reinforces the role of peripheral M2 
receptors in anti-nociception (Bernardini et al., 2002). Potentially, our intrathecal application of 
mAChR antagonists could be blocking these M2 receptors thus leading to a reduction of 
mechanical PWT. 
Plasticity of the tone: Our data also indicate that this cholinergic tone is still present in neuropathic 
mice, and globally acting in the same direction. But several observations demonstrate that it has 
undergone a profound plasticity. From a behavioral point of view, higher concentrations of 
nicotinic antagonist are required to obtain an observable effect in cuff animals, suggesting a change 
in either the number, composition or localization of endogenously activated nAChRs, or alterations 
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in the up-stream or down-stream network. This plasticity also involves mAChRs, although the 
maintained effect of scopolamine (in contrast with the loss of effect of atropine) suggests the 
existence of diverse muscarinic components modulating nociceptive processing. 
In vivo recordings of DH neurons give further insight into possible mechanisms and underlying 
circuits. We found an in vivo correlate of the “cholinergic tone” observed in behaving animals. DH 
neurons responding to mechanical stimulation were under a cholinergic control, impacting their 
ongoing firing and their response to mechanical stimulation (nociceptive or non-nociceptive). With 
the single dose tested in vivo in cuff animals, we could detect only a remnant nicotinic effect on 
the neurons response to touch. Admittedly, only a single dose of atropine was tested in vivo; similar 
experiments with scopolamine would be needed to unravel a potential remnant muscarinic 
component (as observed in behaving mice). 
Putative underling circuit: Experiments with InhAnT (bicuculline and PMBA –GABA-A and 
glycinergic receptor antagonists) in conjunction with the cholinergic drugs has allowed further 
dissection of the spinal circuit involved in the cholinergic modulation of mechanical information 
transmission. A potential minimal circuit is presented in Fig. 3.14. For naïve and sham mice (Fig. 
3.14A), the model proposes the cholinergic tone either activate (via b2* nAChR or M1/M3/M5 
mAChR subtype) or disinhibit (via an inhibitory neuron expressing M2/M4 mAChR subtype) an 
inhibitory interneuron, which is presynaptic to the recorded DH neuron. In the presence of 
InhAnt, the pharmacological disinhibition of the spinal circuit blocks the output of presynaptic 
inhibitory interneurons thus increasing the firing activity directly (disinhibit cell) or via primary 
afferents (disinhibit incoming fiber). In neuropathic conditions (Fig. 3.14b), a change in spinal 
GABA/glycine system and dorsal horn network takes place thus InhAnt loses its disinhibition 
effect on the recoded neuron. However, touch responses continue to be mediated via nAChR. 
In conclusion, we have demonstrated the role of a spinal cholinergic tone in establishing 
mechanical nociceptive thresholds. In the spinal cord, the cholinergic tone has been shown to 
involve both nAChR and mAChR in naïve and sham mice. Following peripheral nerve injury, the 
animals appeared to have an altered cholinergic system acting partially through nAChRs.  
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Figure 3.14: The proposed spinal circuit in the DH of the spinal cord in naive/sham and cuff mice.
3.14A: In naïve/sham animals, the presynaptic GABA-/Glycinergic interneuron, to the recorded DH
neuron, is activated [via β2* nicotinic acetylcholine receptors (nAChR) or M1/M3/M5 muscarinic
acetylcholine receptors (mAChR)] or disinhibited (via an inhibitory (I) interneuron with M2/M4
mAChR) by the cholinergic tone during application of touch or pinch. In the presence of their
respective antagonist, the nAChR and mAChR are blocked thus inhibiting the presynaptic neurons
and increasing the activity in the recorded cell via disinhibition or direct activation of primary
afferent fibers (in turn disinhibited). 3.14B: In neuropathic conditions, the GABA/Glycinergic
system has undergone changes as observed (decolorization of presynaptic cell) however, it is
activated by nAChR by cholinergic tone during touch.
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Chapter 4: Dorsal horn cholinergic interneurons: the 
dual language of a minority population 
1. Context and objectives  
A dense plexus of cholinergic processes (comprising both cholinergic dendrites and axons) lies in 
laminae (L) II­III of the DH of rodents (Barber et al., 1984; Mesnage et al., 2011). Within this 
plexus, cholinergic fibers interact in a synaptic and reciprocal way with incoming sensory afferents 
(Ribeiro-da-Silva and Cuello, 1990; Olave et al., 2002). This interaction appears to be the most 
probable substrate for cholinergic analgesia.  
Our team has characterized DH cholinergic interneurons (Mesnage et al., 2011) utilizing transgenic 
mice expressing the enhanced green fluorescent protein (EGFP) under the control of the ChAT 
promoter (ChAT::EGFP mice) (von Engelhardt et al., 2007). Interestingly, this sparse cholinergic 
population (< 25 cells/ spinal segment) also express GABA and n-NOS. Their unique morphology 
demonstrates dorsally orientated processes with large elongation in the rostro­ caudal axis. Their 
scarcity seems therefore balanced by an important dendritic and axonal territory. In addition, our 
team reported a similar population in the DH of macaque monkeys, with similar densities as in 
rodents. Cholinergic boutons are presynaptic to terminals of sensory primary afferents in both 
rodents and primates (Pawlowski et al., 2013a). These findings suggest a role for cholinergic 
interneurons in the modulation of incoming somatosensory information. Therefore, our objective 
is to understand the role of cholinergic interneurons within the spinal nociceptive network of naïve 
mice. 
2. Characterization of the spinal cholinergic DH neurons 
We recorded from ChAT::EGFP neurons in spinal cord slices, as well as from non-fluorescent 
neurons located in the vicinity of ChAT::EGFP neurons. This latter LIII/IV non-cholinergic 
population will be called Non-ChAT. Recordings were performed in slices with three different 
orientations: transverse (or coronal, TS), parasagittal (PS) and horizontal (HS) (see Methods and 
Fig. 2.1). 
57%
19%
24%
0%
69%6%
0%
25%
Figure 4.1: Firing patterns of ChAT::EGFP and Non-ChAT neurons in LIII/IV of the spinal
cord 4.1A: Recording illustrating of the 4 different types of firing patterns: Tonic; Single; Initial
burst and reluctant firing or silent in ChAT::EGFP. 4.1B: The distribution of different firing
patterns in the two neuron groups. The ChAT::EGFP were recorded in horizontal, parasagittal
and transverse slices whereas the non-ChAT were not recoded in from parasagittal plane.
ChAT::EGFP Non-ChAT
A
B
80 pA
Tonic
20 mV 
100 ms
Single Silent Initial bursting
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2.1. Firing pattern 
After obtaining a stable whole-cell recording, we switched to the current-clamp mode. A very low 
fraction of recorded neurons presented spontaneous ongoing firing at rest: 3 out of 21 (14%) 
ChAT::EGFP neurons, and 4 out of 16 (25%) Non-ChAT neurons (Fig. 4.2). There was no 
statistically significant difference between the two populations (Fisher’s exact test: p = 0.4373). We 
then applied pulses (700 ms) of positive currents (20 up to 600 pA) to investigate the firing pattern 
of the cells.  
ChAT::EGFP neurons presented different types of firing patterns (Fig. 4.1A,B): tonic (57.1% of 
neurons), initial burst (19%), or single spike (23.8%) (n= 21 neurons recorded from HS, PS and 
TS). Among Non-ChAT neurons (n= 16 neurons recorded in HS and TS), 68.8% were tonic, 6.3% 
single spike. In addition, three neurons (25%) were classified as “silent” or reluctant firing, as they 
did not fire action potentials after application of depolarizing current of 180 pA. To compare these 
observations in different slice orientation, firing patterns and neuron types, we have used three-
way contingency table. However there was no statistical difference between ChAT::EGFP and 
Non-ChAT neurons (for HS and TS only) concerning the proportions of the different firing 
patterns (3x3x3 contingency tables, p = 0.693). We only recorded ChAT::EGFP neurons in PS; 
the distribution of these neurons amongst the different firing patterns was not different in PS 
compared to TS and HS (Fisher’s exact test, p = 0.2982). Similarly, there was no significant 
differences between slices for non-ChAT cells (Fisher’s exact test, p =0.281) (Table 4.1). There 
also was no statistical difference in the rheobase for these two populations in different slice 
orientations (Kruskal Wallis test, p = 0.6427) (Table 4.2). 
Interpretation-discussion: A previous publication of our team analyzed the firing pattern of 
ChAT::EGFP neurons in parasagittal and horizontal slices, and reported 67% of tonic firing 
pattern, as well as 27% of neurons with ongoing firing activity (Mesnage et al., 2011). These 
proportions were not significantly different to our observations (chi-square, p=0.56 and p=0.35). 
Interestingly, in the previous study as well as in the present one, neurons with ongoing activity were 
of the “tonic” firing type. ChAT::EGFP neurons also presented other firing patterns, and there 
was no specific feature to this population. 
2.2. Passive properties 
We also injected negative currents (-30 to -90 pA) to investigate the membrane properties of 
recorded neurons. In particular, we measured the input resistance, the cell capacitance, and the 
amplitude of a (potential) sag current (see Methods). ChAT::EGFP neurons were recorded in the 
Table 4.1: Percentage of observed firing patterns in ChAT::EGFP+ and Non-ChAT cells
in three slice orientations of naïve mice.
Firing patterns ChAT::EGFP Non-ChAT ChAT::EGFP ChAT::EGFP Non-ChAT
Tonic Firing 85.7 87.5 28.6 57.1 50.0
Single Firing 0.0 0.0 28.6 28.6 12.5
Initial burst Firing 14.3 0.0 42.9 14.3 0.0
Silent 0.0 12.5 0.0 0.0 37.5
Total N 7 8 7 7 8
Horizontal Parasagittal Transverse
ChAT::EGFP+ Non-ChAT
Horizontal
Parasagittal
Transverse
Figure 4.2: Mean Instantaneous frequencies for ChAT::EGFP and Non-ChAT cells in three
slice orientations. Spontaneously firing cells (blue dots) at rest are present in both populations.
The reluctant firing cells (red dots) were present uniquely in Non-ChAT recorded cells.
A
B
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three slice orientations, while Non-ChAT neurons were recorded in horizontal and transverse slices 
(Table 4.2). There was no difference in the resting potential (ANOVA, p = 0.69), input resistance 
(ANOVA: p = 0.3651) or amplitude of sag current (Scheirer-Ray-Hare test:  p =0.98511), between 
these two cell groups, or between slice orientations. However, a difference in cell capacitance was 
observed between cell groups on different slices (ANOVA: p = 6.5E -003). The capacitance of 
ChAT::EGFP neurons recorded in transverse and parasagittal slices was statistically smaller than 
the one recorded in horizontal slices (Table 4.2) (TukeyHSD: respectively p = 8.7E -004 and p = 
0.006). Furthermore, the cell capacitance of Non-ChAT cells were smaller compared to 
ChAT::EGFP cells on horizontal slices (TukeyHSD: p = 8.6E -004).  
Interpretation-discussion: There was no passive property specific to ChAT::EGFP neurons. The fact 
that these neurons had lower cell capacitance in transverse slices could be explained by the 
morphology of the dendritic arbor: the team has indeed previously reported that cholinergic 
interneurons have an extended dendritic arbor in the rostrocaudal direction, mainly dorsal to the 
cell body (Mesnage et al., 2011). They are therefore potentially profoundly truncated in transverse 
slices. On the other hand, they are fully preserved in horizontal slices, and their average larger cell 
capacitance demonstrates that they are amongst the larger neurons in laminae III-IV. 
2.3. Rebound spiking 
The majority (85.7%) of ChAT::EGFP neurons presented a rebound spike upon the end of the 
hyperpolarizing pulse (Fig. 4.3). This was independent of the slice orientation. In contrast, only 2 
out of 13 Non-ChAT neurons (15.4%) presented such a rebound spike. There was a statistical 
difference between the two populations, when recorded in HS and TS, concerning this feature 
(Fisher’s exact test: p = 0.0004). The proportion of ChAT::EGFP neurons presenting a rebound 
spike was independent of the slice orientation (HS, PS and TS) (Fisher’s exact test: p = 0.7421).
  
Interpretation-discussion: The team previously reported the existence of rebound spikes in half 
ChAT::EGFP neurons (Mesnage et al., 2011). We observed a higher proportion of such rebound 
spiking neurons (chi-square, p=0,03), which even can be considered as a specific feature of the 
cholinergic interneurons in our dataset.  
ChAT::EGFP Non-ChAT
Figure 4.3: Electrophysiological properties of for ChAT::EGFP and Non-ChAT cells on
horizontal (HS), parasagittal (PS) and transverse (TS) slice in naive mice. 4.3A Voltage responses
to hyperpolarizing current steps. Post-IR: post-inhibitory rebound. Arrow: hyperpolarizing “sag.”
4.3B % sag amplitude. There was no observable differences in the sag amplitudes. Fig. 4.3C
Proportion of cells demonstrating rebound spikes after hyperpolarization pulses. The rebound
spikes appear to be a unique feature of ChAT::EGFP neurons
A
B C
-90 pA
20 mV 
100 ms
-90 -60 -30
0
10
20
30
Injected current (pA)
%
 S
ag
 a
m
pl
itu
de
Ih currents
HS - ChAT::EGFP+
PS - ChAT::EGFP+
TS - ChAT::EGFP+
HS - Non-ChAT
TS - Non-ChAT
RMP (mV) Input Resistance (TΩ) Capacitance (pF) Rheobase (pA)
Slice N ChAT::EGFP Non-ChAT ChAT::EGFP Non-ChAT ChAT::EGFP Non-ChAT ChAT::EGFP Non-ChAT
HS
ChAT::EGFP (7) Mean -50.84 -57.85 0.74 0.77 87.89 46.81 *** 42.86 25.71
Non-ChAT (8) SEM 4.44 3.07 0.12 0.11 7.92 3.69 8.92 11.34
PS
ChAT::EGFP (7) Mean -63.35 N/A 0.94 N/A 52.16 ### N/A 34.29 N/A
Non-ChAT (N/A) SEM 7.12 N/A 0.34 N/A 6.32 N/A 7.82 N/A
TS
ChAT::EGFP (7) Mean -56.95 -60.36 0.74 0.67 45.50 ### 41.28 38.57 36.00
Non-ChAT (8) SEM 2.88 4.39 0.10 0.21 8.16 5.54 10.79 11.62
Table 4.2: Electrophysiological properties of ChAT::EGFP and Non-ChAT cells in horizontal
(HS), parasagittal (PS) and transverse (TS) slices of naïve mice. ### p < 0.001 comparing
capacitance of slice vs HS; post-hoc: TukeyHSD *** p < 0.001 comparing capacitance between
ChAT::EGFP+ vs Non-ChAT.
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3. Spontaneous and miniature excitatory synaptic inputs onto 
DH ChAT::EGFP neurons 
3.1. Frequency of excitatory currents 
We recorded spontaneous and miniature EPSCs (for miniature in TTX 0.5 µM) from ChAT::EGFP 
and Non-ChAT neurons in horizontal, parasagittal and transverse slices. The individual traces and 
frequencies of each subsets are illustrated in Fig. 4.4A-B. We first performed a global analysis of 
the variance of all the data point obtained, in order to establish the validity of subsequent group 
comparisons (see Methods). 
The data being non-normal, their log10 was taken to perform the ANOVA. There was a significant 
effect of the type of currents (spontaneous vs. miniatures; p=0.0002), the of type of neurons 
(ChAT::EGFP vs. Non-ChAT; p=0.023) and the slice orientations (p=0.003). In addition, there 
was a significant association between the type of neurons, currents and the slice orientation (p = 
0.029).  
To analyze the specific pairings, we performed Tukey post-hoc tests. The frequency of miniatures 
was significantly lower than the frequency of spontaneous currents (TukeyHSD: p=0.000387; 
Mean spontaneous: 1.05 ± 0.16 Hz vs Mean miniature: 0.53 ± 0.09 Hz). Post-hoc analysis 
confirmed a difference between ChAT::EGFP and Non-ChAT cells (TukeyHSD: p=0.031). 
Finally, the frequency of synaptic currents was significantly lower in transverse slices (0.534 ± 0.09 
Hz) compared to parasagittal slices (1.02 ± 0.22 Hz) (TukeyHSD: p=0.00995) and horizontal slices 
(1.02 ± 0.2 Hz) 
As for the interaction between the type of neurons, currents and the slice orientation, 
ChAT::EGFP neurons received significantly less sEPSCs in transverse slices (0.198 ± 0.04 Hz) 
compared to horizontal (1.38 ± 0.56 Hz) and parasagittal (0.79 ± 0.153 Hz) (Dunn’s test: 
respectively p= 0.0340 and p = 0.0499). Also, ChAT::EGFP neurons in transverse slices received 
significantly less sEPSCs than non-ChAT neurons (Dunn’s test: p=0.0045; Non-ChAT: 1.04 ± 0.17 
Hz vs ChAT::EGFP: 0.63 ± 0.11 Hz). 
Interpretation-discussion: In transverse slices, the frequency of sEPSCs in ChAT::EGFP neurons is 
particularly low. The simplest explanation for this observation would be that the majority of 
excitatory inputs to these neurons are not present in transverse section, i.e. are located more distally 
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in the rostro-caudal directions. However, a more conservative view is to consider that only the 
excitatory drive, i.e. what is necessary for presynaptic excitatory neurons to be active, is missing 
from the slice. Interestingly, the excitatory drive for Non-ChAT neurons is not affected in 
transverse slices. The localization of its excitatory drive, distally in the rostro-caudal axis, appears 
thus to be a unique feature of ChAT::EGFP neurons. 
We however have to keep in mind that the Non-ChAT population is certainly heterogeneous. This 
could explain that, on average, there is no difference depending on the slice orientation.  
It has been demonstrated that slice orientation can affect the frequency of miniature events (Staley 
and Mody, 1991). In our study, however, we found no such effect. The frequency of mEPSCs 
depends on the number of synaptic contacts as well as on their release probability. Our data suggest 
that the overall number and basal activity of excitatory synapses in LIII-IV is the same in all slices.  
It is interesting to compare the frequencies of sEPSCs and mEPSCs. The frequency of sEPSCs in 
transverse sections is so low that it is very similar to the one of mEPSCs. This suggests that the 
currents recorded in the absence of TTX, in transverse slices, are actually miniature currents and 
that the presynaptic excitatory neuron is not present in the slice. This relies on the hypothesis that 
axons sectioned by the slicing do not fire spontaneously. 
We should however mention that, although significantly higher than in transverse, the frequency 
of sEPSCs in horizontal and parasagittal slices is not significantly different from the frequency of 
mEPSCs in these slices. Admittedly, we have been using an ANOVA and post-hoc tests taking 
into account all multiple comparisons (Bonferroni correction), to prevent type-1 error. In this 
experiment, we have 24 pair-comparisons, which decreases the chances of reaching significance. 
However, the lack of difference between sEPSCs and mEPSCs in horizontal and parasagittal slices 
obviously weakens the conclusion of the previous paragraph. 
3.2. Amplitudes of excitatory currents 
We also compared the amplitude of mEPSCs in the different neurons, slice orientation and animals 
(Fig. 4.4C). After normalization of the data (through log10), the ANOVA demonstrated no 
significant association between the “neurons” and “slice” factors (p= 0.2715). 
Interpretation-discussion: There is no difference in the amplitude of mEPSCs linked to the slice 
orientation or neuron type. 
Figure 4.4: The frequencies and amplitudes for spontaneous and miniature excitatory post-
synaptic currents (EPSC) in ChAT::EGFP and Non-ChAT cells in horizontal (HS), parasagittal
(PS) and transverse (TS) slices of naïve mice. 4.4A Representative traces of spontaneous and
miniature EPSC recorded in ChAT::EGFP (left) and non-ChAT (Right) cells. 4.4B Frequencies
of spontaneous and miniature EPSCs. The frequencies of ChAT::EGFP on TS was significantly
lower to those in PS and HS in addition Non-ChAT cells on the same slice. ### p < 0.001
comparing capacitance of slice vs HS; post-hoc: Dunnett’s multiple comparisons * p < 0.05; ##
p < 0.01; * comparing average between between slices and # compare averages within the same
slice. 4.4C The amplitudes of miniature EPSCs of ChAT::EGFP and Non-ChAT. No
observable differences in measured amplitudes were reported between neuron type or slices.
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4. Spontaneous and miniature inhibitory synaptic inputs onto DH 
ChAT::EGFP neurons 
4.1. Frequency of inhibitory currents 
The mean frequencies of inhibitory currents are illustrated in Fig. 4.5A-B. We first performed a 
global analysis of the variance of all the data point obtained, in order to establish the validity of 
subsequent group comparisons. As with the excitatory currents, the data being non-normal, log10 
was taken to perform the ANOVA. There was a significant effect of type of currents (spontaneous 
vs. miniatures; p=0.0005), and of type of neuron (ChAT::EGFP vs. Non-ChAT; p=4.73e-5).  
We simplified the model to take into account only those parameters that were proven meaningful, 
and then performed Tukey post-hoc tests. As expected, the frequency of mIPSCs (0.294 ± 0.08 
Hz) was statistically lower than the frequency of sIPSCs (0.748 ± 0.16 Hz) (TukeyHSD: p = 
0.00072). ChAT::EGFPs neurons had statistically lower frequency of inhibitory currents (0.29 ± 
0.08 Hz) than Non-ChAT neurons (0.81 ± 0.17 Hz) (TukeyHSD: p = 5.79e-05).  
Interpretation-discussion: ChAT::EGFP neurons appear to have lower frequency of inhibitory currents 
compared to Non-ChAT. Since there is no significant difference in the slice orientation, we can 
only suggest that the synaptic strength of inhibitory drive may be lower in cholinergic cells.  
4.2. Amplitude of inhibitory currents 
We compared with a similar approach the amplitude of mIPSCs in the different neurons and slice 
orientations (Fig. 4.5C). After normalization of the data (through log), the ANOVA concluded on 
a significant effect of the “slice” factor (p= 0.0359). LIII/IV neurons had mIPSCs of lower 
amplitude in parasagittal (22.44 ± 2.21 pA) compared to transverse slice (35.17 ± 5.28 pA) 
(TukeyHSD: p = 0.0432). 
Interpretation-discussion: The mIPSCs recorded in parasagittal slices were smaller than those in Non-
ChAT neurons. This difference could suggest another control of inhibitory inputs to transverse 
cells compared to parasagittal.  
Figure 4.5: The frequencies and amplitudes of spontaneous and miniature inhibitory post-
synaptic currents (IPSC) ChAT::EGFP and Non-ChAT cells in horizontal (HS), parasagittal (PS)
and transverse (TS) slices of naïve mice. 4.5A Representative traces of miniature IPSCs recorded
in ChAT::EGFP (top) and non-ChAT (bottom) cells. 4.5B The frequencies of excitatory and
IPSCs. The inhibitory currents remained constant irrespective of slice or neuron types. 4.5C:
The amplitudes of miniature IPSCs of ChAT::EGFP and Non-ChAT cells. No significant
difference has been reported for the amplitudes of inhibitory currents across all groups.
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5. Excitatory/inhibitory ratio onto DH LIII-IV neurons 
The frequencies of excitatory and inhibitory currents were analyzed separately in the previous 
sections, as we considered them to be two independent features of the recorded neurons. However, 
because we actually have both excitatory and inhibitory currents recorded on each individual cell, 
we decided to analyze the ratio between their frequencies (E/I) in a separate analysis. 
The E/I ratio was calculated in ChAT::EGFP and Non-ChAT neurons in horizontal, parasagittal 
and transverse slices. The log10 of the ratios was used to normalize the data (shapiro-wilk test: p 
= 0.0032); we proceeded with ANOVA due to appropriate sized dataset. We first performed a 
global analysis of the variance of all the data point obtained, in order to establish the validity of 
subsequent group comparisons. 
There was a significant effect of the type of neuron (ChAT::EGFP vs. Non-ChAT; p = 0.0276). 
We simplified the model to take into account only those parameters that were proven meaningful, 
and then performed Tukey post-hoc tests (Fig. 4.6). The E/I ratio in ChAT::EGFP neurons (6.75 
± 0.83) was significantly higher than in non-ChAT neurons (5.34 ± 0.91) (TukeyHSD: p = 0.029).  
Interpretation-discussion: We observed a small difference in the E/I ratio between ChAT::EGFP and 
Non-ChAT. We previously reported that the frequency of inhibitory currents was particularly low 
in ChAT::EGFP neurons. This is the most probable source of high E/I ratio in these neurons 
compared to Non-ChAT neurons. Moreover, the cumulative charge of EPSC or IPSC from each 
cell should be taken into account while determining its E/I ratio.  
6. Primary afferent inputs to DH ChAT::EGFP neurons 
6.1. Pharmacological stimulation 
Part of the excitatory currents recorded in DH neurons most likely corresponds to synapses formed 
by primary afferents. Indeed, immuno-histochemical data suggest that ChAT::EGFP neurons 
receive contacts from myelinated and non-myelinated fibers (Ribeiro-da-Silva and Cuello, 1990; 
Olave et al., 2002). We thus decided to more specifically study the peripheral innervation of 
cholinergic interneurons. 
A classical approach to do so is to take advantage from receptors expressed by specific subsets of 
primary afferents (e.g. TRPV1): applying their agonist (in this case capsaicin) in slices enables to 
specifically depolarize these fibers. As primary afferents are glutamatergic, their post-synaptic 
neurons should see an increase in frequency of glutamatergic currents.  
Figure 4.6: The ratio between the frequency (f) of spontaneous (top) and miniature (bottom)
excitatory (EPSC) over inhibitory (IPSC) post-synaptic currents (f.EPSC/f.IPSC) of
ChAT::EGFP and Non-ChAT cells in horizontal (HS) and transverse (TS) slices of naïve, sham
and cuff mice. No significant differences were detected at interactions between the Animal
(Naïve, Sham, Cuff) * Neuron (ChAT::EGFP or Non-ChAT) * Slice (HS or TS) * Current
(Spontaneous or Miniature). However, there were detectable differences observed with fewer
interactions (see text).
ChAT::EGFP Non-ChAT
ChAT::EGFP Non-ChAT
(N=9) (N=16) (N=12) (N=12) (N=14) (N=16) 
(N=9) (N=6) (N=7) (N=12) (N=7) (N=9) 
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6.1.1. Capsaicin-responsive primary afferents 
Capsaicin (5 µM), a specific agonist of TRPV1 receptors was bath-applied during 90 s on horizontal 
spinal slices. This occasionally led to an increase in the frequency of sEPSCs (Fig. 4.7A-B). A 
cumulative plot of the events number over time enabled to quantify this increase (Fig. 4.7A): in 
such a plot, the slope of the curve corresponds to the frequency of events. A significant break in 
the curve (see Methods) demonstrates a response to the drug application. 
71,4% of ChAT::EGFP neurons responded to the application of capsaicin with an increase in the 
frequency of sEPSCs. This however was never observed when TTX was present in the slice (none 
of the 5 tested neurons showed an increase in frequency of mEPSCs). Half of ChAT::EGFP 
neurons demonstrated an increase in frequency in sIPSCs after application of capsaicin. None of 
the ChAT::EGFP neurons tested in TTX responded to capsaicin with an increased frequency of 
mIPSCs. 
Concerning Non-ChAT::EGFP neurons, a third of the neurons responded to capsaicin with an 
increase in the frequency of sEPSCs; similarly almost a third responded with an increase in the 
frequency of mEPSCs, or with an increase in the frequency of sIPSCs (different groups of 
neurons). None responded with an increase in frequency of mIPSCs. 
Interpretation-discussion: Capsaicin is an agonist for TRPV1 receptor, which is expressed in a subset 
of primary afferents. There is a controversial article mentioning the existence of TRPV1 expressing 
GABAergic neurons in the mouse DH (Kim et al., 2012). If true, this could complicate the 
interpretation of the present experiment, as an increase in IPSCs could be due to activation of these 
DH neurons, as well as to activation of a pathway initiated by activation of primary afferents. Our 
data do not favor the existence of TRVP1+ receptors on terminals of neurons impinging onto 
LIII-IV neurons (ChAT::EGFP or non-ChAT neurons), as we observed no increase of the 
frequency of mIPSCs in response to capsaicin application. We cannot rule out the potential 
expression of TRVP1 receptors on DH cell bodies, however the responses we observe to capsaicin 
most probably largely involve TRPV1-expressing primary afferents.  
The absence of response to capsaicin in ChAT::EGFP neurons in presence of TTX suggests that 
these neurons are not directly post-synaptic to primary afferents expressing the TRPV1 receptor. 
In contrast, a proportion of non-ChAT neurons appear to be post-synaptic to TRPV1-expressing 
primary afferents. 
However, we observe an increase in the frequency of spontaneous EPSCs and IPSCs in 
ChAT::EGFP neurons in response to capsaicin. This suggests that this population is downstream 
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of TRPV1-expressing primary afferents, in a pathway involving an intermediate excitatory or 
inhibitory interneuron. This is also the case of some non-ChAT neurons. 
6.1.2. Mustard-oil responsive primary afferents 
We similarly applied Mustard oil (100 mM), an agonist for TRPA1 receptors, during 180 s in the 
bath of parasagittal slices (Fig. 4.8A). None of the ChAT::EGFP or non-ChAT neurons responded 
to this application of Mustard oil with an increase in the frequency of sEPSCs. One non-ChAT 
neuron (out of 9 tested), but no ChAT::EGFP neuron, responded with an increase in frequency of 
sIPSCs.  
We performed a control experiment on lamina II neuron, as a proportion of LII neurons has been 
reported to respond to Mustard oil with an increase in the frequency of sEPSCs. We indeed found 
that 4 out of 5 tested LII neurons responded in that way. 
Interpretation-discussion: The absence of response to Mustard oil in ChAT::EGFP neurons suggests 
that these neurons are not located downstream to primary afferents expressing the TRPA1 
receptor. This is also the case for most non-ChAT neurons; only one appeared to be indirectly 
connected to these primary afferents through an inhibitory neuron. 
In contrast, as previously reported (Kardon et al., 2014), a large proportion of LII neurons are 
downstream to TRPA1-expressing primary afferents. 
6.1.3. Menthol-responsive primary afferents 
Finally, we also looked for responses to bath-application of Menthol (500 mM), an agonist for 
TRPM8 receptors, during 180 s onto parasagittal slices (Fig. 4.8B). None of the ChAT::EGFP or 
non-ChAT neurons responded to this application of menthol with an increase in the frequency of 
sEPSCs. Two non-ChAT neurons (out of 8 tested), but no ChAT::EGFP neuron, responded with 
an increase in frequency of sIPSCs.  
We performed a control experiment on lamina II neuron, as a proportion of LII neurons has been 
reported to respond to menthol with an increase in the frequency of sEPSCs. We indeed found 
that 2 out of 3 tested LII neurons responded in that way. 
Interpretation-discussion: The absence of response to menthol in ChAT::EGFP neurons suggests that 
these neurons are not located downstream to primary afferents expressing the TRPM8 receptor. 
This is also the case for most non-ChAT neurons; only two appeared to be indirectly connected to 
these primary afferents through an inhibitory neuron. 
Figure 4.8: Effect of menthol and mustard oil on the excitatory and inhibitory synaptic
transmission. 4.8A Summary histogram on the effect of 100 µM on spontaneous EPSCs (Left
three bars) and IPSCs (Right two bars) in ChAT::EGFP and Non-ChAT neurons. Mustard oil
did not change the EPSCs frequencies of ChAT::EGFP cell. Similarly, the frequencies of EPSCs
in LII cells and IPSCs in a fraction of Non-ChAT cells were increased. Fisher’s exact test; *P <
0.05 between LIII/IV cells to LII controls. 4.8B Summary histogram on the effect of Menthol
500 µM on spontaneous EPSCs (Left three bars) and IPSCs (Right two bars) in ChAT::EGFP+
and Non-ChAT neurons. Menthol did not alter the EPSCs frequencies of ChAT::EGFP+ cell.
However, it elevated the frequencies of EPSCs in LII cells and IPSCs in a fraction of Non-
ChAT cells.
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In contrast, as previously reported (Kardon et al., 2014), a large proportion of LII neurons are 
downstream to TRPM8-expressing primary afferents. 
6.2. Electrical stimulation of dorsal root 
From anatomical studies, the DH cholinergic interneurons have been demonstrated to be 
downstream both myelinated and unmyelinated fibers (Ribeiro-da-Silva and Cuello, 1990; Olave et 
al., 2002). To examine the functional connection between primary afferents and ChAT::EGFP 
neurons, we recorded these neurons (and Non-ChAT ones for comparison) while stimulating 
electrically the attached dorsal root (DR), on horizontal slices (Fig. 4.9). The stimulation of DR 
inputs resulted in evoked EPSC and IPSC (eEPSC and eIPSC) in both populations. For eEPSCs, 
we classified the responses as single-(i.e. only one response observed when stimulation intensity 
was increased) or multi-component (contained eEPSCs with different latencies) responses. We 
observed a single-component eEPSC in 10% of ChAT::EGFP neurons, while 70% of neurons 
presented multi-component responses. Similarly, 20% of non-ChAT neurons presented a single-
component eEPSC, while 60% presented multi-component responses. The stimulation amplitude 
required to evoke excitatory responses started at 0.005 mA and went up to 0.1 mA and 0.5 mA for 
single- and multi-component responses respectively. 
Almost half of the recorded ChAT::EGFP and Non-ChAT cells received eIPSCs following DR 
stimulation. Interestingly, no cells exhibited eIPSCs without the presence of an eEPSC response. 
The threshold of eIPSC responses ranged from 0.01 up to 0.6 mA. 
Interpretation-discussion: We have demonstrated that both ChAT::EGFP and Non-ChAT cells receive 
excitatory and inhibitory inputs following activation of DRs. From the stimulation threshold 
reported throughout the literature (Nakatsuka et al., 1999; Daniele and MacDermott, 2009; Ganley 
et al., 2015), the eEPSCs responses may result from activation of low-threshold and/or high 
threshold primary afferent fibers. In contrast, the detected eIPSCs were in consequence of high 
threshold activation. Since detected eIPSCs always occurred with eEPSCs, this could suggest that 
exclusively di-synaptic connection (with an intermediate inhibitory interneuron) with primary 
afferents does not exist for LIII/IV interneurons. 
Figure 4.9: The evoked excitatory (left) and inhibitory (right) post-synaptic currents in
ChAT::EGFP and Non-ChAT cells in horizontal slices of naïve mice after dorsal root (DR)
stimulation. (N=10 in each group). 4.9A Representative traces demonstrating single- (left) and
poly- (middle) synaptic eEPSCs and IPSCs (right) in ChAT::EGFP. 4.9B Incidence of eEPSC
and eIPSC observed in both populations.
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7. Downstream targets of ChAT::EGFP neurons 
7.1. Transynaptic tracing 
To investigate the downstream targets of cholinergic interneurons, we have used the trans-synaptic 
anterograde tracer wheat germ agglutinin (WGA). We injected an AAV encoding for a Cre-
dependent form of WGA in the DH of the spinal cord of ChAT-Cre animals: this allows WGA to 
be expressed in ChAT cell expressing the Cre-recombinase enzyme. Once expressed, the WGA 
can in theory jump unlimitedly number of synapses; thus, we have perfused the animals at specific 
time points post-injection. These include: 1.5, 3, 4.5 and 6+ weeks post-injection. The spinal cords 
await analysis. 
In our preliminary results, two ChAT-Cre adult mice have been injected with an AAV2-Flex-WGA 
virus at 6 weeks’ post-injection (Fig. 4.10). We observed expression of WGA neurons throughout 
in the ipsilateral side of the spinal cord. WGA infected cells were in the DH, intermediate zones 
and ventral horn. For the DH, we observed co-localization between the WGA expressing cells and 
ChAT immunoreactivity; these cells are potentially the (first) virus infected cell or downstream cells 
to other cholinergic neurons.  
Interpretation-discussion: Our preliminary experiments demonstrate the feasibility of the approach, as 
we observed WGA expression in DH ChAT::EGFP neurons as well as in non-ChAT-IR ones. 
This strongly suggests that the WGA initially expressed in ChAT neurons has been transported to 
its targets. Only a detailed analysis of the time course of WGA spread will enable us to gain 
information on the post-synaptic targets of DH cholinergic interneurons. 
It remains hard to confirm exactly which populations were the originally infected cells. Potentially, 
it is feasible to inject a floxed non-trans-synaptic AAV- expressing a reporter protein in addition 
to AAV-Flex-WGA. This approach was performed in search of the downstream targets to 
enkephalinergic neurons. The authors injected both AAV-FLEx-WGA and AAV-FLEx-YFP into 
the DH of Penk-Cre mice. The downstream targets were identified to be mostly LII inner 
glutamatergic neurons (Francois et al., 2017).   
7.2. Photostimulation of cholinergic neurons 
Throughout the course of my doctoral work, we have tried to obtain channelrhodopsin (ChR2) 
expression in DH cholinergic interneurons by different means. Although we were unsuccessful in 
our attempts, we collaborated with Dr. Brett Graham (Newcastle University, Australia) who 
obtained mice appropriated for an optogenetic approach. This was achieved by crossing ChAT::Cre 
Figure 4.10: Expression of trans-synaptic anterograde tracer what germ agglutinin (WGA) in the
Dorsal Horn of ChAT Cre animals [N = 2]. Immunoreactivity against Choline
acetylcholinetranferase (ChAT) (Red, Middle panel) to determine cholinergic interneurons (or
potential first infected cell) and the expression of WGA identified with anti-WGA antibodies (Green,
Left panel). In the merged images (Yellow, Right panel), a number of cells colocalized with both
ChAT and WGA (arrowheads) while the downstream cells expressing WGA are detected throughout
the DH (arrows) (Scale = 100 µm).
ChATWGA Merged 
  96 
mice with mice expressing ChR2 in a cre-dependent manner. We are briefly reporting here their 
preliminary results, as they will be part of the manuscript in preparation and useful for the 
discussion of our data. 
DH cholinergic neurons are known to also express GABA in mice and rats, but were reported to 
be non-glycinergic in rat ((Todd, 1991; Mesnage et al., 2011). However, after photo­activation 
(single pulse) of cholinergic interneurons on DH network, they observed in LII neurons mono-
synaptic current consisting of 75% glycinergic and 25% GABAergic component. Amongst non-
ChAT LII neurons, 3.2% (1/31) presented a monosynaptic only response, 38.7% (12/31) a 
polysynaptic only response, and 54.8% (17/31) mono- and poly-synaptic responses while 3.2% 
(1/31) were non-responding. They also recorded cholinergic interneurons in lamina III-IV, and 
found that 18.2% (4/22) had a monosynaptic only response, 18.2% (4/22) a polysynaptic only 
response, 45.5% (10/22) mono- and poly-synaptic responses while 18.18% (4/22) were non-
responding. These results indicate that DH cholinergic interneurons are very well connected with 
LII and amongst themselves.  
A single pulse of photostimulation only produced GABA/Glycine responses. To investigate the 
cholinergic component, they performed a photo-stimulation train of 20 pulses at 20 Hz. The 
downstream LII neurons reported: 18.2% (4/22) nicotinic, 18.18% (4/22) muscarinic, 45.5% 
(10/22) nicotinic and muscarinic responses and 18.18% (4/22) non-responsive. This suggest that 
the cholinergic transmission was less likely observed compared to GABA/Glycinergic IPSCs.  
8. Discussion 
Our results demonstrate that DH cholinergic interneurons are well-integrated in the spinal 
network. From recordings in various slice orientations, we propose that these cholinergic cells 
receive excitatory drive arising from distant spinal segments within LI-IV. In contrast, the 
inhibitory inputs are possibly localized within the same spinal segment and first four laminae of the 
DH. In addition, they receive (directly or indirectly) information from primary afferents (including 
nociceptive ones), and appear to project throughout the dorsal horn. 
8.1. Synaptic inputs 
Excitatory inputs: Synaptic inputs to LIII-IV DH neurons have been studied before in different 
species. Glutamate uncaging experiments have shown that rat LIII/IV neurons with long upward 
projecting dendrites receive excitatory and inhibitory inputs from superficial layers; in contrast 
more ventral LIII/IV cells received only excitatory inputs above LII/III border (Kato et al., 2013). 
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In hamsters, the local LIII/IV connections are generally inhibitory although with low reliability 
(Schneider, 2008). Because all our slices comprised LI/IV, we could not specifically interrogate the 
precise localization of the synaptic drive within these laminae (LI/IIo vs. LIIi/III for example). 
However our data suggest that presynaptic excitatory neurons connect ChAT::EGFP neurons quite 
distally in the rostrocaudal axis. This can be related to the extended rostral-caudal dendritic spread 
of LIII-IV cholinergic interneurons (Mesnage et al., 2011). In contrast, the excitatory and inhibitory 
inputs to Non-ChAT cells remained constant regardless of slice orientations; thus, suggesting the 
recorded cells may receive functional inputs arising locally.  
Inhibitory inputs: It has been proposed that the control of inhibitory transmission in rat LIII/IV 
implicates deeper laminae (LV –VI) (Petitjean et al., 2012; Seibt and Schlichter, 2015). In our hand, 
whatever the different slice orientations, we did not observe any change in the DH inhibitory inputs 
to LIII/IV neurons. One discrepancy between our approaches is that the above-mentioned studies 
recorded inhibitory inputs driven by application of exogenous substances, while we recorded 
spontaneous events. Also, these studies were performed in rat while we recorded mouse tissue.  
8.2. Primary afferents inputs 
Types of inputs: LIII/IV cholinergic interneurons appear to be downstream to incoming 
peripheral inputs. These inputs range from low threshold (potentially myelinated) and high-
threshold (unmyelinated fibers). Traditionally, LIII/IV neurons are known to receive non-
nociceptive information via myelinated fibers. For example, the neurons transiently expressing 
vGLUT3, glycinergic, paravalbumin and/or dynorphin interneurons receive direct inputs from Ab 
fibers (Lu et al., 2013; Duan et al., 2014; Peirs et al., 2015; Petitjean et al., 2015). There are also 
LIII/IV neurons receiving high-threshold inputs: NK1+ neurons with dorsally projecting 
dendrites to LII receive direct inputs from TRPV1 expressing fibers in neonatal rats (Labrakakis 
and MacDermott, 2003). Anatomical information was available for DH cholinergic interneurons 
in rats: they were known to receive inputs from both type I and type II glomeruli, with IB4 and 
CtB expressing contacts (Ribeiro-da-Silva and Cuello, 1990; Olave et al., 2002).  Our preliminary 
data confirms connections with both types of fibers, however further analysis is required to 
determine the type (mono- or poly- synaptic) or nature (Ab, Ad or C fiber) these connections.  
TRPV1 expressing primary afferents: Through pharmacological intervention, we investigated 
the specific modalities of these incoming fibers. We showed that the LIII-IV cholinergic 
interneurons are indirectly connected by TRPV1 expressing fibers, through excitatory and 
inhibitory interneurons.  This was also the case of non-ChAT neurons, also a proportion of them 
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was also directly postsynaptic to TRPV1+ fibers. In rats, the TRPV1 agonist capsaicin has been 
reported to increase both excitatory and inhibitory responses in LIII/IV, although only indirect 
responses were observed (Petitjean et al., 2012). In addition, the mechanical transection between 
LIII/IV and deeper laminae in rat transverse slices reduced the number of responding cells with 
inhibitory current facilitation from 60% to < 10% (Petitjean et al., 2012). Our recordings were 
performed in horizontal slices, devoid of deep laminae (below LIV); we were therefore expecting 
a lower proportion of capsaicin-induced increase in the frequency of inhibitory currents. As this 
was not the case (we observed about half the neurons responding), our results suggest that the 
inhibitory control downstream to TRPV1+ fibers may be different between rats and mice.  
In our voltage clamp recordings, we looked specifically at either excitatory or inhibitory inputs and 
did not study the integrated output, i.e. the firing of the cell following dorsal root stimulation by 
capsaicin. In rats, bath application of capsaicin (300 nM – 1 µM) between 8 – 10 minutes on spinal 
slices did not alter the detected acetylcholine levels (Dussor et al., 2005), suggesting that stimulation 
of TRPV1+ primary afferent does not lead to net excitation of cholinergic neurons. However, this 
could also result from the lower concentrations used as opposed to our study (Capsaicin 5 µM). 
Interestingly, neonatal treatment of capsaicin (to pharmacologically mimic de-afferentation) 
resulted in reduced high-potassium-induced release of ACh, confirming a link between TRPV1+ 
fibers and spinal cholinergic neurons (Dussor et al., 2005). In behavioral experiments in b2 nAChR 
knock-out mice, the effects of a normally sub-threshold dose of capsaicin applied to the paw 
surface resulted in mechanical allodynia, and the effect of a supra-threshold dose was prolonged 
compared to WT mice (Yalcin et al., 2011). This again highly suggests the implication of the spinal 
cholinergic system in the processing of nociceptive information encoded by TRPV1+ primary 
afferents.  
TRPM8 and TRPA1 expressing primary afferents: In contrast, none of ChAT::EGFP cells 
were downstream to TRPM8 and TRPA1 expressing fibers. While it is known that TRMP8 is 
absent from TRPV1 fibers, TRPA1-expressing fibers are considered a subset of TRPV1-expressing 
ones (Kobayashi et al., 2005). This suggest that the fibers upstream to cholinergic cells are a unique 
subset of TRPV1 expressing fibers (not expressing TRPA1). TRPA1 receptors are suggested to be 
involved in noxious cold or chemical induced allodynia while TRPM8 receptors contribute to 
encoding cold sensations (Dubin and Patapoutian, 2010). Interestingly, intrathecal mecamylamine 
(10 µg) and atropine (10 µg) did not alter the flinching responses observed in phase 1 or 2 in the 
formalin test(Hama and Menzaghi, 2001), suggesting again that spinal cholinergic neurons are not 
involved in the processing of chemical inflammation. On the other hand, the cholinergic system 
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has been implicated in mechanism of electro-acupuncture relieving cold allodynia following 
neuropathy (Park et al., 2009); as our results suggest that cholinergic interneurons are not 
downstream TRPM8 fibers, we can hypothesize that other fibers might be implicated, or the link 
between these fibers and ChAT neurons is too faint to be detected using our approach. High 
concentrations icillin (100 µM), activators of TRPA1 and TRPM8, have been shown to increase 
the frequency of miniature EPSCs in LI-III neurons of young male rats (Wrigley et al., 2009). We 
did not record miniature EPSCs but rather spontaneous ones, and similarly found responses to the 
activation of TRPA1+ et TRPM8+ fibers in lamina II, but not in lamina III-IV. 
8.3. Targets 
Our preliminary transynaptic labeling experiments suggest that the potential downstream targets 
to cholinergic interneurons are throughout the DH. Electron Microscopy (EM) studies have 
demonstrated a direct cholinergic innervation of LI neurons (Ribeiro-da-Silva and Cuello, 1990). 
DH cholinergic interneurons are shown to have axons that travel first dorsally and then rostro-
caudally up to 2 mm (Mesnage et al., 2011); this suggests that LII interneurons are also potential 
targets. Finally, DH cholinergic neurons could be presynaptic to primary afferents. Both nicotinic 
and muscarinic receptors are located on primary afferent fibers and the application of exogenous 
cholinergic agonists modulate the responses observed in DH neurons following peripheral nerve 
stimulation (Li et al., 2002; Genzen and McGehee, 2003; Zhang et al., 2007a). In corroboration 
with these functional data, EM studies have shown that cholinergic boutons are pre-synaptic to 
primary afferent fibers found in LIIi, thus suggesting that cholinergic neurons may produce similar 
effects with endogenous ACh.  
The work of our collaborator B. Graham has demonstrated that cholinergic interneurons are 
presynaptic to LII neurons as well as to other LIII-IV ChAT::EGFP cells. Moreover, they 
communicate using GABA, Glycine and Acetylcholine (via nAChR and mAChR). Interestingly, 
such a dual mode of communication for cholinergic neurons has been described previously in the 
brain. For example, when optogenetics were used to study cholinergic neurons from the Habenula 
projecting to the interpeduncular nucleus (Ren et al., 2011). A brief light pulse resulted in a fast-
excitatory synaptic current mediated exclusively by glutamatergic receptors, while a tetanic 
stimulation produced slow inward currents which were largely mediated by nAChR, thus suggesting 
volume transmission of ACh. Our collaborators similarly employed a barrage of light stimulations 
in order to detect cholinergic responses in LII cells.   
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8.4. Functional role 
To improve our understanding in the role of DH cholinergic interneurons at the behavior level, si-
RNA and genetic tools have been used. An antisense anti-ChAT were injected intrathecally in adult 
mice, which resulted in the reduction of thermal and mechanical PWT in treated mice (Matsumoto 
et al., 2007). In contrast, injection of cholino-toxin AF64A did not alter the thermal PWT in naïve 
rats (Chen and Pan, 2001). Recently, ChAT-Cre mice were crossed with Tau-Diphtheria Toxin 
Receptor (DTR) and Lbx1-Flpo mice to drive DTR expression exclusively in DH ChAT neurons. 
Subsequently, DTR-expressing neurons were ablated upon intraperitoneal injection with diphtheria 
toxin (DTX). Following 10 – 14 weeks after ablation, the population-ablated animals demonstrated 
no differences in mechanical, thermal nor cold PWT (Duan et al., 2014). With knock-down and 
cholino-toxin studies, these substances were delivered via intrathecal injections thus could 
potentially act on other cholinergic sources (peripheral, descending fibers) in addition to DH 
cholinergic interneurons. The more recent study has implemented a genetic approach thus allowing 
the precise removal of a specific population. Their conclusions weaken the argument for the role 
of DH cholinergic interneurons as a key player in nociceptive information processing. However, 
one has to keep in mind that they have performed their behavioral studies 10 weeks after DTX 
injection which could imply compensatory mechanisms or potentially redundant systems coming 
into play. Ultimately, with only few studies made on this population the exact contribution of this 
population to spinal nociceptive network remains highly controversial.  
We have demonstrated the LIII/IV cholinergic interneurons are receive both excitatory and 
inhibitory inputs from the DH network and periphery. From local network, the control of 
excitatory inputs is located more distally compared to the inhibitory ones. Potentially low and high 
threshold fibers are upstream to these populations and they are indirectly connected to TRPV1+ 
but not TRPM8 or TRPA1 fibers. Their downstream targets consist of LII and other cholinergic 
interneurons whereby they communicate with GABA, Glycine and ACh.  
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Chapter 5: Characterization of the DH cholinergic 
interneurons following peripheral nerve injury 
1. Context and objectives 
Endogenous acetylcholine (ACh) is an important modulator of nociceptive sensory processing in 
the spinal cord. While a basal tone of spinal ACh seems to modulate the threshold for nociceptive 
responses, this tone appears to be disrupted in neuropathic animals (Rashid and Ueda, 2002). A 
population of cholinergic interneurons identified in the spinal dorsal horn (DH) of rodents and 
primates (Barber et al., 1984; Mesnage et al., 2011; Pawlowski et al., 2013a) is a potential source 
contributing to the spinal cholinergic tone. The previous chapter (Chapter 4) identified the features 
that enable this sparse neuronal population to achieve such a major control over pain processing 
by elucidating the interplay of DH cholinergic interneurons with the surrounding naïve nociceptive 
network. 
Following peripheral neuropathy, several aberrant alterations at a molecular (Coull et al., 2003), 
circuit (Moore et al., 2002) and behavioral levels (Kuner, 2010) have been reported. Herein, to 
improve our understanding of changes occurring in the spinal circuit and cholinergic system 
following nerve injury, we have studied the DH cholinergic interneurons and LIII-IV network in 
a model of peripheral neuropathy.   
2. Behavioral and electrophysiological investigation of cuff mice 
2.1. Mechanical allodynia 
After establishing stable baselines, the ChAT::EGFP+ Cd1 mice went through cuff surgery (c.f. 
methods). All animals were allowed to recover at least 7 days prior to behavior assessment (Fig. 
5.1A). The sensitivity to the mechanical stimulation in the animal right hind paw of cuff groups 
was decreased compared to sham mice. After establishing the PWT, the mice were used for 
electrophysiological recordings.  
Interpretation-discussion: The adult mice developed robust mechanical allodynia as previously 
observed in other experimental data set (Chapter 3). 
Figure 5.1: Behavioral and in vitro electrophysiological characterization of the cuff model. 5.1A:
Mechanical allodynia following peripheral nerve injury [Sham n = 8 and Cuff n = 5]. A reduction
in the PWT is reduced in cuff group after surgery however, the PWT of sham controls is
unchanged [T-test: p < 0.01] 5.1B: Frequency changes in miniature excitatory (EPSC) and
inhibitory (IPSC) post-synaptic currents recorded Lamina II cells. A reduction was observed in
the frequency for miniature IPSCs (Right) but not EPSCs (Left) in cuff mice (Kolmogorov-
Smirnov test, p = 0.042) *p < 0.05 – sham vs cuff. 5.1C: Amplitude measurements from
miniature EPSCs and IPSCs in LII neurons. No observable difference was detected in amplitude
size.
Figure 5.2: Distribution of DH cholinergic interneurons in sham and cuff adult ChAT::EGFP
mice [N for Sham and Cuff = 2]. Comparable numbers of EGFP cells (green) colocalize with
the ChAT antibodies (red) in both animal groups. Only Cuff RHS is shown here. The arrowhead
denotes overlapping cells (Scale = 100 µm).
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2.2. Electrophysiological characterization in LII neurons 
The cuff model of peripheral neuropathy has been well described in behavioral terms, but we were 
the first to analyze the plasticity occurring in the spinal cord with electrophysiology first in vivo 
(Medrano et al., 2016) and now in vitro. In order to put our findings in context with the literature, 
we first performed recordings in LII neurons located on the ipsilateral (to cuff insertion) DH in 
the presence of TTX 0.5 µM (Fig. 5.1B). The frequency of miniature IPSCs was lower in cuff mice 
compared to sham controls (Kolmogorov-Smirnov test, p = 0.042) whereas the frequency of 
miniature EPSCs was unchanged (Kolmogorov-Smirnov test, p = 0.586). However, the amplitudes 
for miniature EPSC and IPSCs remained similar for sham and cuff mice (Fig. 5.1C; un-paired t-
test: mEPSC comparisons –  p= 0.0782; mIPSC comparisons – p = 0.112). 
Interpretation-discussion: We observed a reduction in the frequency of miniature IPSCs in LII from 
cuff mice compared to sham; we did not intend to differentiate GABAergic from glycinergic 
currents. This suggests that the plasticity occurring in LII in the cuff model is similar to the one 
observed in the Spared Nerve Injury (SNI) and Chronic constriction injury (CCI) models of 
neuropathy, where a reduction in the frequencies of miniature GABA-A currents is reported in 
LII. Like our observations, their amplitudes of miniature IPSC remained unchanged after injury 
(Moore et al., 2002; Iura et al., 2016).  
We observe no difference in frequency for mEPSCs. In contrast, a study focusing on GABAergic 
interneurons in the CCI model reports a decrease in frequency of miniature EPSCs, although with 
unaltered amplitudes, in LII. They also observed an increased paired pulse ratio of Aδ- or C-fiber-
evoked monosynaptic EPSCs, and suggested that these changes result from reduced 
neurotransmitter release from primary afferents (Leitner et al., 2013). It is not possible to say, at 
this stage, if such plasticity of excitatory currents in LII does not occur in the cuff model, or if we 
didn’t observe it because we did not focus exclusively on GABAergic neurons but rather on 
identified LII neurons. Nevertheless, our recordings represent the first electrophysiological 
characterization of LII neurons in the cuff model for peripheral nerve injury. 
3. Density of DH cholinergic neurons after cuff surgery 
There is an on-going debate on whether there is a loss of neurons in the DH that would contribute 
to the development of hyperalgesia or allodynia following neuropathy. Therefore, we investigated 
whether DH cholinergic interneurons were affected. Following two weeks’ post-surgery, the 
number of GFP+ were counted in the contralateral and ipsilateral DH of adult ChAT::EGFP+ 
Table 5.1: Percentage of observed firing patterns in ChAT::EGFP and Non-ChAT cells in three
animal types: naïve, sham and cuff mice.
ChAT::EGFP+ Non-ChATFiring patterns ChAT::EGFP Non-ChAT ChAT::EGFP Non-ChAT ChAT::EGFP Non-ChAT
Tonic Firing 85.7 87.5 83.3 71.4 75 66.7
Single Firing 0.0 0.0 16.7 0.0 12.5 16.7
Initial burst Firing 14.3 0.0 0.0 14.3 12.5 0.0
Silent 0.0 12.5 0.0 14.3 0.0 16.7
Total N 7 8 6 7 8 6
Naive Sham Cuff
A
NAIVE
SHAM
CUFF
Non-ChATChAT::EGFP
B
Figure 5.3: Mean Instantaneous frequencies for ChAT::EGFP+ and Non-ChAT cells in
horizontal slices from naïve, sham and cuff adult mice. Spontaneously firing cells (blue dots) at
rest are present in some naïve, sham and cuff cells. The reluctant firing cells (red dots) were
present uniquely in Non-ChAT recorded cells.
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mice. Only sections from L3 – L6 spinal segments were taken into account (Fig. 5.2).  We 
confirmed by co-localization with ChAT antibodies that the vast majority (90%) of these neurons 
were ChAT-IR. For sham, we observed 2.13 ± 0.38 cholinergic neurons per 40 µm thick slices in 
the ipsilateral side of the DH. Similarly, 2.07± 0.38 co-localized ChAT and GFP+ cells in cuff 
animals were seen. 
Interpretation-discussion: The number of cholinergic interneurons appeared to be unchanged following 
peripheral nerve injury. We described comparable cholinergic neuron counts as previously 
reported: 2.8 ± 0.3 neurons per 50 µm thick transverse section in naïve Cd1 mice (Mesnage et al., 
2011).  
4. Characterization of the spinal cholinergic DH neurons 
4.1. Firing pattern 
We recorded from ChAT::EGFP and Non-ChAT neurons in horizontal spinal cord slices, from 
naïve, sham and cuff mice. A fraction of recorded neurons presented spontaneous ongoing firing 
at rest (Fig. 5.2): 1 from a total of 7 (14%) naïve cells, 2 out of 6 (33.3%) cholinergic neurons in 
sham mice, but none out of 8 (0%) in cuff. Among Non-ChAT neurons, 3 out of 8 (37.5%) for 
naive 1 out of 7 (14.2%) in sham mice, and 2 out 6 (33.3%) in cuff mice. There was no significant 
interaction between surgery (sham, cuff); type of neuron (ChAT::EGFP+, Non-ChAT) and 
presence of on-going firing (3x3x3 contingency table, p = 0.4479). 
Analysis of the frequency of action potentials after injection of depolarizing currents (Fig. 5.3) 
enabled us to classify the neurons according to their firing pattern as previously presented for naïve 
mice (Chapter 4). The proportions of the different firing patterns are presented in Table 5.1. There 
was no statistical difference between ChAT::EGFP and Non-ChAT neurons concerning the 
proportion of the different firing patterns in three different animal groups (3x3x3 contingency 
tables, p = 0.131). There also was no statistical difference in the rheobase for these two populations 
(Table 5.2; Scheirer-Ray-Hare test, p = 0.157). 
Interpretation-discussion: Mesnage and co-authors observed 67% of tonic firing pattern amongst 
ChAT::EGFP neurons (n=15), while 27% of neurons had ongoing firing activity. This is not 
significantly different from our proportions (chi-square test, p=0.35 for tonic firing pattern, p=0.52 
for ongoing firing). Lamina III-IV had overall a similar distribution amongst firing pattern in naïve, 
sham and cuff animals, ruling out a massive plasticity in intrinsic neuronal properties.  There was 
no specific feature to ChAT::EGFP neurons.  
ChAT::
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Figure 5.4: Electrophysiological properties of for ChAT::EGFP and Non-ChAT cells on
horizontal slice in three animal types: naïve, sham and cuff mice. Fig. 5.4A % sag demonstrating
concerning sag amplitude. There was no statistical differences between animals and neurons. Fig.
5.4B The proportion of cells demonstrating rebound spikes after hyperpolarization pulses.
RMP (mV) Input Resistance (TΩ) Capacitance (pF) Rheobase (pA)
Animal N ChAT::EGFP Non-ChAT ChAT::EGFP Non-ChAT ChAT::EGFP Non-ChAT ChAT::EGFP Non-ChAT
Naïve
ChAT::EGFP (7) Mean -50.84 -57.85 0.74 0.77 87.89 * 46.81 42.86 25.71
Non-ChAT (8) SEM 4.44 3.07 0.12 0.11 7.92 3.69 8.92 11.34
Sham
ChAT::EGFP (6) Mean -49.27 -49.89 0.58 0.58 81.68 89.81 # 20.00 30.00
Non-ChAT (7) SEM 3.80 2.29 0.07 0.07 6.24 10.70 6.32 7.17
Cuff
ChAT::EGFP (8) Mean -55.62 -49.53 0.54 0.55 97.40 78.45 # 33.75 24.00
Non-ChAT (6) SEM 2.07 3.93 0.05 0.09 5.68 8.34 3.75 10.25
Table 5.2: Electrophysiological properties of ChAT::EGFP and Non-ChAT cells in horizontal
slices in naïve, sham and cuff mice. # p < 0.05 comparing capacitance of non-ChAT cells in
sham and cuff vs naïve of; post-hoc: TukeyHSD * p < 0.05 comparing capacitance between
ChAT::EGFP vs Non-ChAT in naive.
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4.2. Passive properties 
The membrane properties of recorded neurons were investigated as in Result section 2. Similarly, 
the input resistance, the cell capacitance, and the amplitude of a (potential) sag current were 
assessed (Table 5.2). There was no difference in the resting potential (ANOVA, p = 0.1451), input 
resistance (ANOVA, p = 0.9769) or amplitude of a sag current (Fig. 5.4A; Scheirer- Ray-Hare test 
= 0.84373) between ChAT::EGFP or non-ChAT neurons or between animal groups (naïve, sham, 
cuff). For the cell capacitance, there was a significant interaction between type of neuron and animal 
group (Table 5.2; ANOVA, p = 0.007). As previously reported in naïve, GFP+ neurons had a 
statistically larger cell capacitance than non-ChAT neurons recorded in horizontal slices 
(TukeyHSD, p = 0.0026). Moreover, non-ChAT cells in naïve mice had significantly smaller cell 
capacitance compared to those recorded in sham and cuff (TukeyHSD, respectively p = 0.0015 
and  p = 0.045).  
Interpretation-discussion: There was no passive property specific to ChAT::EGFP neurons. The fact 
that these neurons had a higher cell capacitance than non-ChAT cells could be explained by the 
morphology of their dendritic arbor: the team has indeed previously reported that cholinergic 
interneurons have a very extended dendritic arbor in the rostrocaudal direction, well preserved in 
these horizontal slices (Mesnage et al., 2011).  
4.3. Rebound spiking 
The majority of ChAT::EGFP neurons presented a rebound spike upon the end of the 
hyperpolarizing pulse in naïve (100%), sham (80%) and cuff (100%) animals (Fig. 5.4B). In contrast, 
the proportion of Non-ChAT neurons presenting such a rebound spike appeared to differ 
depending on the animal group: 20% in naïve, 50% in sham and 80% in cuff mice. However there 
was a statistical difference between the two populations, when compared between the three animal 
groups, concerning this feature (3x3x3 Contingency table, p = 0.0029). The only significant 
difference in occurrence was between ChAT::EGFP+ and Non-ChAT cells in naïve animals 
(Fisher’s exact test = 0.0101).  
Interpretation-discussion: The team previously reported the existence of rebound spikes in half 
ChAT::EGFP neurons (Mesnage et al., 2011). We observed an even higher proportion of neurons 
producing rebound spikes in naïve mice, as well as in sham and cuff animals. 
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5. Spontaneous excitatory inputs onto DH LIII-IV neurons 
5.1. Frequency of currents 
We recorded sEPSCs and mEPSCs from ChAT::EGFP and Non-ChAT neurons from sham and 
cuff mice, in transverse and horizontal slices. We also compared this data to the ones obtained in 
naïve animals. The individual and mean frequencies are illustrated in Fig. 5.5. We first performed 
a global analysis of the variance of all the data point obtained, in order to establish the validity of 
subsequent group comparisons (see Methods). 
The data being non-normal, their log10 was taken to perform the ANOVA. There was a significant 
effect of the type of animals (Naïve, Sham, Cuff; p = 0.03), of type of currents (spontaneous vs. 
miniatures; p = 0.0006), of type of neuron (ChAT::EGFP vs. Non-ChAT; p = 5.5e-06) and the 
slice orientation (p = 9.3e-05). In addition, there was a significant association between the type of 
neurons and the slice orientation.  
We simplified the model to take into account only those parameters that were proven meaningful, 
and then performed Tukey post-hoc tests. The difference between Naïve, Sham and Cuff proved 
non-significant. The frequency of miniatures (0.47 ± 0.05 Hz) was significantly lower than the 
frequency of spontaneous currents (0.89 ± 0.10 Hz) (TukeyHSD: p=0.0015). The frequency of 
excitatory currents in ChAT::EGFP neurons (0.47 ± 0.06 Hz) was significantly lower than in non-
ChAT neurons (0.93 ± 0.10 Hz) (p=8e-06). Finally, the frequency of synaptic currents was 
significantly lower in transverse slices (0.47 ± 0.05 Hz) compared to horizontal slices (0.84 ± 0.11 
Hz) (TukeyHSD: p=0.00016). 
As for the interaction between the type of neurons and the slice orientation, ChAT::EGFP neurons 
received significantly lower excitatory synaptic inputs in transverse slices (0.17 ± 0.02 Hz) 
compared to horizontal (0.65 ± 0.13 Hz) (TukeyHSD: p=0.9e-0-4); and, in transverse slices, 
ChAT::EGFP neurons (0.17 ± 0.02 Hz) received significantly less excitatory synaptic inputs than 
non-ChAT neurons (0.71 ± 0.09 Hz) (TukeyHSD: p=0.59e-05). 
Interpretation-discussion: We observed a small difference in the frequencies of excitatory currents 
depending on the animals groups (naïve/sham/cuff); however this difference was not due to a 
specific type of neuron, or slice or current, as there was no interaction between these parameters. 
In addition, this difference was not robust, as it was not confirmed by post-hoc testing of the 
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Figure 5.5: The frequencies of spontaneous (top) and miniature (bottom) excitatory post-
synaptic currents (EPSC) of ChAT::EGFP and Non-ChAT cells in horizontal (HS) and
transverse (TS) slices of naïve, sham and cuff mice. There were no significant interactions
between neurons, animals, currents or slices
(N=9) (N=12) (N=9) (N=5) (N=6)(N=7) (N=7) (N=7) (N=7) (N=6) (N=6) (N=9)
(N=9) (N=12)(N=16) (N=13) (N=7)(N=12) (N=11) (N=11) (N=8) (N=10)(N=10) (N=8)
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simplified model. Our data therefore fails to uncover a significant effect of the neuropathic surgery 
onto the frequency excitatory currents in lamina III-IV neurons. 
Like naïve data, we observed a lower frequency of miniature compared to spontaneous currents; a 
lower frequency of currents in ChAT::EGFP with respect to Non-ChAT cells; and in transverse 
slices compared to horizontal slices. We also similarly observed lower EPSCs frequencies in 
ChAT::EGFP neurons on transverse than on horizontal slices, and, in transverse slices, lower 
EPSCs frequency in ChAT::EGFP neurons than in Non-ChAT neurons; however, these last 
differences were no longer unique to spontaneous events. All reported differences were conserved 
across all animal groups Result section 2.   
5.2. Amplitude of currents 
We also compared the amplitude of mEPSCs in the different neurons, slice orientation and animals 
(Fig. 5.6). After normalization of the data (through log10), the ANOVA concluded on a significant 
interaction between the types of neurons (ChAT::EGFP, Non-ChAT) and the type of slice 
(horizontal, transverse) (p=0.0095) and between the type of animal(naïve, sham, cuff) and the slice 
orientation (p=0.0013). However, the post-hoc Tukey analysis did not confirm any of these 
associations. 
Interpretation-discussion: There is no difference in the amplitude of mEPSCs linked to the neuropathy, 
regardless of the neurons studied. 
6. Spontaneous inhibitory inputs onto DH LIII-IV neurons 
6.1. Frequency of currents 
We recorded sIPSCs and mIPSCs from ChAT::EGFP and Non-ChAT neurons from sham and 
cuff mice, in transverse and horizontal slices. We also compared this data to the ones obtained in 
naïve animals. The individual and mean frequencies are illustrated in Fig. 5.7. We first performed 
a global analysis of the variance of all the data point obtained, in order to establish the validity of 
subsequent group comparisons. 
The data being non-normal, their log10 was taken to perform the ANOVA. There was a significant 
effect of type of currents (spontaneous vs. miniatures; p=0.1e-06) and of type of neuron 
(ChAT::EGFP vs. Non-ChAT; p=1.85e-14). In addition, there was a significant association 
between the type of animals and types of neurons (p=0.025) as well as between types of animals 
and the slice orientation (p=0.022).  
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Figure 5.6: The amplitudes of miniature excitatory post-synaptic currents (EPSC) of
ChAT::EGFP and Non-ChAT cells in horizontal (HS) and transverse (TS) slices of naïve, sham
and cuff mice. The measured amplitudes remained unchanged across difference conditions.
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Figure 5.7: The frequencies of spontaneous (top) and miniature (bottom) inhibitory post-
synaptic currents (IPSC) of ChAT::EGFP and Non-ChAT cells in horizontal (HS) and
transverse (TS) slices of naïve, sham and cuff mice. The frequency of inhibitory currents
(regardless of miniature or spontaneous) was significantly smaller in ChAT::EGFP than Non-
ChAT cell (see text).
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We simplified the model to take into account only those parameters that were proven meaningful, 
and then performed Tukey post-hoc tests. As expected, the frequency of mIPSCs (0.26 ± 0.05 Hz) 
was statistically lower than the frequency of sIPSCs (0.75 ± 0.10 Hz) (TukeyHSD: p = 1.18e-05). 
ChAT::EGFPs neurons (0.22 ± 0.05 Hz) had statistically lower frequency of inhibitory currents 
than Non-ChAT neurons (0.85 ± 0.11 Hz) (TukeyHSD: p = 8.20e-15) . As for the second order 
comparisons, there was a particularly highly significant difference between the frequency of IPSCs 
in ChAT::EGFP (Cuff: 0.19 ± 0.07 Hz; Sham: 0.11 ±0.04 Hz) vs Non-ChAT neurons (0.90 ± 0.2 
Hz) in cuff mice (p=0.8e-5), as well as in sham mice (0.88 ± 0.19 Hz) (p<e-7). In addition, 
ChAT::EGFP neurons (Naïve: 0.29 ± 0.08 Hz) having a lower frequency;  was also the case in 
naïve mice (0.81 ±0.17) (although only with p=0.017). There was also a slight difference between 
sham and naïve mice for ChAT::EGFP mice (p=0.022), the frequency being smaller in sham mice. 
The post-hoc analysis revealed no physiologically meaningful difference for the association of types 
of animals and slice orientation. 
Interpretation-discussion: We observed a robust difference in the frequencies of inhibitory currents 
(independently of them being sIPSCs or mIPSCs) between ChAT::EGFP neurons and Non-ChAT 
neurons. In all groups of animals (naïve/sham/cuff), the frequencies recorded in ChAT::EGFP 
neurons were smaller. This confirms results of the previous study taking into account only naïve 
animals (but with slices of three orientations) and demonstrates that this unique feature of 
ChAT::EGFP neurons is maintained after neuropathy. 
6.2. Amplitude of currents 
We compared with a similar approach the amplitude of mIPSCs in the different neurons, slice 
orientation and animals. After normalization of the data (through inversion), the ANOVA 
concluded on a significant effect of the “neurons” factor (p=0.0052). ChAT::EGFP neurons had 
mIPSCs of lower amplitude than Non-ChAT neurons (Fig. 5.8). 
Interpretation-discussion: The mIPSCs recorded in ChAT::EGFP neurons were smaller than those in 
Non-ChAT neurons. Although these recordings were obtained both in transverse and horizontal 
slices, we can link this observation to the difference in capacitance that we reported (for horizontal 
slices) between ChAT::EGFP neurons and Non-ChAT neurons, the latter having a smaller 
capacitance (Result section 2). Indeed, a larger cell capacitance could explain smaller mIPSCs in 
ChAT::EGFP neurons. 
ChAT::
EGFP
Naive
Non-
ChAT
ChAT::
EGFP
Sham
Non-
ChAT
ChAT::
EGFP
Cuff
Non-
ChAT
Figure 5.8: The amplitudes of miniature inhibitory post-synaptic currents (IPSC) of
ChAT::EGFP and Non-ChAT cells in horizontal (HS) and transverse (TS) slices of naïve, sham
and cuff mice. There were no observable link between each defined groups.
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7. Excitatory/inhibitory ratio onto DH LIII-IV neurons 
The frequencies of excitatory and inhibitory currents were analyzed separately in the previous 
sections, as we considered them to be two independent features of the recorded neurons (Fig. 5.9). 
However, because we actually have both excitatory and inhibitory currents recorded on each 
individual cell, we decided to analyze the ratio between their frequencies (E/I) in a separate analysis. 
The E/I ratio was calculated in ChAT::EGFP and Non-ChAT neurons from naïve, sham and cuff 
mice, in transverse and horizontal slices; the log10 of the ratios was used to ensure normality of 
the data. We first performed a global analysis of the variance of all the data point obtained, in order 
to establish the validity of subsequent group comparisons. 
There was a significant effect of the type of currents (spontaneous vs. miniatures; p=0.026), of type 
of neuron (ChAT::EGFP vs. Non-ChAT; p=8.2e-06) and the slice orientation (Horizontal vs 
Transverse; p=0.005). In addition, there was a significant association between the type of animal 
(naïve/sham/cuff) and the type of current.  
We simplified the model to take into account only those parameters that were proven meaningful, 
and then performed Tukey post-hoc tests (Fig. 5.9). The difference between Naïve, Sham and Cuff 
proved non-significant. The E/I ratio was significantly higher from miniature currents (7.30 ± 2.7) 
compared to spontaneous currents (5.82 ± 2.41) (TukeyHSD: p=0.04). The E/I ratio in 
ChAT::EGFP neurons (8.45 ± 0.97) was significantly higher than in non-ChAT neurons (4.63 ± 
0.60) (TukeyHSD: p=4e-06). The E/I ratio was lower in transverse slices (5.37 ± 0.89) compared 
to horizontal ones (7.12 ± 0.92) (Tukey HSD: p = 0.012). 
As for the interaction between the type of animal and the type of current, the E/I ratio was 
significantly higher in miniature currents (10.27 ±  3.20) compared to spontaneous currents (4.94 
± 2.22) in Sham animals (TukeyHSD: p=0.023). 
Interpretation-discussion: We observed a small difference in the E/I ratio depending on the animal 
groups (naïve/sham/cuff), as well as an interaction between this parameter with the type of 
currents (miniatures / spontaneous). However this difference in animals was not robust, as it was 
not confirmed by post-hoc testing of the simplified model. In addition, post-hoc testing of the 
interaction between types of animals and currents only demonstrated a difference between the E/I 
ratio of spontaneous and miniature currents, within sham animals. When analyzing only the naïve 
dataset, we had already observed a difference in the E/I ratio between ChAT:: EGFP and Non-
ChAT:
:EGFP
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Non-
ChAT
ChAT:
:EGFP
Sham
Non-
ChAT
ChAT:
:EGF
Cuff
Non-
ChAT
ChAT::
EGFP
Naive
Non-
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ChAT::
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Sham
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Non-
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Figure 5.9: The ratio between the frequency (f) of spontaneous (top) and miniature (bottom)
excitatory (EPSC) over inhibitory (IPSC) post-synaptic currents (f.EPSC/f.IPSC) of
ChAT::EGFP and Non-ChAT cells in horizontal (HS) and transverse (TS) slices of naïve, sham
and cuff mice. No significant differences were detected at interactions between the Animal
(Naïve, Sham, Cuff) * Neuron (ChAT::EGFP or Non-ChAT) * Slice (HS or TS) * Current
(Spontaneous or Miniature). However, there were detectable differences observed with fewer
interactions (see text).
(N=9) (N=12)(N=16) (N=13) (N=7)(N=12) (N=11)(N=11) (N=8) (N=10)(N=10) (N=8)
(N=9) (N=12) (N=9) (N=5) (N=6)(N=7) (N=7) (N=7) (N=8) (N=6) (N=6) (N=9)
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ChAT, which was confirmed here. Our data therefore fails to uncover a significant effect of the 
neuropathic surgery onto the E/I ratio in lamina III-IV neurons. 
8. Discussion 
We have characterized ChAT::EGFP and Non-ChAT neurons in naïve, sham and cuff adult mice. 
In general, the properties and inputs to LIII/IV neurons remains unchanged following peripheral 
nerve injury.  
8.1. DH cholinergic interneurons during neuropathy 
We have reported a smaller frequency in both excitatory and inhibitory inputs to ChAT::EGFP 
compared to Non-ChAT cells for all animal groups. This informs us that the general activity of 
upstream cells remains unaltered even after peripheral neuropathy. Moreover, the reduced 
frequency of excitatory inputs to ChAT cells in transverse slices compared to horizontal slices 
confirms the possibility that their excitatory drivers are present in distal regions. Finally, the 
elevated E/I ratio in cholinergic interneurons compared to Non-ChAT cells reaffirms that this 
cholinergic population receives a greater excitatory input compared to inhibitory ones, as reported 
in naïve mice.  
The number of ChAT::EGFP neurons, a sub-population of GABAergic neurons, remained 
unchanged following neuropathy. The existence of GABAerigc cell death after peripheral 
neuropathy and its contribution to mechanical allodynia is controversially debated (Polgar et al., 
2004; Scholz et al., 2005). Nevertheless, other morphological alteration may contribute to these 
pathological behaviors, as has been suggested for parvalbumin –PV) interneurons (Petitjean et al., 
2015). PV neurons provide feed-forward inhibition onto PKC gamma neurons thus ‘gating’ the 
transmission of non-noxious information into nociceptive circuits. Their number remains 
unchanged from 3 – 8 weeks’ post-surgery in SNI mice. However, the number PV+ appositions 
on PKC-gamma cell bodies are reduced following injury, which has been proposed to lead to 
mechanical allodynia (Petitjean et al., 2015).  
For the behavior output of cholinergic interneurons after peripheral injury; the intrathecal injection 
of cholino-toxin, AF64A, in neuropathic rats did not exacerbated the mechanical allodynia. 
However, after the highest dose of AF64A (15 nmol), the analgesic effect of clonidine (15µg) was 
lost. The effect absence is correlated to the reduced numbers of DH cholinergic cells (Paqueron et 
al., 2001). This indicates that the action of clonidine involves cholinergic interneurons within the 
spinal pathway during neuropathic conditions.  
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8.2. Cellular changes in the network after neuropathy 
We have reported a smaller capacitance in naïve compared to sham and cuff mice. Our initial 
hypothesis was an age difference between groups:  the naïve group had animals starting from P21 
whereas the youngest animals in sham and cuff groups were P28. However, we performed a linear 
regression analysis between age and cell capacitance and found no correlation (R² = 0.30118). This 
goes in the same direction as a study showing that cell capacitance of superficial DH cells is similar 
for P24 -45 adult mice (Tadros et al., 2012). An alternative hypothesis is that this difference could 
be due to a sampling bias. Slices obtained from older animals and/or neuropathic conditions are 
probably more prone to death, and this possibly concerns different subpopulation differentially. 
As the experiments were performed on horizontal slices, the dorsal superficial white matter partially 
blocks the light illumination pathway. The increased myelination in older animals could decrease 
visibility and perhaps contribute to a selection bias. In order to explain different probabilities of 
finding connected pairs between LI-III in two of their own studies, the group of B. Safronov 
alluded to poorer optics in one of them (Santos et al., 2007; Santos et al., 2009) 
Other passive properties and firing patterns appeared to be similar between ChAT::EGFP and 
Non-ChAT neurons, in different states. This is not completely unexpected as observed for other 
studies on neuronal subpopulations in the DH. A study looking, in LIII, at GAD67::EGFP and 
non-EGFP+ cells found no differences in passive membrane properties (RMP, Capacitance, Input 
resistance) as well as firing patterns between the SNL and control groups. The most common firing 
pattern was tonic firing in both states (Gassner et al., 2013). Similarly, electrophysiological 
properties in LII GABAergic neurons were unchanged after peripheral neuropathy (Schoffnegger 
et al., 2006). Altogether, this suggests that changed membrane excitability or altered firing patterns 
in LIII/IV of the spinal cord dorsal horn are unlikely causes for alterations underlying neuropathic 
pain. 
8.3. General overview of changes occurring during neuropathy 
Between naive and neuropathic states, there was no difference between the frequencies or 
amplitudes in excitatory and inhibitory currents irrespective of neuron type. Moreover, the E/I 
ratio was shown to be also unchanged. This suggests that the inputs into LIII/IV have not been 
altered. Surprisingly, the balance between excitation and inhibition is known to be dysregulated 
after neuropathy. Moreover, the downregulation of chloride transporter KCC2 has been reported 
in superficial laminae in rodents following neuropathy (Coull et al., 2005; Doyon et al., 2016; Kahle 
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et al., 2016). The lower chloride extrusion capacity is expected to lead to disinhibition of spinal 
circuits, but we did not observe such effect in our measured variables on LIII/IV neurons.  
Furthermore, we observed no differences in spontaneous activity (i.e. when no current injected) in 
recorded cells between all conditions (Naïve – 26%; Sham – 23% and Cuff – 14%). Ectopic 
discharge of primary afferents is known to drive central sensitization after peripheral nerve damage 
(Latremoliere and Woolf, 2009). Moreover, in vivo recording demonstrated increased ongoing 
activity in DH neurons following neuropathy (Medrano et al., 2016).The absence of difference in 
the occurrence of spontaneous activity in slices could be due to the isolation of the spinal cord 
during in vitro electrophysiology and thus removing components such as PNS, descending controls 
and/or absent spinal segments/circuits required for such activity.  
Altogether, the absence of effects in our dataset does not imply that LIII/IV circuits are unaltered 
during neuropathy. In naïve animals, the importance of LIII cells are demonstrated by their role in 
feed-forward inhibition which prevents transmission of non-noxious information from reaching 
LI projection neurons, providing substrate for mechanical allodynia (Torsney and MacDermott, 
2006; Miraucourt et al., 2009; Lu et al., 2013; Duan et al., 2014). Importantly, these studies recorded 
evoked measures (currents or potentials), while although we have recorded the spontaneous and 
miniature synaptic currents of LIII/IV cells in naïve and neuropathic animals. This could imply 
that LIII/IV circuit remains unfazed until challenged by incoming stimuli during injured states. 
In summary, we have observed that morphology, membrane properties and incoming synaptic 
inputs to DH cholinergic interneurons and Non-ChAT remain similar to naïve states after 
peripheral nerve injury. Thus, these variables do not underlie the changes following sciatic nerve 
injury.  
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Chapter 6: Global discussion and perspectives 
In this thesis, our main objective was to understand the role of the spinal cholinergic system in the 
nociceptive information processing in naïve and neuropathic states. Therefore, we have studied: 
(1) the spinal cholinergic system modulating noxious mechanical information transmission in vivo, 
and (2) the spinal dorsal Horn (DH) cholinergic interneurons in vitro. These objectives are 
ultimately two parts of a whole, as our working hypothesis is that the DH cholinergic interneurons 
are contributing to the spinal cholinergic tone modulating nociceptive spinal circuits.  
Role of the spinal cholinergic system in pain 
We have demonstrated that a spinal cholinergic tone contributes to mechanical noxious 
information modulation in naïve mice. The modulatory role of cholinergic agonists onto 
nociceptive processing has long been described. Interestingly, nicotinic agonists are known to have 
pro-nociceptive and anti-nociceptive effects (Khan et al., 1998). This can be due to the widespread 
expression of nAChRs along the nociceptive pathway. Expression of nAChRs, as well as of 
mAChRs has been reported in primary afferents (Zhang et al., 2007a; Chen et al., 2014b); 
descending fibers (Cordero-Erausquin and Changeux, 2001), neurons terminals (Marubio et al., 
1999; Genzen and McGehee, 2003; Takeda et al., 2003; Jeong et al., 2013) and postsynaptic DH 
neurons (Baba et al., 1998; Genzen and McGehee, 2005). In our hands, the cholinergic system 
demonstrated only an anti-nociceptive effect, as its inhibition produced a decrease in the threshold 
for behavioral withdrawal to a nociceptive stimulus, or increased response (in terms of action 
potentials) in DH neurons to such stimuli. Admittedly, we have manipulated the endogenous 
cholinergic tone, while exogenous applications of (nicotinic) agonists might have overstimulated 
this endogenous system, and/or differentially activated receptors compared to endogenous 
stimulation. This could explain a difference in net effect of these two manipulations. 
The spinal cholinergic system is also known to be crucially involved in the analgesic effect of 
common analgesics such as clonidine and morphine (Pan et al., 1999; Chen and Pan, 2001). In 
clinics, inhibitors of AChE have been used as a co-adjuvant to reduce overall drug consumption 
(Eisenach, 2009). Both clonidine and morphine have been shown to increased spinal acetylcholine 
levels (Gage et al., 2001; Abelson and Hoglund, 2004). Nevertheless, the clinical application for 
cholinergic drugs is limited due to side effects (Eisenach, 2009). The improved understanding of 
the spinal cholinergic system may pave way for therapeutics.  
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The mode of action of cholinergic interneurons  
Our in vivo recordings demonstrate that the modulatory effect of the endogenous cholinergic 
system involves an effect via nAChR and mAChR on the processing of incoming peripheral signals, 
both low and high threshold (respectively touch and pinch). This effect, recorded in a random DH 
neuron, also involves an inhibitory interneuron (I¢) downstream to the cholino-responsive neuron. 
We have not yet completed the elucidation of the cholinergic source contributing to this effect, but 
DH cholinergic interneurons are very likely candidates.  
These interneurons have been shown to have large dendritic and axonal aborization spreading 
several segments (Mesnage et al., 2011). We have demonstrated that they receive inputs from both 
excitatory and inhibitory neurons from the network, but also following activation of peripheral 
fibers. Our collaborator’s preliminary data has demonstrated ChAT::EGFP are also 
interconnected. Therefore, they could potentially modulate different circuits present at different 
spinal segments through themselves, thus having a major effect on the spinal network in spite of 
their scarcity. This would be reminiscent of scarce, but highly connected, GABAergic interneurons 
in the developing mammalian hippocampus, which can powerfully modulate the network activity 
patterns (Witten et al., 2010). Cholinergic interneurons are also presynaptic to LII cells, and these, 
as well as the post-synaptic LIII/IV ChAT, could represent the I’ neuron revealed in vivo.  
A peculiar feature of DH cholinergic interneurons is indeed that they also express GABA, and 
even Glycine. The combination of these neurotransmitter proves interesting as it potentially 
involves both excitation and inhibition, as has been reported in hippocampus (involving GABA 
and Glutamate) (Gutierrez, 2000). Co-release of acetylcholine with another neurotransmitter has 
also been previously reported (Omalley and Masland, 1989; Manns et al., 2001). In the CNS, 
acetylcholine seems to have a greater role in neuro-modulation as opposed to acting as a fast 
neurotransmitter at the neuromuscular junction (Picciotto et al., 2012). As observed on motor 
neurons, M2 receptors can change neuronal excitability (Wilson et al., 2004). Potentially, the co-
release of GABA/Glycine could be potentiated by acetylcholine. More generally, cholinergic 
terminals have been observed on primary afferent fiber endings in LII (Ribeiro-da-Silva and Cuello, 
1990). This indicates that cholinergic interneurons could modulate incoming information by 
inducing primary afferent depolarization via GABA or even ACh (Hochman et al., 2010).  
An ongoing question in the field of cholinergic physiology, is the exact nature of transmission: 
synaptic vs volumic. In supra-spinal structures, both traditional and extra-synaptic transmission 
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have been reported. The arguments supporting extra-synaptic transmission are the presence of 
cholinergic receptors on non-cholinergic synapses and increased extracellular ACh levels supports 
this notion (Sarter et al., 2009). Extra-synaptic GABA receptors have also been described, and 
implicated in neuropathic and inflammatory pain states (Iura et al., 2016; Perez-Sanchez et al., 
2017). Whether such link exists between the mode of cholinergic transmission and the behavior 
remains to be demonstrated. 
Spinal cholinergic circuit in neuropathic mice 
After peripheral neuropathy, the spinal cholinergic tone appears to have undergone changes. This 
was already reported in the literature, as previous reports even claimed a loss of the cholinergic 
tone after neuropathy (Rashid and Ueda, 2002) or a plasticity in the effect of drugs (clonidine) 
acting through the spinal cholinergic system (Pan et al., 1999). At the behavioral level, we still 
observed the presence of a cholinergic tone acting on nAChR and, to a certain extent, mAChR. In 
vivo recordings confirmed that the plasticity of the tone was differential, affecting more the 
nociceptive pathway. Although plasticity in the cholinergic system has occurred, our in vitro 
recordings fail to uncover alterations in the basal inputs and passive properties of DH cholinergic 
interneurons. Such discrepancies may be explained by technical limitations due to slices or the 
inappropriate measured variables.   
We also observed no difference in the density of ChAT interneurons after neuropathy. However, 
other cholinergic elements could change such as the appositions of ChAT boutons on targets, 
decreased levels of ACh (downregulation of ChAT), altered AChR receptor 
expression/localization/efficacy or AChE distribution/activity. Nevertheless, preliminary data 
suggest that AChE activity was unchanged after neuropathy (collaboration with E. Krejci, Paris 
University, unpublished observations). The exact nature of the changes impacting the spinal 
cholinergic system thus remains to be elucidated. 
Perspectives 
All behavior literature has been working on measures following evoked stimulation. This makes it 
difficult to study the “basal” state and role of the cholinergic system. In order to address this point, 
we could set a conditional place preference paradigm with intrathecal injection of cholinergic drugs 
to see relative contributions of different receptors. 
Identifying the source of ACh involved in the observed behavior is an objective that we expect to 
reach in the coming weeks. However the DREADD experiments described in  Results section 1 
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do not enable to identify the exact contribution of the cholinergic component (vs. the GABA 
and/or glycine one). To specifically address this point, we have designed a virus with a floxed 
construct encoding an inducible form of si-RNA against ChAT. With this tool, the strategy is to 
silence ChAT exclusively in ChAT neurons (due to the cre-dependence and the use of ChAT-Cre 
mice) at a chosen time (to avoid developmental effects). The vector is under production and should 
enable to refine our conclusions on the mode of action of these neurons. 
Finally, we have been trying to record from DH cholinergic interneurons in vivo. This has proven 
difficult, due to their low density, even with tools such as optrode developed by our collaborators 
in Québec (LeChasseur et al., 2011). We will yet pursue our endeavor, as studying the natural 
stimulus in an intact animal is the best way to understand the activators to this population. 
Moreover, following their activity can be an indicator as to how the cholinergic tone and 
acetylcholine levels evolve in vivo. 
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Loss of inhibitory tone on spinal cord dorsal horn
spontaneously and nonspontaneously active
neurons in a mouse model of neuropathic pain
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Abstract
Plasticity of inhibitory transmission in the spinal dorsal horn (SDH) is believed to be a key mechanism responsible for pain
hypersensitivity in neuropathic pain syndromes. We evaluated this plasticity by recording responses to mechanical stimuli in silent
neurons (nonspontaneously active [NSA]) and neurons showing ongoing activity (spontaneously active [SA]) in the SDH of control
and nerve-injured mice (cuff model). The SA and NSA neurons represented 59% and 41% of recorded neurons, respectively, and
were predominantly wide dynamic range (WDR) in naive mice. Nerve-injured mice displayed a marked decrease in the mechanical
threshold of the injured paw. After nerve injury, the proportion of SA neurons was increased to 78%, which suggests that some NSA
neurons became SA. In addition, the response to touch (but not pinch) was dramatically increased in SA neurons, and high-
threshold (nociceptive specific) neurons were no longer observed. Pharmacological blockade of spinal inhibition with a mixture of
GABAA and glycine receptor antagonists significantly increased responses to innocuous mechanical stimuli in SA and NSA neurons
from sham animals, but had no effect in sciatic nerve-injured animals, revealing a dramatic loss of spinal inhibitory tone in this
situation. Moreover, in nerve-injured mice, local spinal administration of acetazolamide, a carbonic anhydrase inhibitor, restored
responses to touch similar to those observed in naive or sham mice. These results suggest that a shift in the reversal potential for
anions is an important component of the abnormal mechanical responses and of the loss of inhibitory tone recorded in a model of
nerve injury-induced neuropathic pain.
Keywords: Dorsal horn, Electrophysiology, Spinal cord, Mice, Mechanical stimuli, Spike, Spontaneous activity, Disinhibition,
Neuropathic pain
1. Introduction
Chronic pain continues to be the most common cause of
disability that impairs quality of life, accruing enormous socio-
economic costs. In particular, neuropathic pain, caused by
a lesion or disease of the somatosensory nervous system, lacks
optimal treatment, often leading to unsatisfactory pain manage-
ment. This may be due to incomplete understanding of the
neuronal circuits involved in nociceptive processing and their
plasticity in pain conditions.41
Spinal dorsal horn (SDH) neurons integrate sensory, nocicep-
tive or innocuous, information, and relay it to the brain through
projection neurons.39–41 Plasticity of the inhibitory transmission in
the SDH is believed to be a key mechanism responsible for the
hypersensitivity occurring during neuropathy.27,28,31,41,43 In rats,
a reduction of GABA release and a decrease in the expression of
GABA-synthesizing enzymes has been observed in different
models of nerve injury.19,21 A change in chloride homeostasis
leading to disinhibition of SDH neurons has also been extensively
characterized in neuropathic rats.9,10,27 Because GABAA and
glycine receptors are permeable to both chloride and bicarbonate
(usually in opposite directions), it has been suggested that
reducing the bicarbonate depolarizing driving force couldmitigate
the disinhibition due to a collapse in chloride gradient.1,2,17
However in vivo recordings performed in rats have provided
controversial data concerning the plasticity of inhibitory trans-
mission in neuropathic models, arguing for either a decrease or
an increase of GABAergic tone.7,15 Both studies have focused on
SDH neurons responding to natural peripheral stimulations but
showing no spontaneous ongoing activity between stimuli
(nonspontaneously active [NSA] neurons). However, some SDH
neurons display considerable ongoing activity in the absence of
experimentally applied stimuli (SA neurons).32,36,37 Interestingly,
an increased level of spontaneous activity has been reported in
animal models of neuropathic pain.12,14,16,38 This implies that
some NSA neurons may become SA after neuropathy, blurring
the borders between NSA and SA populations, and biasing
studies focusing on only one of these populations.
In this study, we systematically analyzed both SA and NSA
neurons to provide an exhaustive characterization of the neurons
involved in sensory processing of mechanical information and
their plasticity after nerve injury in mice. With this approach, we
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aimed at assessing whether an inhibitory tone can be detected in
the mouse SDH, and whether this tone undergoes plasticity in
a model of neuropathy. To evaluate whether this plasticity is
related to reduced activation of GABAA and/or glycine receptors,
or from altered reversal potential of the ions flowing through these
receptors, we tested the consequences of manipulating bi-
carbonate homeostasis in the SDH.17 We used the sciatic nerve
cuffing model that has been broadly used to decipher the
neurobiological mechanisms leading to neuropathic pain in
rats,14,16,25 and has more recently been adapted to the adapted
to the mouse (or) adapted to mice.45 We provide the first
electrophysiological characterization of thismousemodel and the
first evaluation of disinhibition in themouse SDHafter neuropathy.
2. Materials and methods
2.1. Animals
A total of 96male CD1mice, aged 6 to 8 weeks were used for this
study. They were housed 4 or 5 per cage in a facility maintained at
constant temperature (23˚C) with a 12-hour light–dark cycle and
food and water ad libitum. The animal facilities are legally
registered for animal experimentation under Animal House
Agreement A67-2018-38, and scientists in charge of the experi-
ments possess the certificate authorizing experimentation on
living animals, delivered by the governmental veterinary office. All
procedures were performed in accordance with the local animal
care and use committee as well as with European Communities
Council Directive 86/609/EEC.
2.2. Peripheral nerve injury and behavioral testing
The peripheral nerve injury was induced by cuffing the main
branch of the right sciatic nerve.3 Surgeries were performed
under ketamine (17 mg/mL)/xylazine (2.5 mg/mL) anesthesia
(intraperitoneally [i.p.], 4 mL/kg) (Centravet, Taden, France).
The common branch of the right sciatic nerve was exposed and
a 2-mm section of split PE-20 polyethylene tubing (Harvard
Apparatus, Les Ulis, France) was placed around it (cuff group).
The shaved skin was closed using suture. Sham-operated mice
underwent the same surgical procedure without implantation of
the cuff (sham group). Sham and cuff animals were allowed to
recover for at least 1 week after surgery. After this, mechanical
allodynia was tested using von Frey filaments (Bioseb, Vitrolles,
France), which were applied to the plantar surface of each hind
paw (ipsilateral and contralateral to the cuff) until a slight bent was
observed, in a series of ascending forces up to the mechanical
threshold. Each filament was tested 5 times per paw, and the
threshold was defined as the lower one of 2 consecutive filaments
for which 3 ormorewithdrawals out of the 5 trials were observed.5
2.3. In vivo electrophysiology
2.3.1. Animal preparation
Animals were anesthetized with urethane (2.5 g/kg, i.p.), and the
trachea was cannulated. Laminectomy was performed on naive,
sham, and cuff animals to expose L3 to L5 segments of the spinal
cord. Rectal temperature was continuously monitored, and the
animal was maintained at 35.5˚C using a heating pad (TC-1000;
Bioseb). The mouse was placed in a stereotaxic and spinal frame
with 2 clamps fixed on its vertebra to immobilize the spinal cord.
Around the exposed lumbar spinal cord, a small chamber
(approximately 0.1 mL) was created with 2% agar. After removal
of the dura, the spinal cord was covered with saline (NaCl 0.9%).
2.3.2. Single-unit extracellular recordings
Single-unit extracellular recordings were made from SDH
neurons responding to mechanical stimulation of the right hind
paw, ie, from the side ipsilateral to the surgery in sham and cuff
animals. Recordings were made with a glass electrode (Harvard
Apparatus, Holliston, MA) filled with 0.5MCH3COOK (resistance:
15-25 MV). A motorized micromanipulator (Narishige, Tokyo,
Japan) was used to gradually descend the electrode with 4-mm
steps until the single-unit activity of an SDHneuronwas recorded.
The recording electrode was inserted at depths #500 mm from
the surface of the spinal cord (corresponding to lamina I to V). The
signal was amplified (IR-183; Cygnus Technology, Delaware
Water Gap, PA), filtered at 0.3 to 3 kHz (Brownlee amplifier;
AutoMate Scientific, Berkeley, CA), and digitized at 20 kHz with
a MICRO3-1401 (CED, Cambridge, United Kingdom). Data were
analyzed offline with Spike 2 software (CED). The cutaneous
receptive field of the recorded neuron was identified by touching
the ipsilateral hind paw. The response to a nonnociceptive
mechanical stimulus, touch, and to a nociceptive one, pinch, was
determined as described by others.6 The touch stimulus was
applied by brushing the skin with a camel’s hair brush for 10
seconds (8-10 times). The pinch stimulus was applied by means
of small serrated forceps (Graefe forceps; Fine Scientific Tools,
Vancouver, Canada) for 10 seconds. Three types of neurons
could be distinguished based on their differential response to
touch vs pinch: (1) low-threshold (LT) neurons responded equally
or more to nonnoxious touch than to noxious pinch; (2) wide-
dynamic-range (WDR) neurons responded more to pinch than to
touch; and (3) high-threshold (HT) neurons responded only to
pinch, or at least 10 times more to pinch than to touch.
2.4. Drugs
Drugs were applied directly at the surface of the SDH using the
agar chamber described above. The following drugs were
purchased from Sigma (St Louis, MO): acetazolamide (ACTZ,
a carbonic anhydrase inhibitor), bicuculline (a g-aminobutyric acid
[GABAA] receptor antagonist), phenylbenzene v-phosphono-
a-amino acid (PMBA), a glycine receptor antagonist,30 and
D(2)-2-amino-5-phosponopentanoic acid (D-AP5, an N-methyl-
D-aspartate [NMDA] receptor antagonist). 6-cyano-7-
nitroquinoxaline-2,3-dione (CNQX, a non-NMDA ionotropic
glutamate receptor [iGluR] antagonist), was purchased from
Tocris Bioscience (Bristol, United Kingdom). Stock solutionswere
first prepared in water at 1003 their final concentration, stored at
220˚C and, on the day of the experiment, diluted in saline to their
final concentration. Acetazolamide was prepared as previously
described.17 All solutions were applied at 34˚C to 35˚C.
2.5. Data analysis
Putative single-unit activity was isolated online with template
matching (Spike 2). Data are shown as mean 6 SEM. The
baseline ongoing activity (or firing rate [FR]) of SDH neurons is an
average of the number of spikes during the first 2 minutes of
recordings. The same periodwas used to calculate the coefficient
of variation (CV) of the interspike interval, a value used widely as
an indicator of regularity (the lower the CV value, the more regular
the unit activity). The CV was calculated using the Spike 2
toolboxes and the script Meanix (CED). To measure the action
potential widths or spike duration, the time between the first peak
and trough of the action potential was measured, regardless of
the order in which they occurred.20 This analysis was performed
using the Spike 2 toolboxes and the script PTA-analysis version
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1.01 (Sylvain Coˆte´, Laval University, Que´bec). This script also
provided the measurement of the amplitude of the spike (from
peak to trough).
The responses evoked by the mechanical stimuli were
quantified as the mean discharge rate over the duration of the
stimulus (10 seconds) after subtracting the background ongoing
activity recorded for 1 minute before applying the stimulus.6 In
each neuron, touch and pinchwere applied 3 times to confirm the
reproducibility of these stimuli. We calculated and then averaged
the effects elicited by the consecutive applications of each
stimulus. Wewaited at least 60 seconds between application of 2
consecutive stimuli to avoid the development of sensitization.
Postdischarge (PD) was calculated for each neuron as the
cumulative number of action potentials during the 10 seconds
(short PD) or 1minute (long PD) after the end of the stimulus using
a custom-made LabVIEW program. The results were analyzed
with GraphPad Prism (version 5.0 for Windows; GraphPad
Software, Inc, San Diego, CA) and Microsoft Excel (2010).
Statistical evaluation was performed with nonparametric tests
because most of the data did not show a normal distribution
(Shapiro–Wilk normality test). The paired-samples Wilcoxon
signed-rank test was performed to compare the effects before
and after drug application within the same cell. The 2-sample
Wilcoxon–Mann–Whitney rank-sum test was performed to
compare independent groups. The Fisher exact test was used
to compare proportion of SA vs NSA neurons and the proportion
of LT, WDR, and HT in SA and NSA neurons. The level of
significance was set at P 5 0.05.
3. Results
3.1. Quantitative comparison of spontaneously active and
nonspontaneously active neurons in spinal dorsal horn of
naive animals
We recorded single-unit activity from a total of 96 SDH neurons
from 42 naive mice. All of them responded to mechanical
stimulation of the ipsilateral paw. Fifty-seven of those neurons
(59%) showed sustained continuous ongoing activity (the FR
ranging from0.1 to 9.8Hz;mean basal FR: 4.16 0.6Hz,Fig. 1A),
whereas 39 (41%) were silent and only fired when the stimuli were
applied (Fig. 1A). Therefore, those neurons were respectively
named spontaneously active (SA) and non-spontaneously active
(NSA) neurons. We tested whether pharmacological blockade of
fast inhibitory and excitatory synaptic transmission abolished
ongoing activity of SA neurons in naive animals. For this, we used
a cocktail of saturating doses of GABAA, glycine, and glutamate
receptors antagonists (bicuculline, PMBA, D-AP5, and CNQX, all
at 100 mM). The antagonists had no effect on the ongoing activity
(result not shown, P 5 0.4375, paired-samples Wilcoxon test, n
5 6), which suggests that the ongoing firing activity of SA neurons
represents an intrinsic property of these neurons.
To better define SA and NSA neurons, we first compared their
location. Although both types of neurons could be found
throughout the first 5 dorsal laminae (Fig. 1B), SDH SA neurons
were distributed significantly deeper in the spinal cord than NSA
neurons (359 6 18 mm, n 5 57, vs 268 6 25 mm, n 5 39, P 5
0.0054, 2-sample Wilcoxon test) (Figs. 1B and C; Table 1).
Taking this into account, we tested other electrophysiological
parameters that might be useful in further distinguishing SA and
NSA neurons. Although yet unexploited in the spinal cord,
analysis of action potential waveform is classically used in the
brain to characterize and distinguish neuronal types.4,24,33 Spike
duration in SA neurons was on average 0.496 0.04milliseconds,
which was not different from that in NSA neurons: 0.48 6 0.06
milliseconds. However, we found that the spike amplitude was
significantly larger in NSA than in SA neurons (Table 1). These
differences suggest that SA and NSA might represent different
types of neurons.
Having established the fundamental electrophysiological
properties of both types of cells, we quantified the responses of
identified SDH SA and NSA neurons to mechanical stimulation in
naive mice. Two types of mechanical stimuli were applied to the
ipsilateral hind paw: nonnoxious touch using a brush (dynamic
touch) and noxious pinch using serrated forceps (see Material
and methods). In SA neurons, the increase in firing frequency
induced by touch was 2.36 0.5 Hz, whereas the increase in the
FR induced by pinch was significantly larger, 4.06 0.5 Hz (n5 57
in both, P, 0.00001, paired-samples Wilcoxon test, Fig. 2A). In
NSA neurons, the effect of pinch was also significantly larger than
that of touch: 4.1 6 0.4 vs 1.6 6 0.3 Hz, respectively (n 5 40 in
both, P , 0.00001, paired-samples Wilcoxon test, Fig. 2A).
There was no significant difference between SA and NSA
neurons of the naive group in their responses to touch or pinch
(2-sample Wilcoxon test).
Figure 1. Distinguishing features of spontaneously active (SA) and nonspontaneously active (NSA) neurons in naive mice. (A) Representative examples of
extracellular recordings of a spinal dorsal horn (SDH) SA (top) and an NSA (bottom) neuron showing the effect induced by pinch in the ipsilateral paw (10-second
stimulus, solid line). (B) Location of the recorded SA andNSA neurons. Symbols are the individual cells, and red lines aremean6SEMof each group of cells. **P,
0.01, SA vs NSA (2-sample Wilcoxon test). (C) Recordings obtained from 3 different neurons (2 NSA and 1 SA) in the same pipette descent and schematic
representation of their position in the SDH. The solid lines represent the pinch stimulus (10 seconds). Note that the NSA neurons are more superficial than the SA.
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Based on their responses to touch and pinch, SA and NSA
neurons were classified as LT, wide dynamic range (WDR), or
high threshold (HT) (see Materials and methods). In both
populations, the majority of recorded neurons were WDR,
responding more to pinch than to touch (respectively 75% and
62% of SA and NSA neurons, Fig. 2B). The percentage of HT
neurons was 11% in SA neurons and 28% in NSA. Finally, 14% of
SA, and 10% of NSA neurons were classified as LT. There was no
difference in the distribution of SA vs NSA neurons in these 3
categories.
Previous reports have mentioned that some neurons continue
firing after the cessation of the stimulus, a property called post-
discharge (PD)26; this has been proposed to have a peripheral
origin, involving a continuous release of neurotransmitters
(glutamate and substance P) by primary afferents outlasting the
end of the stimulus. We have therefore evaluated whether NSA
and SA neurons could be differentiated by the existence or
absence of a PD. Indeed in NSA neurons, the mean number of
events 60 seconds after touch or pinch was significantly higher
than that recorded 60 seconds before the stimulus: the average
number of spikes during 1 minute before and after touch was 0.0
6 0.0 spikes and 3.4 6 0.7 spikes, respectively (P 5 0.0014,
paired-samples Wilcoxon test), and before vs after pinch 0.0 6
0.0 spikes vs 14.3 6 2.6 spikes (P 5 0.001, paired-samples
Wilcoxon test). The PD induced by the noxious stimuli was larger
than that induced by touch (P 5 0.0003, paired-samples
Wilcoxon test, Fig. 2C). In contrast, SA neurons did not display
a similar “long” PD, nor a shorter one over 10 seconds. Indeed, in
SA neurons, the mean number of events during 60 seconds
before and after touch and pinch was: pretouch: 176.26 25.5 vs
posttouch: 178.4 6 28.4 spikes; prepinch: 195.1 6 34.8 vs
postpinch: 192.4 6 35.1 spikes (Fig. 2C). This difference in the
presence of a PD suggests that SA andNSA neurons differentially
process mechanical stimuli.
Table 1
Electrophysiological properties of mouse spinal cord dorsal horn neurons.
Spontaneously active (SA) Nonspontaneously active (NSA)
Naive Sham Cuff Naive Sham Cuff
Location (mm) 359 6 18 400 6 21 368 6 18 268 6 24* 305 6 15† 297 6 28‡
Firing rate (Hz) 4.1 6 0.6 3.5 6 0.5 4.0 6 0.4 — — —
CV (%) 66.3 6 4.0 (57) 61.1 6 5.1 (41) 63.3 6 4.2 (71) — (39) — (39) — (20)
Spike duration (ms) 0.49 6 0.04 0.54 6 0.05 0.59 6 0.07 0.47 6 0.06 0.51 6 0.06 0.50 6 0.06
Peak to trough spike amplitude (mV) 1.6 6 0.2 (21) 1.1 6 0.2 (25) 1.4 6 0.1 (36) 3.3 6 0.4† (21) 1.7 6 0.2* (29) 1.8 6 0.2 (17)
Mean 6 SEM of different electrophysiological parameters defining SA and NSA neurons in the different groups.
* P , 0.01.
† P , 0.001 NSA vs SA (2-samples Wilcoxon test; the number of neurons analyzed is given in parentheses).
‡ P , 0.05.
CV 5 coefficient of variation.
Figure 2. Effect induced by touch and pinch on spontaneously active (SA) and nonspontaneously active (NSA) neurons in naive mice. (A) Increase of the firing rate
induced by touch and pinch. Bars represent mean 6 SEM of the increase of the firing rate during touch and pinch application (10 seconds); **P, 0.01, ***P ,
0.001 touch vs pinch (paired-samples Wilcoxon test). (B) Percentages of low-threshold (LT), wide dynamic range (WDR), and high-threshold (HT) neurons.
Spontaneously active and NSA neurons were classified into 3 types: LT, WDR, and HT based on the ratio between the effect of touch and pinch. (C) Analysis of
postdischarge (PD) induced by touch and pinch in SA and NSA neurons. The blue line represents themean number of spikes per second, for all analyzed neurons
(n 5 57 SA neurons, n 5 40 NSA neurons). The vertical bars are the SEM. The gray bars represent the application of the stimuli. The PD was considered as the
number of spikes for 60 seconds after the stimuli. **P, 0.01, ***P , 0.001 PD vs basal (paired-samples Wilcoxon test); ###P, 0.005, pinch vs touch (paired-
samples Wilcoxon test).
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3.2. Adaptation of spontaneously and nonspontaneously
active neurons after nerve injury
To study the plasticity induced by nerve injury, we performed in
vivo electrophysiological recordings from SDH neurons in sham
and cuff mice in the second and third weeks after surgery. Before
starting the recording sessions, sham and cuff mice were tested
for the presence of mechanical allodynia using von Frey hairs. As
expected, the cuff group showed a significant reduction in the
mechanical threshold of the hind paw ipsilateral to the surgery in
comparison with the ipsilateral paw in sham (1.05 6 0.10 g, n 5
20 mice vs 3.916 0.21 g, n5 21 mice, respectively, P5 0.001,
Mann–Whitney test, Fig. 3A). These data confirmed the de-
velopment of mechanical allodynia in cuff but not sham mice.
We recorded single-unit activity from a total of 80 SDH neurons
from 21 sham mice and 91 SDH neurons from 23 cuff mice. The
proportions of SA sham and NSA sham neurons were 51% and
49%, respectively, (n 5 41 SA sham neurons, and n 5 39 NSA
sham neurons), which was not significantly different from the
proportions in naive mice (P 5 0.2907, Fisher exact test).
Interestingly, the proportion of SA and NSA neurons was
significantly different in cuff vs sham mice: we observed 78% of
SA cuff neurons and 22% of NSA cuff neurons (n 5 71 and n 5
20, respectively, P5 0.0003, Fisher exact test, cuff vs sham; Fig.
3B). The distribution of the basal FR of SA sham neurons was not
different from that of SA cuff neurons: mean basal FR 3.5 6 0.5
Hz (ranging from 0.1 to 12.7 Hz, n5 41) in SA sham vs 4.06 0.4
Hz (ranging from 0.3 to 15.7 Hz, n 5 71) in SA cuff (P 5 0.3398,
Wilcoxon rank-sum test).
To further characterize SA and NSA neuronal properties after
nerve injury, we analyzed their recording location in sham and cuff
animals. Consistent with the results obtained in naive animals,
recorded SA sham neurons were located significantly deeper
than NSA sham neurons (4006 21mm, n5 41, vs 3056 15mm,
n 5 39, respectively, P 5 0.0005, 2-sample Wilcoxon test,
Fig. 3C). Similarly, in cuff mice, SA neurons were recorded at
significantly deeper locations than silent cells (3686 18 mm, n5
71, vs 297 6 28 mm, n 5 20; P 5 0.04725, 2-sample Wilcoxon
test, Fig. 3C). There was no difference in the location of SA or
NSA neurons in sham vs cuff.
To better understand the changes occurring in SA and NSA
neurons during neuropathy, the electrophysiological parameters
related to the spike waveform were analyzed in neurons from
sham and cuff animals. Overall, there was no difference in the
spike duration between SA and NSA neurons from sham and cuff
(Table 1). As in neurons from naive mice, the amplitude of the
spike of SA sham neurons was significantly smaller than that of
NSA sham neurons (P 5 0.0014, 2-sample Wilcoxon test,
Table 1). Interestingly, in cuff animals, we did not find any
statistical difference in spike amplitude between SA cuff and NSA
cuff neurons (Table 1).
We next explored the responses of SA and NSA neurons to
mechanical stimuli in control and neuropathic mice. First, as seen
in naive animals, there was no significant difference betweenNSA
sham and SA sham neurons in their response to the stimuli (P 5
0.3188 for touch, P 5 0.5601 for pinch). Also, the response
induced by pinch was significantly larger than the response
induced by touch in both SA and NSA neurons recorded from
sham animals (P5 0.0010 and P5 0.0003, respectively, paired-
samples Wilcoxon test, Fig. 4A). However, this was not the case
in cuff animals, in which the response to touch was not
significantly different from the one to pinch in SA cuff neurons
(P5 0.060), or was even significantly larger than the one to pinch
in NSA cuff neurons (P 5 0.0192, paired-sample Wilcoxon test,
Fig. 4A). This was due to a very large increase of the response to
touch (accompanied by a decrease in the response to pinch)
observed in NSA cuff neurons compared with that in NSA sham
neurons (4.96 1.2 Hz vs 2.16 0.3 Hz for touch, 1.96 0.5 Hz vs
3.86 0.4 Hz for pinch, respectively; P5 0.0159 and P5 0.0026,
2-sample Wilcoxon test, Fig. 4A). The decrease in the average
Figure 3.Behavioral assessment of sham and cuff mice, and distribution of spontaneously active (SA) and nonspontaneously active (NSA) neurons in these mice.
(A)Mechanical threshold assessedwith von Frey filaments on the hind pawcontralateral and ipsilateral to the injury in control (sham) and neuropathic (cuff) animals.
Bars aremean6SEMof themechanical pressure (in grams) yielding to pawwithdrawal in each condition. ***P, 0.001, 2-sampleWilcoxon test. (B) Percentage of
SA and NSA neurons recorded in sham and cuff mice (respectively n5 80 and n5 91 total neurons). ***P, 0.001, Fisher exact test. (C) Location of the recorded
SA and NSA neurons in sham and cuff animals. Symbols are the individual cells, and horizontal lines are mean 6 SEM of each group of cells. *P, 0.05, ***P,
0.001, 2-sample Wilcoxon test.
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response to pinch in NSA cuff neurons could be linked to an
overrepresentation of neurons displaying no response at all to
pinch in this group: indeed, although nonresponders to pinch
represented 5% of NSA sham neurons (2 of 39 neurons), they
represented 30% of NSA cuff neurons (6 of 20 neurons, P 5
0.0144, Fisher exact test). The overall proportion of neurons not
responding to pinch in sham vs cuff mice was unchanged (5% vs
12%, respectively, 4 of 80 neurons in sham and 11 of 91 neurons
in cuff, P 5 0.1138, Fisher exact test). This indicated that the
enrichment of nonresponders to pinch observed in NSA cuff was
specific to this group. Our data suggest that, althoughmany silent
neurons become SA in cuff mice (leading to an increase in the
proportion of SA neurons from 51% to 78% in sham vs cuff, Fig.
3B), nonnociceptive neurons (nonresponders to pinch) preferen-
tially remain silent (NSA) after nerve injury.
The increased proportion of neurons with ongoing activity, as
well as the large increase in the response to the low threshold
mechanical stimulation showed that there was neuronal hyper-
sensitivity to nonnoxious stimuli in the SDH after cuffing the sciatic
nerve, consistent with the behavioral allodynia found in cuff
animals (Fig. 3A). To understand the encoding properties of SA
and NSA neurons, it is important to compare the response of
individual neurons with different types of peripheral stimuli. We
therefore analyzed the impact of nerve injury on the proportion of
LT,WDR, andHT neuronswithin SA andNSApopulations. Like in
naive animals, we found the 3 types of neurons in shammice, with
WDR being the predominant population (Fig. 4B). However, after
nerve injury, a similar analysis revealed only 2 types of neurons:
WDR and LT. We could not record HT neurons in cuff animals.
More specifically, SA sham cells were 71% WDR, 24% LT, and
5% HT, respectively. This was significantly different from SA cuff
neurons: 41 % WDR and 59 % of LT (P 5 0.0003, Fisher exact
test, Fig. 4B). Regarding the NSA neurons, this change was even
more striking. Indeed, in NSA sham, we found 62%ofWDR, 20%
of LT, and 18%HT, whereas in NSA cuff, only 20%of the neurons
wereWDR and the other 80%were classified as LT (P5 0.0009,
Fisher exact test, Fig. 4B). These results show that after nerve
injury, in both SA and NSA neurons, there is a decrease of WDR
and HT in favor of LT neurons. It should be noted that the majority
of LT neurons recorded in cuff also responded to the noxious
stimulation (pinch) and should therefore not be considered as
nonnociceptive. These results are consistent with the behavior of
cuff mice that experience a marked decrease in the mechanical
threshold of the injured paw. Finally, all of these data suggest that
both SA andNSA neurons are involved in the plasticity induced by
the peripheral nerve injury in the ipsilateral SDH.
The analysis of the PD showed that, as observed in naive mice,
NSA sham neurons showed a significant long PD after both touch
(pretouch: 0.06 0.0 vs posttouch: 2.76 0.6 spikes over 1minute,
P 5 0.0003, paired-samples Wilcoxon test) and pinch (prepinch:
0.0 6 0.0 vs postpinch: 18.4 6 4.5 spikes over 1 minute, P 5
0.0001, paired-samples Wilcoxon test, Fig. 5A). In NSA sham
neurons the PD induced by the noxious stimuli was larger than the
one induced by touch (P5 0.0001, paired-samplesWilcoxon test,
Fig. 5A). In cuff mice, NSA neurons also showed long PD after
touch (pretouch: 0.06 0.0 vs posttouch: 16.3 6 5.5 spikes over
1 minute, P 5 0.0003, paired-samples Wilcoxon test) and pinch
(prepinch: 0.0 6 0.0 vs postpinch: 29.9 6 12.4 spikes over
1minute,P5 0.0001, paired-samplesWilcoxon test,Fig. 5B); the
PD observed in NSA cuff was significantly larger than that in NSA
shamneurons (P5 0.0001 in both groups, touch and pinch, Figs.
5A and B). Although SA sham neurons did not show any PD after
touching or pinching (Fig. 5A), as observed in naive mice, SA cuff
neurons showed a short-term PD in the first 10 seconds after both
touch and pinch: (pretouch: 27.46 4.2 vs posttouch: 37.26 5.0
spikes over 10 seconds, P 5 0.0001, paired-samples Wilcoxon
test; prepinch: 25.36 4.5 vs postpinch: 35.96 5.0 spikes over 10
seconds, P , 0.01, unpaired t test, Fig. 5B). No significant
difference was found in the PD induced by touch and the one
induced by pinch in neurons from cuff animals.
Figure 4. Effect of touch and pinch in spontaneously active (SA) and nonspontaneously active (NSA) neurons recorded from sham and cuff animals. (A) Increase of
the firing rate induced by touch and pinch in SA (left) and NSA (right) neurons from sham (white) and cuff (black) animals. Bars represent mean 6 SEM of the
increase of the firing rate during touch and pinch application (10 seconds). Note that in NSA cuff, the effect induced by touch was larger than that in NSA sham,
whereas the effect induced by pinch was smaller (*P , 0.05, **P , 0.01, 2-sample Wilcoxon test). In sham (control) mice, the effect of pinch was significantly
greater than the effect of touch for both groups of neurons (##P, 0.01, ###P, 0.001, paired-samplesWilcoxon test). However, in NSA cuff neurons, the effect of
pinch was smaller than the effect induced by touch (#P, 0.05, paired-samplesWilcoxon test). In SA cuff neurons, the effect induced by touch is not different from
that induced by pinch. (B) Percentages of low-threshold (LT), wide dynamic range (WDR), and high-threshold (HT) neurons form sham and cuff animals.
Spontaneously active and NSA neurons were classified into 3 types: LT, WDR, and HT based on the ratio between the effect of touch and pinch. Note that in both
SA and NSA, the percentage of LT neurons increased considerably after nerve injury. ***P, 0.001 SA vs NSA (Fisher exact test). Some LT neurons did not show
any response to pinch (hatched bars,% in white). Note that this percentagewas significantly larger in NSA cuff neurons (in comparison with NSA sham neurons, *P
, 0.05, Fisher exact test).
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3.3. Plasticity of the inhibition in spontaneously and
nonspontaneously active neurons of the spinal dorsal horn
after nerve injury
Previous reports have suggested that spinal disinhibition may be
a substrate for the behavioral hypersensitivity observed after
nerve injury.7,16,32 To address this question in our model, we
tested the effect of the blockade of fast synaptic spinal inhibition
with a mixture of the GABAA antagonist, bicuculline, and the
glycinergic antagonist, PMBA, in both sham and cuff mice.
Combined blockade of GABAA and glycine receptors induced an
increase in the response to touch and pinch in SA sham neurons
(P5 0.0206 and P5 0.0313, respectively; n5 8 in both, paired-
samples Wilcoxon test, Fig. 6A). In addition, the ongoing activity
of SA shamneurons significantly increased after application of the
antagonists (P5 0.0137, paired-samplesWilcoxon test, Fig. 6A).
Likewise, in NSA sham cells, the effect of touch and pinch was
significantly larger after the application of the GABAA and glycine
receptors antagonists (P 5 0.0025 and P 5 0.0010, paired-
samplesWilcoxon test, n5 12 in both, Fig. 6A). Interestingly, 8 of
12 NSA sham neurons developed ongoing activity after the
application of bicuculline and PMBA, leading to an average FR of
0.4 6 0.3 Hz (vs 0.0 6 0.0 Hz before drug, P 5 0.0142, paired-
samples Wilcoxon test, Fig. 6A). These results demonstrate the
importance of the GABAergic and glycinergic systems in the
control of spinal responses to mechanical inputs. Importantly, in
both SA and NSA neurons, the effect of pinch increased
significantly after blocking spinal inhibition (Fig. 6A).
Because of this increase in the responses to pinch, the effect of
blocking spinal inhibition seemed different from the plasticity
observed after nerve injury (where the response to pinch was
unchanged, in SA neurons, or even reduced, in NSA neurons,
Fig. 4A). However, a direct comparison was hampered by the
fact that some of the NSA neurons developed ongoing activity
after bicuculline and PMBA (Fig. 6A). These could therefore not
be directly compared with the neurons classified as NSA in cuff
mice. For this specific comparison, we pooled SA and NSA
neurons. In this total population of neurons, we observed that the
response to pinchwas reduced in cuff mice vs shammice (n5 91
and n 5 80, respectively, P 5 0.0079), whereas the response to
pinch recorded in the presence of bicuculline and PMBA was
increased compared with the control situation (before the drug,
n5 20, P5 0.0003, results not shown). These data demonstrate
that, although blocking spinal inhibition and nerve injury similarly
increase responses of SDH neurons to innocuous stimuli, they
induce opposite effects on their response to noxious stimuli. This
suggests that the underlying mechanisms of these 2 plasticities
are distinct.
Interestingly, bicuculline and PMBA showed no effectiveness in
neurons recorded from cuff animals. Indeed, in silent neurons and
neurons with ongoing activity recorded from cuff mice, application
of the inhibitory antagonists modified neither the ongoing activity
nor the response to stimuli (Fig. 6B). These results suggest that
during neuropathy, the local spinal inhibition induced byGABAand
glycine has no net effect on the control of responses tomechanical
inputs or the ongoing activity of SA neurons.
GABAA and glycine receptors are permeable to both chloride
and bicarbonate, usually in opposite directions (chloride flowing in
and bicarbonate flowing out). If the disinhibition reported here is
due to a collapse in chloride gradient, it could be mitigated by
reducing the bicarbonate driving force. For this reason, we
performed a group of experiments in which we used the carbonic
anhydrase inhibitor acetazolamide (ACTZ) thus limiting the
production of bicarbonate.17 We compared the effects induced
by touch and pinch when saline or ACTZ (10 mM) was topically
applied on the exposed spinal cord of sham or cuff mice. In sham
mice, as previously reported,17 there was no difference in the
responses to touch (or pinch) in neurons after topical application
of saline or ACTZ (2-sample Mann–Whitney test, n 5 6 with 4
Figure 5.Postdischarge (PD) induced by touch and pinch of spontaneously active (SA) and nonspontaneously active (NSA) neurons in sham and cuff animals. The
green (sham) and red (cuff) lines and the vertical bars represent mean 6 SEM of the number of spikes per second, respectively. The gray bars represent the
application of the stimuli. (A) Long PD (measured over 1 minute) induced by touch and pinch in neurons recorded from sham animals. Note that in NSA sham
neurons, touch and pinch induce a PD, which is greater after pinching. (B) PD induced by touch and pinch in neurons recorded from cuff animals. Note that in SA
cuff neurons, both touch and pinch induce a short-term PD. In NSA cuff neurons, the PD is greater than in NSA sham cells. *P, 0.05, ***P, 0.001 PD vs basal
(paired-samples Wilcoxon test). ###P, 0.001 touch vs pinch (paired-samples Wilcoxon test); mmmP, 0.001, short-term PD vs basal (paired-samples Wilcoxon
test); &&&P , 0.001 sham vs cuff (2-sample Wilcoxon test).
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Figure 6.Pharmacologically induced disinhibition in spontaneously active (SA) and nonspontaneously active (NSA) neurons of the spinal dorsal horn. (A) Data from
shammice. On the left, representative examples of the firing rate from1SA (top) and 1NSA (bottom) neurons recorded in shamanimals showing the effect induced
by the mechanical stimuli (touch and pinch) in control conditions (saline) and during the application of the inhibitory antagonists. The vertical bars represent the
firing rate (spikes/s). Touch and pinch were applied for the period indicated by the horizontal bars (10 seconds). On the right, bars represent mean6 SEM of the
ongoing activity and the increase of firing rate induced by touch and pinch in SA (n5 8) and NSA (n5 12) neurons from shammice. (B) Data from cuff mice. On the
left, representative examples of the firing rate from 1 SA (top) and 1NSA (bottom) neuron recorded from cuff animals showing the effect induced by themechanical
stimuli (touch and pinch) in control conditions (saline) and during the application of the inhibitory antagonists. The vertical bars represent the firing rate (spikes/s).
Touch and pinchwere applied for the period indicated by the horizontal bars (10 seconds). On the right, bars representmean6SEMof the ongoing activity and the
increase of firing rate induced by touch and pinch in SA (n5 8) andNSA (n5 9) neurons from cuff mice. Note the difference in scale for the Y-axis of ongoing activity
graphs in SA vsNSA neurons. Pharmacological disinhibition enhances the ongoing activity and the responses to the stimuli in sham animals, but it did not have any
effect in neurons recorded from cuff mice (*P , 0.05, **P , 0.01, ***P , 0.001, compared with the control, paired-samples Wilcoxon test).
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NSA and 2 SA neurons in the saline group, and n5 6 with 3 NSA
and 3 SA neurons in the ACTZ group; Fig. 7A). In contrast, in cuff
mice, responses to touch were considerably diminished in the
presence of ACTZ compared with those obtained in saline (P 5
0.0037, 2-sample Mann–Whitney test, n5 14 with 3 NSA and 11
SA neurons in the saline group, and n5 14 with 5 NSA and 9 SA
neurons in the ACTZ group, Fig. 7A). A consequence of this
reduced response to touch in the presence of ACTZ was that,
although in control conditions (saline), cuff neurons showed
a significantly larger response to touch than to pinch (P5 0.0059,
paired-samples Wilcoxon test, Fig. 7A), this was normalized in
the presence of ACTZ. Indeed, after ACTZ, the response to touch
became again significantly smaller than the response to pinch
(P5 0.0238, paired-samples Wilcoxon test, n5 14, Fig. 7A), as
observed in naive or sham mice (cf. Fig. 2 or Fig. 4). In this cuff
sample (n 5 14), 86% of recorded neurons were LT and 14%
WDR; however, among neurons (also n 5 14) recorded in the
same mice but in the presence of ACTZ, the proportion of LT
neurons was reduced to 21%, whereas 79% were WDR (P 5
0.0018, Fisher exact test, saline vs ACTZ, Fig. 7B). Importantly,
among the 14 recordings obtained in saline conditions (cuff mice),
10 of them were also recorded for a sufficiently long period after
ACTZ, enabling direct paired analysis of the ACTZ effect. Only 1
neuron was classified as WDR, whereas the other 9 were
classified as LT when recorded under saline. After ACTZ
application, 6 of the 9 LT neurons were switched to WDR, the
other 3 remaining classified as LT (and theWDRneuron remained
WDR). This phenotypical switch was statistically significant (P 5
0.0198, Fisher exact test). These results suggest that reducing
bicarbonate efflux by blocking carbonic anhydrase can counter-
act the phenotypical switch in neuronal responses observed in
cuff animals.
4. Discussion
In this study, we propose that 2 different categories of neurons
can be distinguished in the SDH based on their ongoing activity:
SA and NSA neurons. We demonstrate that both types of
neurons contribute to the processing of mechanical inputs and
are under the control of an inhibitory tone in naive animals.
Although NSA neurons could still be recorded after nerve injury,
our results strongly suggest that some previously silent neurons
developed spontaneous activity in cuff mice. Interestingly, neither
SA nor NSA neurons seem to be placed under a tonic inhibitory
tone in neuropathic conditions, in line with the common
hypothesis of reduced inhibition in this condition (see below).
The fact that some neurons switched fromNSA to SA implies that
it is important to proceed to the simultaneous study of both types
of neurons to fully elucidate the alterations occurring in the spinal
cord during neuropathic pain.
Spontaneous activity has been observed in injured primary
sensory and SDH neurons, in animal models and patients.41
Spinal dorsal horn neurons with spontaneous activity have also
been sporadically reported in naive rats,32 cats,20,34,35 and
monkeys.46 It has been suggested that they may provide a basal
level of activity that can be adjusted by intraspinal and descending
inputs20; however, their function is still unclear. Their properties
had never been systematically compared with those of non-
spontaneous activity neurons until now. We observed that SA
neurons are on average located deeper thanNSA neurons. This is
consistent with the results of Sandku¨hler and Eblen-Zajjur32 who
reported that, for some groups of neurons, the deeper they are,
the more rhythmicity they show. They also observed spontane-
ous, or background, activity in the 3 types of neurons recorded in
the rat dorsal horn: LT, WDR, and HT, with proportions
comparable to those we observed in mice. There was no
difference in the effect induced by the mechanical stimuli
between the 2 categories of neurons, SA and NSA. Altogether,
these results suggest that both SA and NSA neurons are involved
in the processing of innocuous and noxious mechanical inputs.
It is interesting to note that, when projection neurons are
specifically targeted for in vivo electrophysiological recordings,
they are always described as silent in control conditions.6,7,14,16
However, studies reporting neurons with background activity,
including ours, have not tested the possibility of a supraspinal
projection site.12,20,25,32 It is therefore tempting to suggest,
although it remains to be demonstrated, that SA neurons
correspond to interneurons that only project locally. They might
be part of the spontaneously synchronizing system described in
the SDH of rats, cats, and macaques that has been suggested
Figure 7. Effect of the carbonic anhydrase inhibitor acetazolamide (ACTZ 10 mM) on the effect induced by touch and pinch in neurons recorded from sham and
cuff animals. (A) Increase of the firing rate induced by touch and pinch in neurons from sham (left) and cuff (right) animals. Bars represent the mean of the effect
induced by touch and pinch. Note that in cuff neurons in the control situation, the effect induced by touch was larger than the effect induced by pinch (*P, 0.01,
paired-samples Wilcoxon test). However, after ACTZ application, the effect of touch was smaller than the effect induced by pinch (*P , 0.05, paired-samples
Wilcoxon test). (B) Percentages of low-threshold (LT), wide dynamic range (WDR), and high-threshold (HT) neurons form sham and cuff animals before and after
the application of ACTZ (10 mM). Note that the percentage of LT neurons recorded in cuff animals decreased considerably after ACTZ application (**P , 0.01,
Fisher exact test).
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to provide a basal level of activity in sensory and motor
pathways.18,20,32,42
Previous reports suggest that neurons in nerve-injured rodents
are characterized by an increased level of spontaneous
activity.12,14,16,38 Our data similarly demonstrate an increased
proportion of SA neurons after neuropathy (78% in cuff vs 51% in
sham). The average FR of SA cuff neurons did not differ from the
one of SA sham neurons; this observation does not exclude the
possibility that neurons that were already SA in the control
situation displayed an increased ongoing FR after nerve injury.
Indeed, the SA cuff population is also formed of formerly NSA
neurons in control conditions that developed ongoing activity,
and whose low FR could balance the increased FR of formerly SA
neurons, therefore leading to an unchanged FR of SA cuff vs SA
sham at the population level.
One of the objectives of our study was to elucidate the
contribution of SA and NSA neurons to the processing of
mechanical inputs. To gain more insight into the sensory modality
preferentially encoded by the recorded neurons, we analyzed the
ratio between their responses to light touch vs pinch. This
enabled us to classify the neurons as LT, WDR, and HT, as
previously described. However, although previous studies focus
on a single neuronal type, typically WDR or HT neu-
rons,7,13,15,23,25,32 we systematically studied all 3 types of
neurons. To our knowledge, this is the first study in which the
properties of LT, WDR, and HT neurons are compared in control
and neuropathic mice. This not only enabled to analyze the
changes in the proportions of these 3 categories in neuropathic
mice, but also to compare their distribution in SA vsNSA neurons.
Importantly, both SA and NSA neurons can still be observed
after neuropathy, ruling out the idea that all SDH neurons would
be SA in this condition. Both populations were subject to an
important plasticity, impacting in particular the ratio of their
response to touch vs pinch. The increase in the response to touch
was such, in nerve-injured mice, that the increase in the FR
induced by touch in NSA neurons was significantly larger than the
one induced by pinch. Accordingly, most neurons recorded in
cuff animals were classified as LT, a smaller proportion of WDR,
and we observed noHT cells. The increase in the proportion of LT
neurons was also most noticeable among NSA neurons, as they
represented only 18% of NSA sham neurons, compared with
80% of NSA cuff neurons. It should be noted that although
according to the classical classification, the majority of neurons
were assigned to the LT category, the majority still responded to
pinch, ie, processed nociceptive information. They should
therefore not be considered as “nonnociceptive.” The number
of neurons truly nonresponsive to pinch was unchanged in cuff vs
sham mice (combined NSA and SA neurons); however, these
neurons were enriched in NSA cuff (compared with SA cuff),
which suggests that nonnociceptive neurons are less prone to
develop ongoing activity after nerve injury.
The cuff model of neuropathic pain has first been developed for
rats22 and used to explore the cellular changes occurring in the
SDH during neuropathy.14,16,25,26 This model was more recently
adapted for mice3 and, to our knowledge, our study is the first to
characterize the electrophysiological properties of SDH neurons
in vivo in cuff mice. It is important to mention that all of our
experiments were made during the second and third weeks after
surgery, once the behavioral allodynia was stably established.44
Within this time frame, the animals do not present
anxiodepressive-like behaviors that characterize later stages of
the neuropathy.3,44
The plasticity of spinal inhibitory transmission occurring after
nerve injury is believed to be a key mechanism responsible for
allodynia.27 Yet previous in vivo recordings in the rat SDH
provided controversial data, supporting either a decrease or an
increase in the GABAergic (but not glycinergic) tone in neuro-
pathic rats.7,15 In our hands, blocking GABAergic and glycinergic
receptors with bicuculline and PMBA, respectively, had no effect
on the peripherally driven responses in the neuropathic SDH. This
indicates that the inhibitory tone is either absent, or has lost its net
effect on SDH neurons after nerve injury. This could be due to
chloride homeostasis dysregulation elevating the reversal poten-
tial for anions (Eanion) close to the neurons resting potential and
therefore leading to the absence of net effect of GABAergic
signaling.11 Indeed, hyperpolarizing Eanion by inhibiting carbonic
anhydrase (with acetazolamide) reversed the exacerbated
neuronal responses to light touch that were observed in cuff
mice. By disrupting bicarbonate homeostasis, ACTZ is also
expected to limit the emergence of a depolarizing phase in
GABAergic currents, in situations in which chloride extrusion
capacities are highly compromised.8,29 Interestingly, ACTZ has
been shown to reduce neuropathic allodynia in different models
and tests.1,2
However, our data argue against reduced inhibitory receptor
expression (or activation) as the main contributor to SDH
disinhibition, in agreement with a recent study by Lee and
Prescott.17 Indeed, pharmacological reduction of inhibition (in
control mice) only partially recapitulated the neuronal phenotype
observed in cuff animals. As previously described in naive rats
and cats, inhibition of GABAA and/or glycine receptors induced
an increased response to both low- and high-intensity mechan-
ical stimulation (see Refs. 7,17,34,35, but see also Ref. 15).
Interestingly, we demonstrate that in cuff mice, only the
responses to touch are markedly increased, whereas those to
pinch are reduced compared with sham animals. Our recordings
therefore demonstrate that the dramatic loss of general impact of
inhibitory transmission (ie, disinhibition) occurring in neuropathic
mice cannot be fully accounted for by reduced inhibitory receptor
expression or activation.
In summary, in this study, we have demonstrated that we can
distinguish 2 categories of SDH neurons involved in the
processing of mechanical information. By recording them under
the same conditions, we could compare their properties and
demonstrate that both silent neurons and neurons with back-
ground activity experience essential modifications after nerve
injury. Although previous studies predominantly focus on silent
spinal neurons, our study demonstrates that neurons with
spontaneous activity should not be neglected to gain a full
understanding of the spinal nociceptive network in control
conditions and during neuropathy. Our findings demonstrate
a dramatic loss of spinal inhibitory transmission in nerve injury–
induced neuropathic pain.
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Appendix B: Résume de la thèse (prolongé) et résume ́ 
grand public 
 
Résume de la thèse (Prolongé) 
Introduction :  
L’Acétylcholine (ACh) endogène est un important modulateur des processus sensoriels nociceptifs 
dans la moelle épinière. L’administration péridurale de néostigmine (un inhibiteur de l’acétylcholine 
estérase) empêche la dégradation de l’acétylcholine et de ce fait en augmente la concentration. Cette 
administration permettant de soulager la douleur est utilisée en clinique, lors des accouchements et 
dans le cadre post-opératoire (Eisenach, 2009). Il a été démontré que l’effet de certains analgésiques 
couramment utilisés, tels que la clonidine et la morphine, passe par l’augmentation de la 
concentration d’ACh (Pan et al., 1999; Chen and Pan, 2001). Chez le rongeur, antagoniser les 
récepteurs cholinergiques nicotiniques et muscariniques dans la moelle épinière provoque une 
hyperalgésie et/ou une allodynie, c’est-à-dire respectivement une réaction accrue à une stimulation 
nociceptive (douloureuse) et/ou une réponse nociceptive à une stimulation habituellement non-
nociceptive(Honda et al., 2002; Rashid et al., 2006). Cela suggère l’existence d’un « tonus » basal 
d’ACh dans la moelle épinière modulant le seuil de réponse aux signaux nociceptifs. De façon 
intéressante, ce « tonus » est modifié à la suite d’une neuropathie (Rashid and Ueda, 2002). 
Cependant, les mécanismes précis de la plasticité des systèmes cholinergiques spinaux observée 
dans le cadre neuropathique ne sont pas encore bien compris.  
Bien que les preuves de l’existence du « tonus » cholinergique soient bien documentées, il reste 
encore des controverses au sujet de la source de l’ACh libérée dans ce contexte. Trois structures 
possèdent des neurones exprimant la Choline Acétyltransférase (ChAT) et des terminaisons au 
niveau de la Corne Dorsale de la Moelle Épinière (CDME). Il s’agit des ganglions rachidiens (DRG) 
(Matsumoto et al., 2007), de la Médulla Ventromédiale Rostrale (RVM) (Stornetta et al., 2013) et 
enfin, de la moelle épinière. Cette dernière structure possède une source potentielle locale, 
constituée d’une population d’interneurones située dans la corne dorsale, décrite chez le rat par 
Barber et ses collaborateurs (Barber et al., 1984).  
Cette population éparse d’interneurones cholinergiques a récemment été caractérisée par notre 
équipe dans la CDME des souris et des primates (Mesnage et al., 2011; Pawlowski et al., 2013). Un 
plexus dense de fibres cholinergiques a été décrit dans les couches II-III de la moelle épinière 
(Barber et al., 1984; Olave et al., 2002). Ces fibres ChAT contenant dendrites et axones, forment 
des synapses et interagissent de manière réciproque avec les terminaisons des afférences 
somatosensorielles. En effet, les axones cholinergiques réalisent des connections présynaptiques 
avec des fibres afférentes primaires de bas seuil et non myélinisées qui en retour, contactent des 
dendrites cholinergiques (Ribeiro-da-Silva and Cuello, 1990). Ainsi, l’interaction entre les neurones 
ChAT et les fibres afférentes primaires semble être le substrat le plus probable sous-tendant 
l’analgésie cholinergique. Ces quelques interneurones ont des corps cellulaires localisés dans les 
couches LIII et IV. Ils possèdent des territoires dendritiques et axonaux très étendus, orientés 
dorsalement et participant ainsi au plexus cholinergique (Mesnage et al., 2011). Ces données 
suggèrent que ces interneurones joueraient un rôle dans la modulation de l’information sensorielle. 
De ce fait, notre objectif est d’identifier les paramètres qui permettraient à cette population de 
neurones d’effectuer ce contrôle majeur qui à été constaté sur les processus douloureux, en 
élucidant les mécanismes d’interactions entre les interneurones cholinergiques de la corne dorsale 
et le réseau nociceptif avoisinant.  
Méthodes et Résultats :  
Résultats 1 : Plasticity of the spinal cholinergic tone after neuropathy  
Nous avons évalué le rôle de la modulation cholinergique spinale sur la transmission nociceptive 
mécanique chez des souris Cd1 naïves et neuropathiques. Pour induire une douleur neuropathique 
chez la souris, nous avons utilisé le model du « cuff » (Benbouzid et al., 2008). Le seuil mécanique 
de retrait des pates arrières a été déterminé grâce à l’utilisation de filaments de von Frey. Après 
l’établissement des seuils de base, des injections intrathécales ont étés réalisées, suivies de tests de 
von Frey exécutés à des temps fixes après injection.  
Chez les animaux naïfs, nous avons confirmé la présence d’un « tonus » cholinergique endogène et 
spinal modulant les seuils nociceptifs mécaniques, impliquant les récepteurs nicotiniques (nAChR) 
et muscariniques (mAChR). Suite à la neuropathie, le « tonus » cholinergique est altéré, et agit la 
aussi à travers les nAChRs et les mAChRs. Enfin, pour contrôler la spécificité de la dose la plus 
élevée de mécamylamine (antagoniste des nAChR) utilisée, nous avons confirmé que chez des 
souris transgéniques chez lesquelles la sous unité β2 nicotinique est absente cet antagoniste n’avait 
pas d’effet.  
Dans un contexte in vivo, le taux de décharge des neurones de la CDME à été enregistré en réponse 
à des stimulations de type non-nociceptives (toucher) et nociceptives (pincement). En présence 
d’antagonistes des AChRs nicotiniques et muscariniques, la réponse des neurones de la CDME 
était augmentée pour les deux types de stimulations, dans les animaux sham et naifs. Chez les souris 
cuff par contre, les réponses aux deux types de stimulations n’étaient plus modifiées par des 
antagonistes des AChRs, à l’exception des réponses au toucher lors de l’application des antagonistes 
des nAChRs. Ainsi, nous avons mis en évidence la présence d’un “tonus” cholinergique impliquant 
les nAChRs et mAChRs chez les sham et naifs qui subit des changements à la suite de neuropathie. 
De façon intéressante, l’action de ce système cholinergique sur les sensations du toucher et de 
pincement est sous contrôle d’autres “tonus” inhibiteurs (GABAergiques ou glycinergiques) dans 
les conditions naives, sham et cuff. 
Pour clarifier la contribution des populations cholinergiques des DRG, de la RVM et de la moelle 
épinière dans le « tonus » cholinergique spinal impliqué dans la transmission nociceptive mécanique, 
nous avons utilisé l’approche du DREADD (Designer Receptor Exclusively Activated by Designer 
Drugs). Pour cela, nous avons effectué des injections de virus recombinant adéno associé (rAAV) 
codant pour une construction cre-dépendante dans des souris ChAT::Cre. Cela a permis l’infection 
des neurones cholinergiques au niveau spinal L3-L4, dans la RVM et, grâce à des injections dans 
les pattes arrières de souriceaux, dans les ganglions rachidiens. Trois semaines après une telle 
infection, les neurones exprimaient le récepteur hDMi4, que nous avons activé par l’injection de 
son agoniste, la clozapine-N-oxide, en i.p.. Nous avons ensuite réalisé les tests de von Frey afin 
d’évaluer un changement comportemental suite à l’inhibition de différentes populations 
cholinergiques infectées.  
Résultats 2: Dorsal horn cholinergic interneurons: the dual language of a minority 
population 
Nous avons cherché à élucider la nature des contacts reçus par les interneurones cholinergiques 
d’intérêt provenant du réseau de la corne dorsale, mais aussi de la périphérie. Pour cela, nous 
sommes passés par une approche in vitro. En effet, nous avons réalisé des tranches aigues de moelle 
épinière de souris transgéniques exprimant la protéine fluorescente EGFP (enhanced Green 
Fluorescent Protein) uniquement dans les neurones cholinergiques. Nous avons alors enregistré 
ces neurones fluorescents par la technique du Patch-Clamp en configuration cellule entière afin 
d’analyser les courants spontanés post-synaptiques excitateurs (sCPSE) et inhibiteurs (sCPSI) qu’ils 
reçoivent, et ceci sur des tranches de trois orientations différentes (horizontales, parasagitales et 
transverses).  
Chez les animaux naïfs, nos données suggèrent que les interneurones cholinergiques de la corne 
dorsale spinale reçoivent sCPSE et sCPSI. Il semblerait qu’ils reçoivent des sCPSE à une fréquence 
plus basse sur des tranches transversales en comparaison des deux autres types de tranches. De ce 
fait, il se pourrait que la source des informations excitatrices reçues par cette population soit 
localisée sur des segments plus distants. De façon intéressante, nous avons constaté une fréquence 
plus faible de sCPSI dans nos neurones d’intérêts par rapport aux neurones Non-ChAT, toutes 
tranches confondues. Afin d’étudier plus en détail la localisation des cellules présynaptique aux 
neurones ChAT, nous avons réalisé des enregistrements en présence de tetrodotoxine (TTX). Cette 
drogue a pour effet de bloquer l’initialisation et la propagation des potentiels d’action, par 
conséquent, cela nous à permis de détecter des courants post-synaptiques miniatures excitateurs 
(mCPSE) et inhibiteurs (mCPSI). Cependant, nous n’avons pas pu en conclure la localisation des 
neurones présynaptiques car il n’y avait pas de différence significative dans la fréquence de mCPSE 
(ou mCPSI) en fonction des différentes orientations de tranches. 
Dans la mesure où les courants excitateurs et inhibiteurs étaient enregistrés dans les mêmes cellules, 
nous avons décidé d’analyser le ratio de fréquence des CPSE/CPSI pour les neurones 
ChAT::EGFP et Non-ChAT. Ce ratio était plus élevé chez les neurones cholinergiques de la 
CDME, suggérant que les entrées inhibitrices étaient plus basses comparées aux entrées 
excitatrices.  
Afin d’étudier les proprieties membranaires passives des neurones (résistance d’entrée, potentiel de 
repos, amplitude du “sag”), et leur patron de décharge, nous avons appliqué des sauts de courant 
dépolarisants et hyperpolarisants. Nous n’avons pas observé de différences dans les patrons de 
décharge et la plupart des propriétés membranaires passives entre neurones ChAT::EGFP et non-
ChAT. Toutefois, les neurones cholinergiques avaient une capacité membranaire plus grande dans 
les tranches horizontales par rapport aux tranches parasagittales ou transverses. Cela peut être dû 
à la grande étendue de l’arbre axo-dendritique de ces neurones dans l’axe rostro-caudal, mieux 
conservé dans les tranches horizontales que dans les autres. De plus, la présence de potentiel 
d’action rebond à la fin d’un saut hyperpolarisant semble être une caractéristique des neurones 
ChAT::EGFP chez les animaux naïfs. 
Pour mieux comprendre l’identité des afférences reçues par les interneurones cholinergiques, nous 
avons utilisé une approche pharmacologique dans le but d’activer les fibres qui les contactent. Nous 
avons donc appliqué, sur des tranches horizontales, un bain de Capsaïcine, agoniste des récepteurs 
TRPV1 que l’on retrouve sur certaines des fibres nociceptives. Cette drogue a eu pour effet 
d’augmenter la fréquence des sCPSE ainsi que des sCPSI enregistrés dans la population qui nous 
intéresse. En vue de localiser les récepteurs TRPV1, nous avons testé l’effet de la capsaïcine en 
présence de TTX. Nous n’avons pas observé de changement de la fréquence des mCPSE dans ces 
conditions, ce qui a permis de conclure que nos interneurones reçoivent uniquement des contacts 
indirects provenant des fibres afférentes primaires sensibles à la capsaïcine. Par contre, le menthol, 
agoniste du récepteur TRPM8 et l’huile de moutarde, agoniste du récepteur TRPA1, n’ont pas 
altéré les fréquences des sCPSE ou sCPSI au niveau des cellules ChAT. Ces données suggèrent que 
ces interneurones ne reçoivent pas de contacts provenant des fibres afférentes primaires exprimant 
TRPA1 ou TRPM8. Nous avons également étudié les afférences périphériques des neurones 
cholinergiques en stimulant électriquement les racines dorsales sur des tranches de moelle épinière. 
Nous avons démontré que les interneurones cholinergiques étaient en aval des fibres afférentes via 
un réseau d’interneurones excitateurs et inhibiteurs. Le seuil de stimulation de ces réponses 
implique que des fibres de bas seuil et de haut seuil sont en amont des interneurones cholinergiques. 
Une analyse plus approfondie devrait permettre de déterminer la connectivité exacte (mono- ou 
poly-synaptique) et la nature (A-beta; A-delta ou C) de ces fibres. 
Afin d’étudier le réseau en aval des interneurones cholinergiques, nous avons injecté un rAAV 
exprimant la Lectine du blé ou Wheat Germ Agglutinin (WGA) dans des souris ChAT::Cre. Cette 
lectine permet un marquage trans-synaptique antérograde, et permet ainsi d’identifier les cibles 
post- synaptiques des neurones infectés, et de cette manière d’obtenir des informations sur leur 
localisation et leurs propriétés neurochimiques.  
Résultats 3: Characterization of the DH cholinergic interneurons following peripheral 
nerve injury 
Dans les neurones de la laminae II, nous avons observé une réduction au niveau de la fréquence 
des mCPSI chez les animaux « Cuff » par rapport aux animaux « Sham », ce qui nous à permis de 
vérifier que notre modèle « Cuff » présentait des changements électrophysiologiques similaires à 
ceux observés dans les autres modèles établis de neuropathie. 
Dans des conditions de neuropathie, nous avons tenté d’élucider les changements plastiques qui 
ont lieu au niveau des interneurones cholinergiques. Le nombre de cellules cholinergiques observé 
dans les souris ChAT::EGFP ne diffère pas entre les conditions « Sham » et « Cuff ».   
Après comparaison des données recueillies concernant les profils de décharge, les propriétés 
passives des membranes et courants entrant des animaux naïfs, sham et cuff, nous avons constaté 
que plusieurs profils de décharge et propriétés passives sont resté inchangés à la suite d’une lésion 
nerveuse périphérique. De façon surprenante, nous avons noté que la proportion des cellules non 
ChAT présentant un potentiel d’action “rebond” augmente dans les groupes sham et cuff. Au sujet 
des afférences de la corne dorsale, nous avons là aussi étudié les fréquences de courants spontanés 
et miniatures excitateurs et inhibiteurs des neurones ChAT dans les orientations horizontales et 
transverses, mais n’avons constaté aucune différence entre les deux conditions. En conclusion, 
nous n’avons observé aucune différence au niveau des courants entrants des neurones des laminae 
III et IV, dans les conditions sham et cuff.  
Conclusions : 
Notre étude apporte une nouvelle vision du système cholinergique spinal. Nous avons démontré 
que le « tonus » cholinergique endogène de la moelle épinière a pour rôle de définir un seuil 
nociceptif mécanique dans les conditions normales et dans les conditions neuropathiques. Nous 
poursuivons actuellement notre investigation de la contribution des différentes sources 
cholinergiques dans la modulation des informations nociceptives mécaniques.  
Les interneurones cholinergiques sont bien intégrés dans le réseau de la corne dorsale, et reçoivent 
des informations excitatrices et inhibitrices provenant vraisemblablement d’autres segments 
spinaux. De surcroît, cette population reçoit des messages indirects provenant de fibres afférentes 
primaires exprimant le récepteur TRPV1. En outre, de toute les propriétés membranaires passives 
mesurées, nous avons observé que les neurones cholinergiques ont une large capacitance. Cette 
notion est renforcée par leur morphologie comportant de larges prolongements axonaux et 
dendritiques.  
Dans des conditions neuropathiques, la quantité d’interneurones cholinergiques et les courants 
spontanés qu’ils reçoivent semblent inchangés. De plus, nous avons montré que les propriétés 
actives et passives des membranes des neurones ChAT n’ont pas changé à la suite d’une lésion. 
Une meilleure compréhension du système cholinergique spinal pourrait ouvrir une voie vers des 
alternatives dans les traitements de la douleur.  
 
 
 
 
 
 
Bibliographie 
Barber RP, Phelps PE, Houser CR, Crawford GD, Salvaterra PM, Vaughn JE (1984) The morphology 
and distribution of neurons containing choline-acetyltransferase in the adult-rat spinal-cord - 
an immunocytochemical study. J Comp Neurol 229:329-346. 
Benbouzid M, Choucair-Jaafar N, Yalcin I, Waltisperger E, Muller A, Freund-Mercier MJ, Barrot M 
(2008) Chronic, but not acute, tricyclic antidepressant treatment alleviates neuropathic 
allodynia after sciatic nerve cuffing in mice. European Journal of Pain 12:1008-1017. 
Chen SR, Pan HL (2001) Spinal endogenous acetylcholine contributes to the analgesic effect of systemic 
morphine in rats. Anesthesiology 95:525-530. 
Eisenach JC (2009) Epidural Neostigmine: Will It Replace Lipid Soluble Opioids for Postoperative and 
Labor Analgesia? Anesth Analg 109:293-295. 
Honda K, Koga K, Moriyama T, Koguchi M, Takano Y, Kamiya H (2002) Intrathecal alpha(2) 
adrenoceptor agonist clonidine inhibits mechanical transmission in mouse spinal cord via 
activation of muscarinic M-1 receptors. Neurosci Lett 322:161-164. 
Matsumoto M, Xie WJ, Inoue M, Ueda H (2007) Evidence for the tonic inhibition of spinal pain by 
nicotinic cholinergic transmission through primary afferents. Mol Pain 3:41. 
Mesnage B, Gaillard S, Godin AG, Rodeau JL, Hammer M, Von Engelhardt J, Wiseman PW, De 
Koninck Y, Schlichter R, Cordero-Erausquin M (2011) Morphological and Functional 
Characterization of Cholinergic Interneurons in the Dorsal Horn of the Mouse Spinal Cord. J 
Comp Neurol 519:3139-3158. 
Olave MJ, Puri N, Kerr R, Maxwell DJ (2002) Myelinated and unmyelinated primary afferent axons 
form contacts with cholinergic interneurons in the spinal dorsal horn. Exp Brain Res 145:448-
456. 
Pan HL, Chen SR, Eisenach JC (1999) Intrathecal clonidine alleviates allodynia in neuropathic rats - 
Interaction with spinal muscarinic and nicotinic receptors. Anesthesiology 90:509-514. 
Pawlowski SA, Gaillard S, Ghorayeb I, Ribeiro-da-Silva A, Schlichter R, Cordero-Erausquin M (2013) 
A Novel Population of Cholinergic Neurons in the Macaque Spinal Dorsal Horn of Potential 
Clinical Relevance for Pain Therapy. Journal of Neuroscience 33:3727-+. 
Rashid MH, Ueda H (2002) Neuropathy-specitic analgesic action of intrathecal nicotinic agonists and 
its spinal GABA-mediated mechanism. Brain Res 953:53-62. 
Rashid MH, Furue H, Yoshimura M, Ueda H (2006) Tonic inhibitory role of alpha 4 beta 2 subtype of 
nicotinic acetylcholine receptors on nociceptive transmission in the spinal cord in mice. Pain 
125:125-135. 
Ribeiro-da-Silva A, Cuello AC (1990) Choline acetyltransferase-immunoreactive profiles are 
presynaptic to primary sensory fibers in the rat superficial dorsal horn. J Comp Neurol 295:370-
384. 
Stornetta RL, Macon CJ, Nguyen TM, Coates MB, Guyenet PG (2013) Cholinergic neurons in the 
mouse rostral ventrolateral medulla target sensory afferent areas. Brain Structure & Function 
218:455-475. 
 
  
Résumé Grand Public 
L’objectif général du projet est d’identifier de nouvelles cibles thérapeutiques pour le traitement de 
la douleur. Pour ce faire, nous nous intéressons à une population de neurones présents dans la 
moelle épinière, qui ont la particularité de moduler les influx nerveux signalant la douleur. 
Nous travaillons sur la moelle épinière car c’est par là que l’information douloureuse transite (et est 
intégrée) avant d’être relayée vers le cerveau. Les neurones qui nous intéressent sont ceux qui 
libèrent un neurotransmetteur appelé acétylcholine (ACh). Des expériences précédentes ont 
montré que ces neurones sont également impliqués dans les effets d’analgésiques utilises en clinique 
tels que la morphine et la clonidine. Nous avons récemment démontré que cette population de 
neurones, qu’on appelle « cholinergiques », se retrouvait aussi dans la moelle épinière des singes 
macaques, avec une densité similaire à celle observée chez la souris, ce qui valide notre modelé 
murin. Ces neurones sont la source probable d’ACh impliquée dans les propriétés d’analgésiques 
utilisés en clinique en injection péridurale (les inhibiteurs d’acétylcholinestérase). 
Nous étudions le mécanisme d’action analgésique de l’ACh spinale, grâce à des expériences de 
comportement, et des enregistrements électrophysiologiques in vitro et in vivo. Nous utilisons 
également un modele de douleur neuropathique afin d’étudier la plasticité du système cholinergique 
dans cette situation, et les possibilités de le stimuler pour soulager les douleurs. Allant au de delà 
de l’amélioration de notre compréhension de l’analgésie cholinergique, notre projet contribue à 
l’élucidation d’une partie de la micro-circuiterie neuronale de la moelle épinière, et apporte une 
nouvelle lumière sur le mode d’action d’analgésiques classiques. Notre étude contribue ainsi à 
l’identification de nouvelles cibles thérapeutiques pour le traitement de la douleur chronique. 
 Dhanasak DHANASOBHON 
Spinal cholinergic system and 
chronic pain 
 
 
Résumé 
Chez les rongeurs et humains, un « tonus » cholinergique spinal endogène modulant les 
comportements nociceptifs (douloureux) a été décrit. Une source potentielle de cette acétylcholine 
sont les interneurones cholinergiques de la corne dorsale (CD) de la moelle épinière. Nos objectifs 
étaient les suivants : (1) caractériser le « tonus » cholinergique spinal responsable de l’établissement 
des seuils mécaniques nociceptifs et (2) élucider le rôle des neurones cholinergiques CD dans la 
modulation de l'information sensorielle chez des animaux naïfs et neuropathiques. Nous avons 
confirmé la présence d'un « tonus » cholinergique qui module les seuils mécaniques et démontré 
qu'il est encore présent, bien qu'il soit modifié, après une neuropathie. Les interneurones 
cholinergiques reçoivent des entrées excitatrices localisées sur des segments plus distants et 
reçoivent généralement une faible fréquence d’entrées inhibitrices. De plus, ils sont indirectement 
reliés par des afférences primaires nociceptives qui expriment TRPV1, ce qui démontre leur 
implication dans le circuit nociceptif. Dans les conditions neuropathiques, les entrées des neurones 
LIII / IV ne sont pas affectées après une lésion du nerf périphérique. Une meilleure compréhension 
du système cholinergique spinal peut ouvrir la voie à une thérapie alternative contre la douleur. 
Mot clés : Moelle épinière ; Corne Dorsale ; Neuropathique ; Douleur chronique ; Acétylcholine ; 
Seuils mécanique ; transmission synaptique 
 
Résumé en anglais 
An endogenous spinal cholinergic tone modulating nociceptive (pain­like) behaviors has been 
demonstrated in rodents and humans. One potential source of this acetylcholine is the spinal Dorsal 
Horn (DH) cholinergic interneurons. Our objectives were to: (1) characterize the spinal cholinergic 
tone establishing mechanical nociceptive thresholds and (2) to elucidate the role of DH cholinergic 
neurons in the modulation of sensory information of naïve and neuropathic animals. We have 
confirmed the presence of a cholinergic tone modulating mechanical thresholds and demonstrated 
that it is still present, although altered, after neuropathy. The DH cholinergic interneurons receive 
excitatory inputs from distant spinal segments and generally receive lower inhibitory inputs. In 
addition, they are indirectly connected by a subset of nociceptive primary afferents expressing 
TRPV1, demonstrating their involvement in nociceptive processing. In neuropathic spinal circuits, the 
inputs to LIII/IV neurons appears to be unaffected after injury. Better understanding the spinal 
cholinergic system can pave way to alternative pain therapy. 
Key words: Spinal cord; Dorsal Horn; Neuropathy; Chronic pain; Acetylcholine; Mechanical 
thresholds; synaptic transmission 
